Members of the Center for Outcomes Research in Liver Diseases have been tremendously active with hundreds of publications and presentations related to NAFLD, NASH, Patient Reported Outcomes (PROs), Health Related Quality of Life (HRQL), Economic Analysis, Meta-Analysis and other outcomes and health services research. The following is a list of pertinent publications and presentations.
Manuscripts
| Num | Title |
|---|---|
| 1 | Maria Stepanova, Khaled W. Kabbara, Denise Mohess, Manisha Verma, Roche-green Alva, Saleh Alqahtani, Janus P. Ong, Patrizia Burra, Zobair M Younossi. Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients, Hepatology. Hepatol Commun . 2022 Jul;6(7):1506-1515. doi: 10.1002/hep4.1915. Epub 2022 Feb 28.. |
| 2 | Zobair M Younossi, Janus P. Ong, Hirokazu Takahashi, Yusuf Yilmaz, Yuichiro Eguchi, Mohamed El Kassas, Maria Buti, Moises Diago, Ming-Hua Zheng, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Jun;20(6):e1456-e1468. doi: 10.1016/j.cgh.2021.06.048. Epub 2021 Jul 3.. |
| 3 | Zobair M Younossi, Maria Stepanova, Rebecca A Taub, Jordan Mark Barbone, Stephen A. Harrison. Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Jun;20(6):1354-1361.e7. doi: 10.1016/j.cgh.2021.07.039. Epub 2021 Jul 27.. |
| 4 | John Paul Verderese, Linda Henry, Zobair M Younossi. Reply to Bailly et al, Clinical Infectious Diseases. Clin Infect Dis . 2022 May 3;74(9):1707-1708. doi: 10.1093/cid/ciab870.. |
| 5 | James Minhui Paik, Khaled W. Kabbara, Katherine Elizabeth Eberly, Youssef Younossi, Linda Henry, Zobair M Younossi. Global burden of NAFLD and chronic liver disease among adolescents and young adults, Hepatology. Hepatology . 2022 May;75(5):1204-1217. doi: 10.1002/hep.32228. Epub 2021 Dec 21.. |
| 6 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Brian P. Lam, Fatema Nader, Henry A. Tran, Ingrid Schneider, Maria Stepanova. Serum Biomarkers are Associated with Atherosclerotic Cardiovascular Disease among Patients with Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 May;20(5):e1149-e1156. doi: 10.1016/j.cgh.2021.08.038. Epub 2021 Aug 28.. |
| 7 | Saleh Alqahtani, Maria Stepanova, Khaled W. Kabbara, Issah Younossi, Alita Mishra, Zobair M Younossi. Liver Transplant Center Size and the Impact on Clinical Outcomes and Resource Utilization, Transplantation. Transplantation . 2022 May 1;106(5):988-996. doi: 10.1097/TP.0000000000003915. Epub 2021 Aug 5.. |
| 8 | Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W Timothy Garvey, Sangeeta Kashyap, Jeffrey I. Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E. Rinella, Mariam Vos, Zobair M Younossi. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD), Endocrine Practice. Endocr Pract . 2022 May;28(5):528-562. doi: 10.1016/j.eprac.2022.03.010.. |
| 9 | Elizabeth Brunt, Andrew D. Clouston, Zachary Goodman, Cynthia Guy, David E. Kleiner, Carolin Lackner, Dina G. Tiniakos, Aileen Wee, Matthew Yeh, Wei Qiang Leow, Elaine Chng, Yayun Ren, Goerge Boon Bee Goh, Elizabeth E. Powell, Mary E. Rinella, Arun J. Sanyal, Brent A. Neuschwander-Tetri, Zobair M Younossi, Michael R. Charlton, Vlad Ratziu, Stephen A. Harrison, Dean Tai, Quentin Anstee. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD, Journal of Hepatology. J Hepatol . 2022 May;76(5):1030-1041. doi: 10.1016/j.jhep.2022.01.011. Epub 2022 Jan 25.. |
| 10 | Jeffrey V. Lazarus, Henry E. Mark, Marcela Villota-Rivas, Adam Palayew, Maria Patrizia Carrieri, Massimo Colombo, Mattias Ekstedt, Gamal Esmat, Jacob George, Giulio Marchesini, Marcelo Silva, C Wendy Spearman, Frank Tacke, Emmanuel A. Tsochatzis, Yusuf Yilmaz, Zobair M Younossi, Vincent Wai-Sun Wong, Shira Zelber-Sagi, Helena Cortez-Pinto, Quentin Anstee. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?, Journal of Hepatology. J Hepatol . 2022 Apr;76(4):771-780. doi: 10.1016/j.jhep.2021.10.025. Epub 2021 Dec 9.. |
| 11 | Joana Viera Barbosa, Scott Milligan, Andrew Frick, Jeremy Broestl, Zobair M Younossi, Nezam H. Afdhal, Michelle Lai. Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD, Hepatology Communications. Hepatol Commun . 2022 Apr;6(4):765-779. doi: 10.1002/hep4.1841. Epub 2021 Dec 30.. |
| 12 | Issah Younossi, Maria Stepanova, Mercedes Walters, Pegah Golabi, Manirath Srishord, Zobair M Younossi. Health-Related Quality of Life and Health Care Resource Utilization in Patients With Chronic Liver Disease and Primary Liver Cancer in the United States: Analysis of Medical Expenditure Panel Survey, Journal of Clinical and Experimental Hepatology. J Clin Exp Hepatol . 2022 Mar-Apr;12(2):272-277. doi: 10.1016/j.jceh.2021.12.012. Epub 2021 Dec 29.. |
| 13 | Ali Weinstein, Leyla de Avila, Saisruthi Kannan, James Minhui Paik, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Interrelationship between physical activity and depression in nonalcoholic fatty liver disease, World Journal of Hepatology. World J Hepatol . 2022 Mar 27;14(3):612-622. doi: 10.4254/wjh.v14.i3.612.. |
| 14 | Joana Viera Barbosa, Scott Milligan, Andrew Frick, Jeremy Broestl, Zobair M Younossi, Nezam H. Afdhal, Michelle Lai. Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease, American Journal of Gastroenterology. Am J Gastroenterol . 2022 Mar 1;117(3):453-461. doi: 10.14309/ajg.0000000000001606.. |
| 15 | Ashiq Mannan, Nick Sutingco, Svetolik Djurkovic, Mary Jane Reyes, Mehul Desai, Soleyah C. Groves, Ivan Garcia, Wali Azizi, Andrew Miner, Sam Elgawey, Gregory Trimble, Paul Weisbruch, Eric Osborn, Steven Dean, Maruf Haider, Madeline Erario, Patricia Horgas, Erin Hodson, Brian P. Lam, Jennifer Bautista, Andrei Racila, Andrej Kolacevski, Linda Henry, Steven Motew, Chapy Venkatesan, Ann Huston, Lynn Gerber, Stephen Jones, Zobair M Younossi. Service Line Care Delivery Model for COVID-19 Patient-Centric Care, American Journal of Managed Care. Am J Manag Care . 2022 Mar 1;28(3):e80-e87. doi: 10.37765/ajmc.2022.88731.. |
| 16 | Mary E. Rinella, Jean-Francois Dufour, Quentin Anstee, Zachary Goodman, Zobair M Younossi, Stephen A. Harrison, Rohit Loomba, Arun J. Sanyal, Martin Bonacci, Aldo Trylesinski, Macky Natha, Reshma Shringapure, Tanya Granston, Aditya Venugopal, Vlad Ratziu. Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study, Journal of Hepatology. J Hepatol . 2022 Mar;76(3):536-548. doi: 10.1016/j.jhep.2021.10.029. Epub 2021 Nov 15.. |
| 17 | Brian P. Lam, Maria Stepanova, Chapy Venkatesan, Ivan Garcia, Mary Jane Reyes, Ashiq Mannan, Soleyah C. Groves, Mehul Desai, Andrei Racila, Andrej Kolacevski, Linda Henry, Lynn Gerber, Zobair M Younossi. Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system, PLOS One. . |
| 18 | Zobair M Younossi, Andrei Racila, Andrew J. Muir, Marc Bourliere, Alessandra Mangia, Stefan Zeuzem, Massimo Colombo, Michael Manns, Georgios Papatheodoridis, Maria Buti, Anuj Gaggar, Fatema Nader, Issah Younossi, Linda Henry, Maria Stepanova. Long-Term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2022 Feb;20(2):438-446. doi: 10.1016/j.cgh.2021.01.026. Epub 2021 Jan 22.. |
| 19 | Zobair M Younossi, Linda Henry. Fatty Liver Through the Ages: Nonalcoholic Steatohepatitis, Endocrine Practice. Endocr Pract . 2022 Feb;28(2):204-213. doi: 10.1016/j.eprac.2021.12.010. Epub 2021 Dec 22.. |
| 20 | Pegah Golabi, James Minhui Paik, Katherine Elizabeth Eberly, Leyla de Avila, Saleh Alqahtani, Zobair M Younossi. Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C, Annals of Hepatology. Ann Hepatol . 2022 Jan-Feb;27(1):100556. doi: 10.1016/j.aohep.2021.100556. Epub 2021 Nov 18.. |
| 21 | James Minhui Paik, Seema Mir, Saleh Alqahtani, Youssef Younossi, Janus P. Ong, Zobair M Younossi. Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data, Hepatology Communications. Hepatol Commun . 2022 Jan;6(1):90-100. doi: 10.1002/hep4.1707. Epub 2021 Jul 8.. |
| 22 | Jeffrey V. Lazarus, Henry E. Mark, Quentin Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven Francques, Jacob George, Hannes Hagstrom, Terry T-K Huang, Mona H. Ismail, Achim Kautz, Shiv Sarin, Rohit Loomba, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary E. Rinella, Diana Romero, Manuel Romero-Gomez, Jorn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi. Advancing the global public health agenda for NAFLD: a consensus statement, Nature Reviews Gastroenterology & Hepatology. Nat Rev Gastroenterol Hepatol . 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.. |
| 23 | Pegah Golabi, James Minhui Paik, Saleh Alqahtani, Youssef Younossi, Gabriela Tuncer, Zobair M Younossi. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019, Journal of Hepatology. J Hepatol . 2021 May 31;S0168-8278(21)00358-5. doi: 10.1016/j.jhep.2021.05.022. Online ahead of print.. |
| 24 | John Paul Verderese, Linda Henry, Zobair M Younossi. Reply to Author: Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2- specific monoclonal antibodies, Clinical Infectious Diseases. . |
| 25 | Jeffrey V. Lazarus, Quentin Anstee, Hannes Hagstrom, Kenneth Cusi, Helena Cortez-Pinto, Henry E. Mark, Michael Roden, Emmanuel A. Tsochatzis, Vincent Wai-Sun Wong, Zobair M Younossi, Shira Zelber-Sagi, Manuel Romero-Gomez, Jorn M. Schattenberg. Defining comprehensive models of care for NAFLD, Nature Reviews Gastroenterology & Hepatology. Nat Rev Gastroenterol Hepatol . 2021 Oct;18(10):717-729. doi: 10.1038/s41575-021-00477-7. Epub 2021 Jun 25.. |
| 26 | Tamoore Arshad, James Minhui Paik, Rakesh Biswas, Saleh Alqahtani, Linda Henry, Zobair M Younossi. Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016, Hepatology Communications. Hepatol Commun . 2021 Jul 1. doi: 10.1002/hep4.1760. Online ahead of print.. |
| 27 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Huong T. Pham, Arian Afendy, Rebecca Cable, Andrei Racila, Zahra Younoszai, Brian P. Lam, Pegah Golabi. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease, Journal of American Medical Association Network Open. JAMA Netw Open . 2021 Sep 1;4(9):e2123923. doi: 10.1001/jamanetworkopen.2021.23923.. |
| 28 | Manisha Verma, James Minhui Paik, Issah Younossi, Daisong Tan, Hala Abdelaal, Zobair M Younossi. The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of life, Cancer Medicine. Cancer Med . 2021 Sep;10(18):6273-6281. doi: 10.1002/cam4.4166. Epub 2021 Aug 18.. |
| 29 | Fasiha Kanwal, Jay H. Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, H.B. El-Serag, Kenneth Cusi. Preparing for the NASH Epidemic: A Call to Action, Metabolism: Clinical & Experimental. Metabolism . 2021 Sep;122:154822. doi: 10.1016/j.metabol.2021.154822. Epub 2021 Jul 19.. |
| 30 | Fasiha Kanwal, Jay H. Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, H.B. El-Serag, Kenneth Cusi. Preparing for the NASH Epidemic: A Call to Action , Obesity Society. Obesity (Silver Spring) . 2021 Sep;29(9):1401-1412. doi: 10.1002/oby.23250. Epub 2021 Aug 8.. |
| 31 | Michael P. Curry, Steven L. Flamm, Scott Milligan, Naoky Tsai, Nicole Wick, Zobair M Younossi, Nezam H. Afdhal. Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study, Journal of Managed Care. J Manag Care Spec Pharm . 2021 Sep;27(9):1239-1248. doi: 10.18553/jmcp.2021.20550. Epub 2021 Jun 9.. |
| 32 | Fasiha Kanwal, Jay H. Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, H.B. El-Serag, Kenneth Cusi. Preparing for the NASH epidemic: A call to action, Diabetes Care. Diabetes Care . 2021 Sep;44(9):2162-2172. doi: 10.2337/dci21-0020. Epub 2021 Jul 26.. |
| 33 | Khaled W. Kabbara, Pegah Golabi, Zobair M Younossi. Nonalcoholic steatohepatitis: global impact and clinical consequences, Endocrine Connections. Gastroenterology . 2021 Sep;161(3):1030-1042.e8. doi: 10.1053/j.gastro.2021.04.074. Epub 2021 Jul 26.. |
| 34 | Saleh Alqahtani, Maria Stepanova, Khaled W. Kabbara, Issah Younossi, Alita Mishra, Zobair M Younossi. Liver Transplant Center Size and The Impact on the Clinical Outcomes and Resource Utilization, Transplantation. Transplantation . 2021 Aug 5. doi: 10.1097/TP.0000000000003915. Online ahead of print.. |
| 35 | Peter Jepsen, Zobair M Younossi. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs, Journal of Hepatology. J Hepatol . 2021 Jul;75 Suppl 1:S3-S13. doi: 10.1016/j.jhep.2020.11.042.. |
| 36 | John Paul Verderese, Maria Stepanova, Brian P. Lam, Andrei Racila, Andrej Kolacevski, David Allen, Erin Hodson, Bahareh Aslani-Amoli, Michael Homeyer, Sarah Stanmyre, Helen Stevens, Stephanie Garofalo, Linda Henry, Chapy Venkatesan, Lynn Gerber, Steven Motew, Stephen Jones, Zobair M Younossi. Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience., Clinical Infectious Diseases. Clin Infect Dis . 2021 Jun 24;ciab579. doi: 10.1093/cid/ciab579. Online ahead of print.. |
| 37 | Donghee Kim, Soumya Murag, George Cholankeril, Amanda Cheung, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Physical Activity, Measured Objectively, is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Jun;19(6):1240-1247.e5. doi: 10.1016/j.cgh.2020.07.023. Epub 2020 Jul 16.. |
| 38 | Maria Stepanova, Zobair M Younossi. Reply, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Jun;19(6):1299-1300. doi: 10.1016/j.cgh.2020.07.038. Epub 2020 Nov 26.. |
| 39 | Elizabeth Brunt, David E. Kleiner, Danielle H. Carpenter, Mary E. Rinella, Stephen A. Harrison, Rohit Loomba, Zobair M Younossi, Brent A. Neuschwander-Tetri, Arun J. Sanyal. NAFLD: Reporting Histologic Findings in Clinical Practice, Hepatology. Hepatology . 2021 May;73(5):2028-2038. doi: 10.1002/hep.31599.. |
| 40 | Saleh Alqahtani, Pegah Golabi, James Minhui Paik, Brian P. Lam, Amir Moazzez, Hazem Elariny, Zachary Goodman, Zobair M Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease, Obesity Surgery. Obes Surg . 2021 May;31(5):2002-2010. doi: 10.1007/s11695-020-04996-1. Epub 2021 Feb 22.. |
| 41 | Susana Borges Gonzalez, Maria Stepanova, Mirtha Infante Velazquez, Caridad Ruenes Domech, Sila Gonzalez Suero, Zaily Dorta Guridi, Enrique Rogelio Arus Soler, Andrei Racila, Zobair M Younossi. Health-related quality of life in Cuban patients with chronic liver disease: A real-world experience, Annals of Hepatology. Ann Hepatol . May-Jun 2021;22:100277. doi: 10.1016/j.aohep.2020.10.005. Epub 2020 Oct 29.. |
| 42 | Zobair M Younossi, Quentin Anstee, Vincent Wai-Sun Wong, Michael Trauner, Eric Lawitz, Stephen A. Harrison, Marianne Camargo, Kathryn Kersey, Mani Subramanian, Robert P. Myers, Maria Stepanova. The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis, Gastroenterology. Gastroenterology . 2021 Apr;160(5):1608-1619.e13. doi: 10.1053/j.gastro.2020.12.003. Epub 2020 Dec 8.. |
| 43 | Manisha Verma, Zobair M Younossi. Integrating Patient-Reported Outcomes Within Routine Hepatology Care: A Prompt to Action, Hepatology. Hepatology . 2021 Apr;73(4):1570-1580. doi: 10.1002/hep.31550. Epub 2021 Mar 16.. |
| 44 | James Minhui Paik, Youssef Younossi, Linda Henry, Alita Mishra, Zobair M Younossi. Recent Trends in the Global Burden of Hepatitis B Virus: 2007-2017, Gastroenterology. Gastroenterology . 2021 Apr;160(5):1845-1846.e3. doi: 10.1053/j.gastro.2020.11.057. Epub 2021 Jan 6.. |
| 45 | Sakura Yamamura, Dan Nakano, Ryuki Hashida, Tsubasa Tsutsumi, Takumi Kawaguchi, Michiaki Okada, Hiroshi Isoda, Hirokazu Takahashi, Hiroo Matsuse, Yuichiro Eguchi, Yoshio Sumida, Atushi Nakajima, Lynn Gerber, Zobair M Younossi, Takuji Torimura. Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, Journal of Gastroenterology and Hepatology. J Gastroenterol Hepatol . 2021 Mar;36(3):629-636. doi: 10.1111/jgh.15172. Epub 2020 Jul 16.. |
| 46 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Gregory Trimble, Saleh Alqahtani, Issah Younossi, Aijaz Ahmed, Andrei Racila, Linda Henry. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol . 2021 Mar;19(3):580-589.e5. doi: 10.1016/j.cgh.2020.05.064. Epub 2020 Jun 9.. |
| 47 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV, Journal of Viral Hepatitis. J Viral Hepat . 2021 Mar;28(3):484-492. doi: 10.1111/jvh.13451. Epub 2020 Dec 20.. |
| 48 | Zobair M Younossi, Mary E. Rinella, Arun J. Sanyal, Stephen A. Harrison, Elizabeth Brunt, Zachary Goodman, David E. Cohen, Rohit Loomba. From NAFLD to MAFLD: Implications of a premature change in terminology, Hepatology. Hepatology . 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6.. |
| 49 | Chapy Venkatesan, Michelle Vassallo, Melanie Massiah-White, Anne Brittain, Jonathan Puhl, Toni Ardabell, Maureen Sintich, Zobair M Younossi, Steven Motew. Rapid Operationalization of a Large-Scale Covid-19 Vaccination Program in an Integrated Community Health System, NEJM Catalyst Innovations in Care Delivery. . |
| 50 | Zobair M Younossi, Kathleen E. Corey, Joseph K Lim. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review, Gastroenterology. Gastroenterology . 2021 Feb;160(3):912-918. doi: 10.1053/j.gastro.2020.11.051. Epub 2020 Dec 9.. |
| 51 | Zobair M Younossi, Mazen Noureddin, David Bernstein, Paul Y. Kwo, Mark Russo, Mitchell L. Shiffman, Ziad Younes, Manal F. Abdelmalek. Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations, American Journal of Gastroenterology. Am J Gastroenterol . 2021 Feb 1;116(2):254-262. doi: 10.14309/ajg.0000000000001054.. |
| 52 | Victor de Avila, James Minhui Paik, Leyla de Avila, Linda Henry, Denise Mohess, Roche-green Alva, Zobair M Younossi. Hospice care utilisation among elderly patients who died with hepatocellular carcinoma in the United States, JHEP Reports. JHEP Rep . 2021 Jan 27;3(2):100236. doi: 10.1016/j.jhepr.2021.100236. eCollection 2021 Apr.. |
| 53 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M Younossi. The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017, Hepatology Communications. Hepatol Commun . 2021 Jan 14;5(5):749-759. doi: 10.1002/hep4.1673. eCollection 2021 May.. |
| 54 | Azza Karrar, Bijal Rajput, Siddharth Hariharan, Dinan Abdelatif, Mohamad Houry, Ali Moosvi, Irfan Ali, Daisong Tan, Sohailla Noor, Zahra Younoszai, Donna Esmaeili, Sean C. Felix, Lakshmi Alaparthi, Munkhzul Otgonsuren, Brian P. Lam, Zachary Goodman, Zobair M Younossi. Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease, Hepatology Communications. Hepatol Commun . 2020 Sep 30;5(1):63-73. doi: 10.1002/hep4.1610. eCollection 2021 Jan.. |
| 55 | Zobair M Younossi. The case for simplifying and using absolute targets for viral hepatitis elimination goals, Journal of Viral Hepatitis. J Viral Hepat . 2021 Jan;28(1):12-19. doi: 10.1111/jvh.13412. Epub 2020 Nov 4.. |
| 56 | Vlad Ratziu, Mary E. Rinella, Ulrich Beuers, Rohit Loomba, Quentin Anstee, Stephen A. Harrison, Sven Francques, Arun J. Sanyal, Philip N Newsome, Zobair M Younossi. The times they are a-changin' (for NAFLD as well), Journal of Hepatology. J Hepatol . 2020 Dec;73(6):1307-1309. doi: 10.1016/j.jhep.2020.08.028. Epub 2020 Sep 2.. |
| 57 | Zobair M Younossi, Linda Henry. Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening. Authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Dec;52(11-12):1761. doi: 10.1111/apt.16091.. |
| 58 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Alita Mishra, Zobair M Younossi. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD, Hepatology. Hepatology . 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.. |
| 59 | Donghee Kim, Peter Konyn, George Cholankeril, Robert John Wong, Zobair M Younossi, Aijaz Ahmed. Decline in Annual Mortality of Hepatitis C Virus-related Hepatocellular Carcinoma in the United States, From 2009 to 2018, Gastroenterology. Gastroenterology. 2020 Oct;159(4):1558-1560.e2. doi: 10.1053/j.gastro.2020.05.007. Epub 2020 May 8.. |
| 60 | Jillian Kallman Price, Carey Escheik, Ali Weinstein, Patrice Winter, Lynn Gerber, Zobair M Younossi. Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease, The Journal of Clinical Hypertension. J Clin Hypertens (Greenwich) . 2020 Oct;22(10):1915-1923. doi: 10.1111/jch.13938. Epub 2020 Sep 17.. |
| 61 | Radhika Tampi, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Sally Shu, Henry Lik-Yuen Chan, James Fung, Maria Stepanova, Zobair M Younossi. Modelling the Economic and Clinical Burden of Non-Alcoholic Steatohepatitis in East Asia: Data from Hong Kong, Hepatology Research. Hepatol Res . 2020 Jun 14. doi: 10.1111/hepr.13535. Online ahead of print.. |
| 62 | James Minhui Paik, Pegah Golabi, Youssef Younossi, Manirath Srishord, Alita Mishra, Zobair M Younossi. The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017, Hepatology Communications. Hepatol Commun . 2020 Sep 14;4(12):1769-1780. doi: 10.1002/hep4.1599. eCollection 2020 Dec.. |
| 63 | Vlad Ratziu, Zobair M Younossi, Jason Campagna, Leigh MacConell, Arun J. Sanyal. Clinical endpoints are necessary in the interim analysis of REGENERATE - Authors' reply, Lancet. Lancet . 2020 Sep 5;396(10252):663-664. doi: 10.1016/S0140-6736(20)30807-2.. |
| 64 | Donghee Kim, Luis Miguel Vazquez-Montesino, Jessica A Escober, Christopher T Fernandes, George Cholankeril, Rohit Loomba, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality, American Journal of Gastroenterology. Am J Gastroenterol . 2020 Sep;115(9):1496-1504. doi: 10.14309/ajg.0000000000000654.. |
| 65 | Pegah Golabi, James Minhui Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M Younossi. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities, Hepatology Communications. Hepatol Commun . 2020 May 19;4(8):1136-1148. doi: 10.1002/hep4.1534. eCollection 2020 Aug.. |
| 66 | Zobair M Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira M. Jacobson, Brian P. Lam, Stephen C. Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhran, Puneet Puri, Mary E. Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry. Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Aug;52(3):513-526. doi: 10.1111/apt.15830. Epub 2020 Jun 29.. |
| 67 | Zobair M Younossi, Vincent Wai-Sun Wong, Quentin Anstee, Manuel Romero-Gomez, Michael Trauner, Stephen A. Harrison, Eric Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P. Myers, Zachary Goodman, Maria Stepanova. Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes, Hepatology Communications. Hepatol Commun . 2020 Aug 28;4(11):1637-1650. doi: 10.1002/hep4.1581. eCollection 2020 Nov.. |
| 68 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Arian Afendy, Eric Lawitz, Christian Schwabe, Peter Ruane, Jay Lalezari, K. Rajender Reddy, Ira M. Jacobson, Andrew J. Muir, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2020 Feb;18(2):468-476.e11. doi: 10.1016/j.cgh.2019.07.047. Epub 2019 Jul 31.. |
| 69 | Zobair M Younossi, Linda Henry. Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD-Authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Aug;52(4):712. doi: 10.1111/apt.15929.. |
| 70 | Faisal M. Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle East, World Journal of Gastroenterology. World J Gastroenterol . 2020 Jul 7;26(25):3528-3541. doi: 10.3748/wjg.v26.i25.3528.. |
| 71 | Stephen A. Harrison, Vincent Wai-Sun Wong, Takeshi Okanoue, Raj Vuppalanchi, Ziad Younes, Anita Kohli, Shiv Sarin, Caldwell. Stephen H. , Naim Alkhouri, Mitchell L. Shiffman, Marianne Camargo, Georgia Li, Kathryn Kersey, Catherine Jia, Yanni Zhu, CS Djedjos, GM Subramanian, Robert P. Myers, Nadege T Gunn, Aasim M. Sheikh, Quentin Anstee, Manuel Romero-Gomez, Michael Trauner, Zachary Goodman, Eric Lawitz, Zobair M Younossi. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials, Journal of Hepatology. J Hepatol . 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6.. |
| 72 | Mehmet Sayiner, Tamoore Arshad, Pegah Golabi, James Minhui Paik, F Farhat, Zobair M Younossi. Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the Medicare population., Hepatology International. Hepatol Int . 2020 Jul;14(4):556-566. doi: 10.1007/s12072-020-10038-w. Epub 2020 Apr 16.. |
| 73 | Rod S. Taylor, Rebecca J. Taylor, Sue Bayliss, Hannes Hagstrom, Patrik Nasr, Jorn M. Schattenberg, Masatoshi Ishigami, Hidenori Toyoda, Vincent Wai-Sun Wong, Noam Peleg, Amir Shlomai, Giada Sebastiani, Yuya Seko, Neeraj Bhala, Zobair M Younossi, Quentin Anstee, Stuart McPherson, Philip N Newsome. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis, Gastroenterology. Gastroenterology . 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4.. |
| 74 | Danubia Hester, Pegah Golabi, James Minhui Paik, Issah Younossi, Alita Mishra, Zobair M Younossi. Among Medicare Patients with Hepatocellular Carcinoma, Non-alcoholic Fatty Liver Disease Is the Most Common Etiology and Cause of Mortality, Journal of Clinical Gastroenterology. J Clin Gastroenterol . May/Jun 2020;54(5):459-467. doi: 10.1097/MCG.0000000000001172.. |
| 75 | M Eslam, Arun J. Sanyal, Jacob George, Zobair M Younossi. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease, Gastroenterology. Gastroenterology . 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.. |
| 76 | Maria Stepanova, Saleh Alqahtani, Alita Mishra, Issah Younossi, Chapy Venkatesan, Zobair M Younossi. Outcomes of liver transplantation by insurance types in the United States., American Journal of Managed Care. Am J Manag Care . 2020 Apr 1;26(4):e121-e126. doi: 10.37765/ajmc.2020.42839.. |
| 77 | Tamoore Arshad, Pegah Golabi, Linda Henry, Zobair M Younossi. Epidemiology of Non-alcoholic Fatty Liver Disease in North America, Current Pharmaceutical Design. Curr Pharm Des . 2020;26(10):993-997. doi: 10.2174/1381612826666200303114934.. |
| 78 | Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, Victor Vargas, Macarena Simon-Talero, Juan Cordoba, Paolo Angeli, Silvia Rosi, Stewart MacDonald, Massimo Malago, Maria Stepanova, Zobair M Younossi, Claudia Trepte, Randall Watson, Oleg Borisenko, Sun Sun, Neil Inhaber, Rajiv Jalan. Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949], Journal of Hepatology. J Hepatol. 2020 Mar;72(3):595-596. doi: 10.1016/j.jhep.2019.11.023. Epub 2020 Jan 9.. |
| 79 | Zobair M Younossi, Maria Stepanova, Youssef Younossi, Pegah Golabi, Alita Mishra, Nila Rafiq, Linda Henry. Epidemiology of chronic liver diseases in the USA in the past three decades., GUT. Gut . 2020 Mar;69(3):564-568. doi: 10.1136/gutjnl-2019-318813. Epub 2019 Jul 31.. |
| 80 | Anders H. Nyberg, Ekaterina Sadikova, T. Craig Cheetham, Kevin M. Chiang, Jiaxiao M. Shi, Susan Caparosa, Zobair M Younossi, Lisa M. Nyberg. Increased cancer rates in patients with chronic hepatitis C, Liver International. Liver Int . 2020 Mar;40(3):685-693. doi: 10.1111/liv.14305. Epub 2019 Dec 22.. |
| 81 | Donghee Kim, W.R. Kim, SK Joo, J Han, JH Kim, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Association Between Body Size-Metabolic Phenotype and Nonalcoholic Steatohepatitis and Significant Fibrosis, Journal of Gastroenterology. J Gastroenterol . 2020 Mar;55(3):330-341. doi: 10.1007/s00535-019-01628-z. Epub 2019 Sep 18.. |
| 82 | Angelos Hatzakis, Jeffrey V. Lazarus, Evangelos Cholongitas, Ricardo Bapista-Leite, Charles Boucher, Cristian-Silviu Busoi, Sylvie Deuffic-Burban, Jagpreet Chhatwal, Gamal Esmat, Sharon Hutchinson, Minerva-Melpomeni Malliori, Mojca Maticic, Antons Mozalevskis, Francesco Negro, George A Papandreou, Georgios Papatheodoridis, Markus Peck-Radosavljevic, Homie Razavi, Tatjana Reic, Eberhard Schatz, Nurdan Tozun, Zobair M Younossi, Michael Manns. Securing sustainable funding for viral hepatitis elimination plans, Liver International. Liver Int . 2020 Feb;40(2):260-270. doi: 10.1111/liv.14282. Epub 2019 Dec 5.. |
| 83 | Zobair M Younossi, Radhika Tampi, Andrei Racila, Ying Qiu, Leah Burns, Issah Younossi, Fatema Nader. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S, Diabetes Care. Diabetes Care . 2020 Feb;43(2):283-289. doi: 10.2337/dc19-1113. Epub 2019 Oct 28.. |
| 84 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes., Liver International. Liver Int . 2020 Feb;40(2):308-318. doi: 10.1111/liv.14292. Epub 2019 Nov 25.. |
| 85 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Ziad Younes, Robert Herring, Eric Lawitz, Issah Younossi, Andrei Racila. Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes, Clinical Infectious Diseases. Clin Infect Dis. 2020 Feb 3;70(4):628-632. doi: 10.1093/cid/ciz243.. |
| 86 | Quentin Anstee, Brent A. Neuschwander-Tetri, Vincent Wai-Sun Wong, Manal F. Abdelmalek, Zobair M Younossi, Jiacheng Yuan, Maria, Lucia Pecoraro, Star Seyedkazemi, Laurent Fischer, Pierre Bedossa, Zachary Goodman, Naim Alkhouri, Frank Tacke, Arun J. Sanyal. Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design, Contemporary Clinical Trials. Contemp Clin Trials . 2020 Feb;89:105922. doi: 10.1016/j.cct.2019.105922. Epub 2019 Dec 24.. |
| 87 | Mehmet Sayiner, Maria Stepanova, Leyla de Avila, Pegah Golabi, Andrei Racila, Zobair M Younossi. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients, Digestive Diseases And Sciences. Dig Dis Sci. 2020 Feb;65(2):416-422. doi: 10.1007/s10620-019-05786-1. Epub 2019 Aug 27.. |
| 88 | James Minhui Paik, Linda Henry, Pegah Golabi, Saleh Alqahtani, Gregory Trimble, Zobair M Younossi. Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006-2016, Open Journal Infectious Diseases. Open Forum Infect Dis . 2020 Jan 7;7(1):ofz509. doi: 10.1093/ofid/ofz509. eCollection 2020 Jan.. |
| 89 | Zobair M Younossi, Linda Henry. Are Noninvasive Scoring Systems for Persons With Chronic Liver Disease Ready for Prime Time?, Gastroenterology. Gastroenterology. 2020 Jan;158(1):40-42. doi: 10.1053/j.gastro.2019.11.024. Epub 2019 Nov 16.. |
| 90 | James Minhui Paik, Rati Deshpande, Pegah Golabi, Issah Younossi, Linda Henry, Zobair M Younossi. The Impact of Modifiable Risk Factors on the Long-term Outcomes of Non-alcoholic Fatty Liver Disease, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther . 2020 Jan;51(2):291-304. doi: 10.1111/apt.15580. Epub 2019 Nov 29.. |
| 91 | Zobair M Younossi, Vlad Ratziu, Rohit Loomba, Mary E. Rinella, Quentin Anstee, Zachary Goodman, Pierre Bedossa, Andreas Geier, Susanne Beckebaum, Philip N Newsome, David A. Sheridan, Muhammad Y. Sheikh, James F. Trotter, Whitfield Knapple, Eric Lawitz, Manal F. Abdelmalek, Kris V. Kowdley, Aldo J Montano-Loza, Jerome Boursier, Philippe Mathurin, Elisabetta Bugianesi, Giuseppe Mazzella, Antonio Olveria, Helena Cortez-Pinto, Isabela Graupera, David Orr, Lise L. Gluud, Jean-Francois Dufour, David Shapiro, Jason Campagna, Luna Zaru, Leigh MacConell, Reshma Shringapure, Stephen A. Harrison, Arun J. Sanyal. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, Lancet. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.. |
| 92 | Adrian Newland, Roy Bentley, Anna Jakubowska, Howard Liebman, Joanna Lorens, Markus Peck-Radosavljevic, Vanessa Taieb, Akiyoshi Takami, Ryosuke Tateishi, Zobair M Younossi. A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia., Hematological Oncology. Hematology. 2019 Dec;24(1):679-719. doi: 10.1080/16078454.2019.1662200.. |
| 93 | Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Caldwell. Stephen H. , Mitchell L. Shiffman, Raul Aguilar Schall, Catherine Jia, Bryan McColgan, Stephen Djedjos, John McHutchison, Mani Subramanian, Robert P. Myers, Zobair M Younossi, Andrew J. Muir, Nezam H. Afdhal, Jaime Bosch, Zachary Goodman. The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials., Hepatology. Hepatology. 2019 Dec;70(6):1913-1927. doi: 10.1002/hep.30664. Epub 2019 May 28.. |
| 94 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical Treatment of Patients with Nonalcoholic Steatohepatitis: Potential Impact on Important Clinical Outcomes, Liver International. . |
| 95 | Zobair M Younossi, Radhika Tampi, Fatema Nader, Issah Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical Treatment of Patients with Advanced Non-Alcoholic Steatohepatitis: Impact on Important Clinical Outcomes, Liver International. Liver Int. 2019 Nov 9. doi: 10.1111/liv.14292. [Epub ahead of print]. |
| 96 | Pegah Golabi, Logan Rhea, Linda Henry, Zobair M Younossi. Hepatocellular carcinoma and non-alcoholic fatty liver disease., Hepatology International. Hepatol Int. 2019 Nov;13(6):688-694. doi: 10.1007/s12072-019-09995-8. Epub 2019 Nov 7.. |
| 97 | Zobair M Younossi, Linda Henry. The Impact of Obesity and Type 2 Diabetes on Chronic Liver Disease, American Journal of Gastroenterology. Am J Gastroenterol. 2019 Nov;114(11):1714-1715. doi: 10.14309/ajg.0000000000000433.. |
| 98 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Kathryn Kersey, Georgia Li, Mani Subramanian, Robert P. Myers, Stephen Djedjos, Takeshi Okanoue, Michael Trauner, Zachary Goodman, Stephen A. Harrison. Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Nov;17(12):2552-2560.e10. doi: 10.1016/j.cgh.2019.02.024. Epub 2019 Feb 16.. |
| 99 | Zobair M Younossi, Radhika Tampi, Andrei Racila, Ying Qiu, Leah Burns, Issah Younossi, Fatema Nader. Economic and Clinical Burden of Non-alcoholic Steatohepatitis (NASH) in Patients with Type 2 Diabetes Mellitus (T2DM) in the United States, Journal of Hepatology. J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4.. |
| 100 | Quentin Anstee, Eric Lawitz, Naim Alkhouri, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Kathryn Kersey, Georgia Li, Ling Han, Catherine Jia, Lulu Wang, Chen Guang, Mani Subramanian, Robert P. Myers, CS Djedjos, Anita Kohli, Natalie Bzowej, Ziad Younes, Shiv Sarin, Mitchell L. Shiffman, Stephen A. Harrison, Nezam H. Afdhal, Zachary Goodman, Zobair M Younossi. Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials., Hepatology. Hepatology. 2019 Nov;70(5):1521-1530. doi: 10.1002/hep.30842. Epub 2019 Aug 19.. |
| 101 | Ali Weinstein, James M. Estep, Leyla de Avila, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study, Journal of Neuroimmunology. Send to J Neuroimmunol. 2019 Oct 15;335:577022. doi: 10.1016/j.jneuroim.2019.577022. Epub 2019 Aug 14.. |
| 102 | Ali Weinstein, James M. Estep, Leyla de Avila, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Relationship Among Neurotransmitters, Cytokines and Cognitive Performance for Individuals with Hepatitis C Achieving Sustained Virologic Response: A Pilot Study, Journal of Neuroimmunology. J Neuroimmunol. 2019 Oct 15;335:577022. doi: 10.1016/j.jneuroim.2019.577022. Epub 2019 Aug 14.. |
| 103 | Zobair M Younossi, Maria Stepanova, Pegah Golabi, Robert S. Epstein, Marcie Strauss, Fatema Nader, Andrei Racila. Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Oct;53(9):693-698. doi: 10.1097/MCG.0000000000001120.. |
| 104 | Leyla de Avila, Ali Weinstein, James M. Estep, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C., Liver International. Liver Int. 2019 Sep;39(9):1631-1640. doi: 10.1111/liv.14115. Epub 2019 May 3.. |
| 105 | Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis, Journal of Hepatology. J Hepatol. 2019 Oct;71(4):793-801. doi: 10.1016/j.jhep.2019.06.021. Epub 2019 Jul 4.. |
| 106 | Min Kim, James Minhui Paik, Pegah Golabi, Thomas Jeffers, Alita Mishra, Zobair M Younossi. Resource Utilization and Outcomes of Medicare Recipients With Chronic Hepatitis B in the United States., Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Sep;53(8):e341-e347. doi: 10.1097/MCG.0000000000001110.. |
| 107 | Vlad Ratziu, Arun J. Sanyal, Rohit Loomba, Mary E. Rinella, Stephen A. Harrison, Quentin Anstee, Zachary Goodman, Pierre Bedossa, Leigh MacConell, Reshma Shringarpure, Amrik Shah, Zobair M Younossi. REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis, Contemporary Clinical Trials. Send to Contemp Clin Trials. 2019 Sep;84:105803. doi: 10.1016/j.cct.2019.06.017. Epub 2019 Jun 29.. |
| 108 | Donghee Kim, George Cholankeril, Andrew A. Li, Won Kim, Sean P. Tighe, Bilal Hameed, Paul Y. Kwo, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014, Liver International. Send to Liver Int. 2019 Sep;39(9):1661-1671. doi: 10.1111/liv.14135. Epub 2019 Jun 4.. |
| 109 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, K. Rajender Reddy, Robert John Wong, Alessandra Mangia, Andrew J. Muir, Ira M. Jacobson, CS Djedjos, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader, Andrei Racila. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life, American Journal of Gastroenterology. . |
| 110 | James Minhui Paik, Linda Henry, Leyla de Avila, Elena Younossi, Andrei Racila, Zobair M Younossi. Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States, Hepatology Communications. Hepatol Commun. 2019 Aug 14;3(11):1459-1471. doi: 10.1002/hep4.1419. eCollection 2019 Nov.. |
| 111 | Azza Karrar, Siddharth Hariharan, Yousef Fazel, Ali Moosvi, Mohamad Houry, Zahra Younoszai, Thomas Jeffers, Li Zheng, Munkhzul Otgonsuren, Sharon Hunt, Fanny Monge, Zachary Goodman, Zobair M Younossi. Analysis of Human Leukocyte Antigen (HLA) Allele Polymorphism in Patients with Non Alcoholic Fatty Liver Disease, Medicine. Medicine (Baltimore). 2019 Aug;98(32):e16704. doi: 10.1097/MD.0000000000016704.. |
| 112 | Tamoore Arshad, Linda Henry, Zobair M Younossi. Validation of the chronic liver disease questionnaire for non-alcoholic steatohepatitis in patients: impact for the clinic, Expert Review of Gastroenterology Hepatology. Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):709-710. doi: 10.1080/17474124.2019.1636646. Epub 2019 Jun 28.. |
| 113 | Patrick Austin, Lynn Gerber, James Minhui Paik, Jillian Kallman Price, Carey Escheik, Zobair M Younossi. Aerobic Capacity and Exercise Performance in Nonalcoholic Fatty Liver Disease, The Journal of Sports Medicine and Physical Fitness. J Sports Med Phys Fitness. 2019 Aug;59(8):1376-1388. doi: 10.23736/S0022-4707.19.09231-4. Epub 2019 Feb 12.. |
| 114 | Patrick Austin, Lynn Gerber, James Minhui Paik, Jillian Kallman Price, Carey Escheik, Zobair M Younossi. Exercise Responsiveness in Non-alcoholic Fatty Liver Disease (NAFLD), The Journal of Sports Medicine and Physical Fitness. J Sports Med Phys Fitness. 2019 Aug;59(8):1376-1388. doi: 10.23736/S0022-4707.19.09231-4. Epub 2019 Feb 12.. |
| 115 | Lynn Gerber, Ali Weinstein, Rohini Mehta, Zobair M Younossi. Importance of fatigue and its measurement in chronic liver disease, World Journal of Gastroenterology. World J Gastroenterol. 2019 Jul 28;25(28):3669-3683. doi: 10.3748/wjg.v25.i28.3669.. |
| 116 | Rati Deshpande, Maria Stepanova, Pegah Golabi, Kimberly Brown, Zobair M Younossi. Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units., Journal of Viral Hepatitis. J Viral Hepat. 2019 Nov;26(11):1293-1300. doi: 10.1111/jvh.13173. Epub 2019 Aug 2.. |
| 117 | Azza Karrar, Siddharth Hariharan, Yousef Fazel, Ali Moosvi, Mohamad Houry, Zahra Younoszai, Thomas Jeffers, Li Zheng, Munkhzul Otgonsuren, Sharon Hunt, Fanny Monge, Zachary Goodman, Zobair M Younossi. Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease, Medicine. . |
| 118 | Naoky Tsai, Bruce R. Bacon, Michael P. Curry, Steven L. Flamm, Scott Milligan, Nicole Wick, Zobair M Younossi, Nezam H. Afdhal. Changing demographics among populations prescribed HCV treatment, 2013-2017., American Journal of Managed Care. Am J Manag Care. 2019 Jul;25(7):319-323.. |
| 119 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Yusuf Yilmaz, Ajay Duseja, Yuichiro Eguchi, Mohamed El Kassas, Marlen Castellanos-Fernandez, Jacob George, Ira M. Jacobson, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Marco Arrese, Victor de Ledinghen, Manuel Romero-Gomez, Nahum Mendez-Sanchez, Aijaz Ahmed, Robert John Wong, Georgios Papatheodoridis, Lawrence Serfaty, Issah Younossi, Mariam Ziayee, H. Afendy. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease., Clinical Gastroenterology And Hepatology. . |
| 120 | Pegah Golabi, Natsu Fukui, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Zobair M Younossi. Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients with Nonalcoholic Fatty Liver Disease, Hepatology Communications. Hepatol Commun. 2019 Jun 6;3(8):1050-1060. doi: 10.1002/hep4.1387. eCollection 2019 Aug.. |
| 121 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Georgios Papatheodoridis, Harry Janssen, Kosh Agarwal, Mindie H. Nguyen, Edward J. Gane, Naoky Tsai, Fatema Nader. Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication., Liver International. Liver Int. 2019 Oct;39(10):1837-1844. doi: 10.1111/liv.14171. Epub 2019 Jul 2.. |
| 122 | Zobair M Younossi. Emerging Research on MGL-3196 for the Treatment of Nonalcoholic Steatohepatitis., Journal of Gastroenterology and Hepatology. Gastroenterol Hepatol (N Y). 2019 Jun;15(6):317-319.. |
| 123 | Zobair M Younossi, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Yusuf Yilmaz, Jacob George, Jian-Gao Fan, Mariam Vos. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Hepatology. Hepatology . 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251.. |
| 124 | Zobair M Younossi, Pegah Golabi, Linda Henry. A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases., Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 May/Jun;53(5):331-341. doi: 10.1097/MCG.0000000000001179.. |
| 125 | Pegah Golabi, James Minhui Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M Younossi. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States., BMC Gastroenterology. BMC Gastroenterol. 2019 Apr 16;19(1):56. doi: 10.1186/s12876-019-0972-6.. |
| 126 | Leyla de Avila, Ali Weinstein, James M. Estep, Michael P. Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Cytokine Balance is Restored as Patient Reported Outcomes (PROs) Improve in Patients Recovering from Chronic Hepatitis C (CHC), Liver International. Liver Int. 2019 Sep;39(9):1631-1640. doi: 10.1111/liv.14115. Epub 2019 May 3.. |
| 127 | Haley Bush, Nila Rafiq, Zobair M Younossi. Implementation of Value-based Medicine (VBM) to Patients with Chronic Hepatitis C (HCV) Infection, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Apr;53(4):262-268. doi: 10.1097/MCG.0000000000001174.. |
| 128 | Mehmet Sayiner, Pegah Golabi, Zobair M Younossi. Disease Burden of Hepatocellular Carcinoma: A Global Perspective, Digestive Diseases And Sciences. Dig Dis Sci . 2019 Apr;64(4):910-917. doi: 10.1007/s10620-019-05537-2.. |
| 129 | Pegah Golabi, James Minhui Paik, Jessica P. Hwang, Su H. Wang, Hannah Lee, Zobair M Younossi. Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States, Liver International. Liver Int. 2019 Apr;39(4):748-757. doi: 10.1111/liv.14038. Epub 2019 Feb 13.. |
| 130 | Donghee Kim, Andrew A. Li, Brandon J. Perumpail, Chiranjeevi Gadiparthi, Won Kim, George Cholankeril, Jeffrey S. Glenn, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States, Hepatology. Hepatology. 2019 Mar;69(3):1064-1074. doi: 10.1002/hep.30161. Epub 2019 Feb 11.. |
| 131 | Zobair M Younossi. Non-alcoholic fatty liver disease - A global public health perspective, Journal of Hepatology. J Hepatol . 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9.. |
| 132 | Donghee Kim, Won Kim, Adeyinka Adejumo, George Cholankeril, Sean P. Tighe, Robert John Wong, Stevan Gonzalez, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016, Hepatology International. Hepatol Int. 2019 Mar;13(2):205-213. doi: 10.1007/s12072-018-09926-z. Epub 2019 Jan 29.. |
| 133 | Zobair M Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro, Eguchi, Masashi Mizokami, Young-Suk Lim, Yock-Young Lim, Ming-Lung Yu, Maria Stepanova. Systematic Review with Meta-Analysis: The Extrahepatic Manifestations in Chronic Hepatitis C Virus-Infected Patients in East Asia, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2019 Mar;49(6):644-653. doi: 10.1111/apt.15131. Epub 2019 Feb 13.. |
| 134 | Zobair M Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro, Eguchi, Masashi Mizokami, Young-Suk Lim, Yock Young Dan, Ming-Lung Yu, Maria Stepanova. Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2019 Mar;49(6):644-653. doi: 10.1111/apt.15131. Epub 2019 Feb 13.. |
| 135 | James M. Estep, Rohini Mehta, Gary Bratthauer, Lakshmi Alaparthi, Fanny Monge, Irfan Ali, Dinan Abdelatif, Zahra Younoszai, Maria Stepanova, Zachary Goodman, Zobair M Younossi. Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis., BMC Gastroenterology. BMC Gastroenterol. 2019 Feb 11;19(1):27. doi: 10.1186/s12876-019-0951-y.. |
| 136 | Haley Bush, James Minhui Paik, Pegah Golabi, Leyla de Avila, Carey Escheik, Zobair M Younossi. Impact of hepatitis C virus and insurance coverage on mortality., American Journal of Managed Care. Am J Manag Care. 2019 Feb;25(2):61-67.. |
| 137 | Zobair M Younossi, Radhika Tampi, Masoom Priyadarshini, Fatema Nader, Issah Younossi, Andrei Racila. Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States, Hepatology. Hepatology. 2019 Feb;69(2):564-572. doi: 10.1002/hep.30254. Epub 2019 Jan 8.. |
| 138 | Omer Shahab, Mehmet Sayiner, James Minhui Paik, Sean C. Felix, Pegah Golabi, Zobair M Younossi. Burden of Primary Biliary Cholangitis among Inpatient Population in the United States, Hepatology Communications. Hepatol Commun. 2019 Jan 28;3(3):356-364. doi: 10.1002/hep4.1314. eCollection 2019 Mar.. |
| 139 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2093-2100.e3. doi: 10.1016/j.cgh.2019.01.001. Epub 2019 Jan 11.. |
| 140 | Mehmet Sayiner, Zobair M Younossi. Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide, Liver Transplantation. Liver Transpl. 2019 Jan;25(1):10-11. doi: 10.1002/lt.25387.. |
| 141 | Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Nila Rafiq, Chapy Venkatesan, Zobair M Younossi. Non-alcoholic Fatty Liver Is Contributing to the Increase in Cases of Liver Disease in U.S. Emergency Departments, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2019 Jan;53(1):58-64. doi: 10.1097/MCG.0000000000001026.. |
| 142 | Zobair M Younossi, Maria Stepanova, K. Rajender Reddy, Michael Manns, Marc Bourliere, Stuart C. Gordon, Eugene R. Schiff, Tram T. Tran, Issah Younossi, Andrei Racila. Viral Eradication is Required for Sustained Improvement of Patient-Reported Outcomes in Patients with Hepatitis C, Liver International. Liver Int. 2019 Jan;39(1):54-59. doi: 10.1111/liv.13900. Epub 2018 Jul 15. |
| 143 | Zobair M Younossi, Giulio Marchesini, Helena Cortez-Pinto, Salvatore Petta. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation., Transplantation. Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484.. |
| 144 | Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Nila Rafiq, Chapy Venkatesan, Zobair M Younossi. Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments, Journal of Clinical Gastroenterology. . |
| 145 | Zobair M Younossi, David Bernstein, Mitchell L. Shiffman, Paul Y. Kwo, W.R. Kim, Kris V. Kowdley, Ira M. Jacobson. Diagnosis and Management of Primary Biliary Cholangitis, American Journal of Gastroenterology. Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3.. |
| 146 | Uchenna Agbim, Yu Jiang, Satish K. Kedia, Ashwani K. Singal, Aijaz Ahmed, Kalyan Ram Bhamidimarri, David Bernstein, Stephen A. Harrison, Zobair M Younossi, Sanjaya Satapathy. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis, Liver International. Liver Transpl. 2019 Jan;25(1):68-78. doi: 10.1002/lt.25322.. |
| 147 | Pegah Golabi, James Minhui Paik, Natsu Fukui, Cameron T. Locklear, Leyla de Avila, Zobair M Younossi. Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality., Clinical Diabetes. Clin Diabetes. 2019 Jan;37(1):65-72. doi: 10.2337/cd18-0026.. |
| 148 | Pegah Golabi, James Minhui Paik, Jessica P. Hwang, Su H. Wang, Hannah Lee, Zobair M Younossi. Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States, Liver International. . |
| 149 | Tamoore Arshad, Pegah Golabi, James Minhui Paik, Alita Mishra, Zobair M Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population., Hepatology Communications. Hepatol Commun. 2018 Nov 27;3(1):74-83. doi: 10.1002/hep4.1285. eCollection 2019 Jan.. |
| 150 | Mehmet Sayiner, Brian P. Lam, Pegah Golabi, Zobair M Younossi. Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis., Therapeutic Advances in Gastroenterology. Therap Adv Gastroenterol. 2018 Nov 15;11:1756284818811508. doi: 10.1177/1756284818811508. eCollection 2018.. |
| 151 | Haley Bush, Lynn Gerber, Maria Stepanova, Carey Escheik, Zobair M Younossi. Impact of Healthcare Reform on the Payer Mix Among Young Adult Emergency Department Utilizers Across the United States (2005-2015), Medical Care Research and Review. . |
| 152 | Zobair M Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis. The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease., Journal of Viral Hepatitis. . |
| 153 | Ali Weinstein, Leyla de Avila, James Minhui Paik, Pegah Golabi, Carey Escheik, Lynn Gerber, Zobair M Younossi. Cognitive Performance in Individuals With Non-Alcoholic Fatty Liver Disease and/or Type 2 Diabetes Mellitus., Psychosomatics. . |
| 154 | James Minhui Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M Younossi. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease, Liver International. Liver Int. 2019 Feb;39(2):342-352. doi: 10.1111/liv.13992. Epub 2018 Dec 4.. |
| 155 | James Minhui Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M Younossi. Chronic Kidney Disease is Independently Associated with Increased Mortality in Patients with Non-alcoholic Fatty Liver Disease, Liver International. Liver Int. 2018 Oct 22. doi: 10.1111/liv.13992. [Epub ahead of print]. |
| 156 | Brian P. Lam, Kyle Kurzke, Zobair M Younossi. The Clinical and Economic Burden of Nonalcoholic Steatohepatitis, Current Hepatology Reports. . |
| 157 | Pegah Golabi, Yousef Fazel, Munkhzul Otgonsuren, Carey Escheik, Mehmet Sayiner, Zobair M Younossi. Association of Parity in Patients with Chronic Liver Disease., Annals of Hepatology. Ann Hepatol. 2018 Oct 16;17(6):1035-1041. doi: 10.5604/01.3001.0012.7204.. |
| 158 | Donghee Kim, W.R. Kim, SK Joo, JH Kim, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease., Liver International. . |
| 159 | Atsushi Takahashi, Kei Moriya, Hiromasa Ohira, Teruko Arinaga-Hino, Mikio Zeniya, Takuji Torimura, Tomoo Fujisawa, Kaname Yoshizawa, Yoshiyuki Suzuki, Nobuhiro Nakamoto, Kazuhiko Koike, Hitoshi Yoshiji, Aya Goto, Atsushi Tanaka, Zobair M Younossi, Hajime Takikawa. Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey., PLOS One. PLoS One. 2018 Oct 4;13(10):e0204772. doi: 10.1371/journal.pone.0204772. eCollection 2018.. |
| 160 | Patrice Cacoub, Marc Bourliere, Tarik Asselah, Victor de Ledinghen, Philippe Mathurin, Christophe Hezode, Linda Henry, Maria Stepanova, Zobair M Younossi. French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes., Value in Health. . |
| 161 | Cameron T. Locklear, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Exercise as an intervention for patients with end-stage liver disease: Systematic review., Medicine. Medicine (Baltimore). 2018 Oct;97(42):e12774. doi: 10.1097/MD.0000000000012774.. |
| 162 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, Michael R. Charlton, Rohit Loomba, Robert P. Myers, Mani Subramanian, John McHutchison, Zachary Goodman. Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib., Liver International. Liver Int. 2018 Oct;38(10):1849-1859. doi: 10.1111/liv.13706. Epub 2018 Feb 22.. |
| 163 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Calvin Q. Pan, Harry Janssen, Georgios Papatheodoridis, Fatema Nader. Long-term Effects of Treatment for Chronic HBV Infection on Patient-Reported Outcomes., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1641-1642.e1. doi: 10.1016/j.cgh.2018.09.041. Epub 2018 Sep 27.. |
| 164 | Zobair M Younossi, Maria Stepanova, William Balistreri, Kathleen B. Schwarz, Karen Murray, Philip Rosenthal, Sanjay Bansal, Sharon Hunt. Health-Related Quality of Life in Adolescent Patients with Hepatitis C Genotype 1 Treated with Sofosbuvir and Ledipasvir, Journal of Pediatric Gastroenterology And Nutrition. J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):112-116. doi: 10.1097/MPG.0000000000001754.. |
| 165 | Omer Shahab, Rakesh Biswas, James Minhui Paik, Haley Bush, Pegah Golabi, Zobair M Younossi. Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality., Hepatology Communications. Hepatol Commun. 2018 Sep 24;2(10):1227-1234. doi: 10.1002/hep4.1241. eCollection 2018 Oct.. |
| 166 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Aybike Birerdinc, Maria Stepanova, Dinan Abdelatif, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Jeiran Kianoush, Alex Hodge, Weidong Zhou, Fanny Monge, Lakshmi Alaparthi, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease., BMC Medical Genomics. BMC Med. 2018 Sep 12;16(1):170. doi: 10.1186/s12916-018-1136-1.. |
| 167 | Zobair M Younossi, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, Caldwell. Stephen H. , Mitchell L. Shiffman, Raul Aguilar Schall, Bryan McColgan, GM Subramanian, Robert P. Myers, A Miur, Nezam H. Afdhal, Jaime Bosch, Zachary Goodman. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options., Journal of Hepatology. J Hepatol. 2018 Dec;69(6):1365-1370. doi: 10.1016/j.jhep.2018.08.013. Epub 2018 Aug 23.. |
| 168 | Andrew A. Li, Donghee Kim, W.R. Kim, Pratima Dibba, Katherine Wong, George Cholankeril, Ira M. Jacobson, Zobair M Younossi, Aijaz Ahmed. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016., Journal of Viral Hepatitis. . |
| 169 | Pegah Golabi, Haley Bush, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Zachary Goodman, Zobair M Younossi. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016., Medicine. Medicine (Baltimore). 2018 Aug;97(31):e11518. doi: 10.1097/MD.0000000000011518.. |
| 170 | Zobair M Younossi. Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition., Hepatology. Hepatology. 2018 Dec;68(6):2405-2412. doi: 10.1002/hep.30125.. |
| 171 | Zobair M Younossi. Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status., American Journal of Gastroenterology. Send to Am J Gastroenterol. 2018 Sep;113(9):1285-1286. doi: 10.1038/s41395-018-0200-y. Epub 2018 Jul 18.. |
| 172 | Mehmet Sayiner, Pegah Golabi, Maria Stepanova, Fatema Nader, Issah Younossi, Andrei Racila, Zobair M Younossi. Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Utilization, Hepatology. Hepatology. 2018 Jul 17. doi: 10.1002/hep.30174. [Epub ahead of print]. |
| 173 | Stephen A. Harrison, Manal F. Abdelmalek, Caldwell. Stephen H. , Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric Lawitz, Don C. Rockey, Raul Aguilar Schall, Catherine Jia, Bryan McColgan, John McHutchison, GM Subramanian, Robert P. Myers, Zobair M Younossi, Vlad Ratziu, Andrew J. Muir, Nezam H. Afdhal, Zachary Goodman, Jaime Bosch, Arun J. Sanyal. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis., Gastroenterology. Gastroenterology. 2018 Oct;155(4):1140-1153. doi: 10.1053/j.gastro.2018.07.006. Epub 2018 Jul 7.. |
| 174 | Zobair M Younossi, Rohit Loomba, Quentin Anstee, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Caldwell. Stephen H. , Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel Lavine, Philippe Mathurin, Michael R. Charlton, Zachary Goodman, Naga Chalasani, Kris V. Kowdley, Jacob George, Keith Lindor. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis., Hepatology. Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721.. |
| 175 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Henry Lik-Yuen Chan, Lai Wei. Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection., Journal of Viral Hepatitis. . |
| 176 | Zobair M Younossi, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim. Sofosbuvir and Ledipasvir is Associated with High Sustained Virologic Response and Improvement of Health-Related Quality of Life in East Asian Patients with Hepatitis C Virus Infection, Journal of Viral Hepatitis. J Viral Hepat. 2018 Jul 4. doi: 10.1111/jvh.12965. [Epub ahead of print]. |
| 177 | Zobair M Younossi, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, William Lenderling, Anne Skalicky, Robert P. Myers, Mani Subramanian, John McHutchison, Cynthia Levy, Christopher L. Bowlus, Kris V. Kowdley, Andrew J. Muir. Development and Validation of a Primary Sclerosing Cholangitis-Specific Patient-Reported Outcomes Instrument: The PSC PRO, Hepatology. Hepatology. 2018 Jul;68(1):155-165. doi: 10.1002/hep.29664. Epub 2018 May 10.. |
| 178 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. The Effect of Interferon-Free Regimens on Health-Related Quality of Life in East Asian Patients with Chronic Hepatitis C., Liver International. Liver Int. 2018 Jul;38(7):1179-1187. doi: 10.1111/liv.13650. Epub 2018 Jan 25.. |
| 179 | Linda Henry, Zobair M Younossi. Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives., Liver International. Liver Int. 2018 Jul;38(7):1331. doi: 10.1111/liv.13891.. |
| 180 | Rohini Mehta, Gladys Shaw, Peter Masschelin, Sean C. Felix, Munkhzul Otgonsuren, Ancha Baranova, Zachary Goodman, Zobair M Younossi. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)., PLOS One. 2018 Jun 21;13(6):e0199294. doi: 10.1371/journal.pone.0199294. eCollection 2018.. |
| 181 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Ira M. Jacobson, Elisabetta Bugianesi, Ajay Duseja, Yuichiro Eguchi, Vincent Wai-Sun Wong, Francesco Negro, Yusuf Yilmaz, Manuel Romero-Gomez, Jacob George, Aijaz Ahmed, Robert John Wong, Issah Younossi, Mariam Ziayee, Arian Afendy. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.. |
| 182 | Zobair M Younossi, Rohit Loomba, Mary E. Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A. Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Caldwell. Stephen H. , Vlad Ratziu, Kathleen E. Corey, Scott L. Friedman, Manal F. Abdelmalek, Stephen A. Harrison, Arun J. Sanyal, Joel Lavine, Philippe Mathurin, Michael R. Charlton, Naga Chalasani, Quentin Anstee, Kris V. Kowdley, Jacob George, Zachary Goodman, Keith Lindor. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis., Hepatology. Hepatology. 2018 Jul;68(1):361-371. doi: 10.1002/hep.29724.. |
| 183 | Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham R. Foster, Keyur Patel, Norbert Brau, Mark G. Swain, Tram T. Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C in Patients with Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes, Clinical Infectious Diseases. Clin Infect Dis. 2018 May 17;66(11):1742-1750. doi: 10.1093/cid/cix1106.. |
| 184 | EY Choe, Youn-Jae Lee, YJ Choi, BW Huh, BW Lee, SK Kim, ES Kang, BS Cha, EJ Lee, KB Huh, Zobair M Younossi. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes., Journal of Gastroenterology and Hepatology. J Gastroenterol Hepatol. 2018 May;33(5):1082-1091. doi: 10.1111/jgh.14011. Epub 2018 Feb 6.. |
| 185 | Maria Stepanova, Issah Younossi, Andrei Racila, Zobair M Younossi. Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)., Value in Health. Value Health. 2018 May;21(5):612-621. doi: 10.1016/j.jval.2017.10.005. Epub 2017 Dec 6.. |
| 186 | Zobair M Younossi. The epidemiology of nonalcoholic steatohepatitis, Clinical Liver Disease. . |
| 187 | Zobair M Younossi. Patient-Reported Outcomes for Patients With Chronic Liver Disease., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Jun;16(6):793-799. doi: 10.1016/j.cgh.2017.12.028. Epub 2018 Apr 19.. |
| 188 | Aybike Birerdinc, Sasha Stoddard, Zobair M Younossi. The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD)., Current Gastroenterology Report. Curr Gastroenterol Rep. 2018 Apr 19;20(6):24. doi: 10.1007/s11894-018-0629-6.. |
| 189 | Steven L. Flamm, Bruce R. Bacon, Michael P. Curry, Scott Milligan, Chizoba Nwankwo, Naoky Tsai, Zobair M Younossi, Nezam H. Afdhal. Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2018 Jun;47(11):1511-1522. doi: 10.1111/apt.14635. Epub 2018 Apr 17.. |
| 190 | Zobair M Younossi, Maria Stepanova, Kathleen B. Schwarz, Wirth Stefan , Philip Rosenthal, Regino Gonzalez-Peralta, Karen Murray, Linda Henry, Sharon Hunt. Quality of Life in Adolescents with Hepatitis C Treated with Sofosbuvir and Ribavirin., Journal of Viral Hepatitis. J Viral Hepat. 2018 Apr;25(4):354-362. doi: 10.1111/jvh.12830. Epub 2017 Dec 26.. |
| 191 | Zobair M Younossi, Maria Stepanova, Stuart C. Gordon, Stefan Zeuzem, Michael Mann, Ira M. Jacobson, Marc Bourliere, Curtis L. Cooper, Steven L. Flamm, K. Rajender Reddy, Kris V. Kowdley, Issah Younossi, Sharon Hunt. Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Apr;16(4):567-574.e6. doi: 10.1016/j.cgh.2017.11.023. Epub 2017 Nov 16.. |
| 192 | Zobair M Younossi. Reply., Hepatology. Hepatology. 2018 Jul;68(1):390. doi: 10.1002/hep.29896.. |
| 193 | Pegah Golabi, Maria Stepanova, Huong T. Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic Steatofibrosis Can Independently Predict Mortality in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000198. doi: 10.1136/bmjgast-2018-000198. eCollection 2018.. |
| 194 | Maria Stepanova, Alexander Thompson, J Doyle, Issah Younossi, Leyla de Avila, Zobair M Younossi. Hepatitis C Virus-Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens., Journal of Infectious Diseases. J Infect Dis. 2018 Mar 13;217(7):1033-1043. doi: 10.1093/infdis/jix681.. |
| 195 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Kaushik Agarwal, Mindie H. Nguyen, Edward J. Gane, Naoky Tsai, Issah Younossi, Andrei Racila. Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Oct;16(10):1641-1649.e6. doi: 10.1016/j.cgh.2018.02.037. Epub 2018 Mar 2.. |
| 196 | Pegah Golabi, Maria Stepanova, Huong T. Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD), BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2018 Mar 20;5(1):e000198. doi: 10.1136/bmjgast-2018-000198. eCollection 2018.. |
| 197 | Zobair M Younossi, Henry Lik-Yuen Chan, Yock Young Dan, Mei Hsuan Lee, Young-Suk Lim, Eliza Kruger, Seng Tan. Impact of Ledipasvir/Sofosbuvir on the Work Productivity of Genotype 1 Chronic Hepatitis C Patients in Asia., Journal of Viral Hepatitis. J Viral Hepat. 2018 Mar;25(3):228-235. doi: 10.1111/jvh.12808. Epub 2017 Nov 29.. |
| 198 | Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Mehmet Sayiner, Nila Rafiq, Zobair M Younossi. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)., Medicine. Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214.. |
| 199 | Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Mehmet Sayiner, Nila Rafiq, Zobair M Younossi. Components of Metabolic Syndrome Increase the Risk of Mortality in Non-alcoholic Fatty Liver Disease (NAFLD), Medicine. Medicine (Baltimore). 2018 Mar;97(13):e0214. doi: 10.1097/MD.0000000000010214.. |
| 200 | George Cholankeril, Andrew A. Li, KL March, Eric R. Yoo, Donghee Kim, H Snyder, Stevan Gonzalez, Zobair M Younossi, Aijaz Ahmed. Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2018 Mar;16(3):452-453. doi: 10.1016/j.cgh.2017.08.020. Epub 2017 Aug 31.. |
| 201 | Zobair M Younossi. The efficacy of new antiviral regimens for hepatitis C infection: Evidence from a systematic review., Hepatology. Hepatology. 2018 Mar;67(3):1160-1162. doi: 10.1002/hep.29580. Epub 2018 Jan 26.. |
| 202 | Zobair M Younossi, Atsushi Tanaka, Yuichiro, Eguchi, Linda Henry, Rachel Beckerman, Masashi Mizokami. Treatment of Hepatitis C Virus Leads to Economic Gains Related to Reduction in Cases of Hepatocellular Carcinoma and Decompensated Cirrhosis in Japan., Journal of Viral Hepatitis. J Viral Hepat. 2018 Feb 25. doi: 10.1111/jvh.12886. [Epub ahead of print]. |
| 203 | Patrice Cacoub, Peter Buggisch, J.A. Carrion, G.S. Cooke, Anna Linda Zignego, Rachel Beckerman, Zobair M Younossi. Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe., Journal of Viral Hepatitis. . |
| 204 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered., Liver International. Liver Int. 2018 Feb;38(2):258-265. doi: 10.1111/liv.13519. Epub 2017 Aug 24.. |
| 205 | Zobair M Younossi, Linda Henry, Haley Bush, P Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis., Clinical Liver Disease. Clin Liver Dis. 2018 Feb;22(1):1-10. doi: 10.1016/j.cld.2017.08.001. Epub 2017 Oct 14.. |
| 206 | Zobair M Younossi. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation., Liver Transplantation. . |
| 207 | Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, Reyad Abbadi, Victor Vargas, Macarena Simon-Talero, Juan Cordoba, Paolo Angeli, Silvia Rosi, Stewart MacDonald, Massimo Malago, Maria Stepanova, Zobair M Younossi, Claudia Trepte, Randall Watson, Oleg Borisenko, Sun Sun, Neil Inhaber, Rajiv Jalan. Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949]., Journal of Hepatology. J Hepatol. 2018 Mar;68(3):630. doi: 10.1016/j.jhep.2017.12.017. Epub 2018 Feb 1.. |
| 208 | Omer Shahab, Pegah Golabi, Zobair M Younossi. Chronic kidney disease in patients with chronic hepatitis C virus infection., Minerva Gastroenterologica e Dietologica. . |
| 209 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Haley Bush, Zobair M Younossi. Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality., Alimentary Pharmacology & Therapeutics. . |
| 210 | Chris Estes, Homie Razavi, Rohit Loomba, Zobair M Younossi, Arun J. Sanyal. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease., Hepatology. Hepatology. 2018 Jan;67(1):123-133. doi: 10.1002/hep.29466. Epub 2017 Dec 1.. |
| 211 | Patrice Cacoub, M Vauthier, Anne Claire Desbois, David Saadoun, Zobair M Younossi. Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2018 Jan;47(1):123-128. doi: 10.1111/apt.14382. Epub 2017 Oct 18.. |
| 212 | Zobair M Younossi, Quentin Anstee, M Marietti, T Hardy, Linda Henry, M Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention., Nature Reviews Gastroenterology & Hepatology. Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.. |
| 213 | Naga Chalasani, Zobair M Younossi, Joel Lavine, Michael R. Charlton, Kenneth Cusi, Mary E. Rinella, Stephen A. Harrison, Elizabeth Brunt, Arun J. Sanyal. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases., Hepatology. Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.. |
| 214 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Tarik Asselah, Edward J. Gane, Eric Lawitz, Graham R. Foster, Stuart Roberts, Alexander Thompson, Bernard Willems, Tania M. Welzel, Brian Pearlman, Issah Younossi, Andrei Racila, Linda Henry. Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3., Alimentary Pharmacology & Therapeutics. Send to Aliment Pharmacol Ther. 2018 Jan;47(2):259-267. doi: 10.1111/apt.14423. Epub 2017 Nov 27.. |
| 215 | Maria Stepanova, Alexander Thompson, J Doyle, Leyla de Avila, Zobair M Younossi. Hepatitis C Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment with Interferon-Free Regimens., Journal of Infectious Diseases. J Infect Dis. 2017 Dec 26. doi: 10.1093/infdis/jix681. [Epub ahead of print]. |
| 216 | Zobair M Younossi. Nonalcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: Implications for Liver Transplantation., Liver Transplantation. . |
| 217 | Aybike Birerdinc, Zobair M Younossi. Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis, Annals of Hepatology. Ann Hepatol. 2018 January-February;17(1):11-13. doi: 10.5604/01.3001.0010.7530.. |
| 218 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, Haley Bush, Zobair M Younossi. Hospice Care in Medicare Patients with Primary Liver Cancer: The Impact on Resource Utilization and Mortality, Alimentary Pharmacology & Therapeutics. 2018 Mar;47(5):680-688. doi: 10.1111/apt.14484. Epub 2018 Jan 3.. |
| 219 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C, Liver International. Liver Int. 2018 Jul;38(7):1179-1187. doi: 10.1111/liv.13650. Epub 2018 Jan 25.. |
| 220 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. Demographics, Resource Utilization and Outcomes of Patients with Chronic Liver Disease Receiving Hospice Care in the United States , American Journal of Gastroenterology. Am J Gastroenterol. 2017 Nov;112(11):1700-1708. doi: 10.1038/ajg.2017.290. Epub 2017 Oct 10.. |
| 221 | Zobair M Younossi. The Efficacy of New Anti-Viral Regimens for Hepatitis C Infection: Evidence from A Systematic Review., Hepatology. Hepatology. 2017 Oct 10. doi: 10.1002/hep.29580. [Epub ahead of print]. |
| 222 | Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States., American Journal of Gastroenterology. Am J Gastroenterol. 2017 Nov;112(11):1700-1708. doi: 10.1038/ajg.2017.290. Epub 2017 Oct 10.. |
| 223 | Aijaz Ahmed, Rachel Beckerman, Zobair M Younossi. Equitable Access to All-Oral Direct-Acting Antiviral Therapy is a Mandatory Step to Achieve Global Hepatitis C Virus Eradication., Hepatology. Hepatology. 2017 Sep 27. doi: 10.1002/hep.29555. [Epub ahead of print]. |
| 224 | Kellie Young, Benny Liu, Taft Bhuket, Zobair M Younossi, Sammy Saab, Aijaz Ahmed, Robert John Wong. Long-term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States., Journal of Viral Hepatitis. J Viral Hepat. 2017 Sep;24(9):789-796. doi: 10.1111/jvh.12703. Epub 2017 May 5.. |
| 225 | Michael P. Curry, Elliot B. Tapper, Bruce R. Bacon, Douglas T. Dieterich, Steven L. Flamm, Lauren Guest, Kris V. Kowdley, Yoori Lee, Scott Milligan, Naoky Tsai, Zobair M Younossi, Nezam H. Afdhal. Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2017 Sep;46(5):540-548. doi: 10.1111/apt.14204. Epub 2017 Jul 10.. |
| 226 | Mehmet Sayiner, Pegah Golabi, F Farhat, Zobair M Younossi. Dermatologic Manifestations of Chronic Hepatitis C Infection., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):555-564. doi: 10.1016/j.cld.2017.03.010. Epub 2017 Apr 25.. |
| 227 | Zobair M Younossi. Preface., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):xiii. doi: 10.1016/j.cld.2017.05.001.. |
| 228 | Pegah Golabi, Haley Bush, Zobair M Younossi. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Clinics In Liver Disease. Clin Liver Dis. 2017 Nov;21(4):739-753. doi: 10.1016/j.cld.2017.06.010. Epub 2017 Jul 29.. |
| 229 | Zobair M Younossi, Katrin Kochems, Marc De Ridder, Desmond Curran, Eveline Bunge, Laurence de Moerlooze. The impact of diabetes mellitus on the progression of chronic hepatitis B: a systematic review, Human Vaccines and Immunotherapeutics. Hum Vaccin Immunother. 2017 Nov 2;13(11):2695-2706. doi: 10.1080/21645515.2017.1353850. Epub 2017 Jul 25.. |
| 230 | George Cholankeril, Robert John Wong, Menghan Hu, Ryan Perumpail, Eric R. Yoo, Puneet Puri, Zobair M Younossi, Stephen A. Harrison, Aijaz Ahmed. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes., Digestive Diseases And Sciences. Dig Dis Sci. 2017 Oct;62(10):2915-2922. doi: 10.1007/s10620-017-4684-x. Epub 2017 Jul 25.. |
| 231 | Christina Spataro, Sophie K. Afdhal, Ali Weinstein, Carey Escheik, Patrick Austin, Kathryn Brodie, Lynn Gerber, Zobair M Younossi. Fatigue & Hepatitis C: A Focus Group Study, Qualitative Health Research. https://doi.org/10.4081/qrmh.2017.6698. |
| 232 | Ira M. Jacobson, Mary Kay Washington, Maria Buti, Alexander Thompson, Nezam H. Afdhal, Robert Flisiak, Ulus Saith Akarca, Konstantin G Tchernev, John Flaherty, Raul Aguilar Schall, Robert P. Myers, GM Subramanian, John McHutchison, Zobair M Younossi, Patrick Marcellin, Keyur Patel. Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1087-1094.e2. doi: 10.1016/j.cgh.2017.01.032. Epub 2017 Feb 12.. |
| 233 | Zobair M Younossi, Katrin Kochems, Marc De Ridder, Desmond Curran, Eveline Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease., Human Vaccines and Immunotherapeutics. Hum Vaccin Immunother. 2017 Nov 2;13(11):2695-2706. doi: 10.1080/21645515.2017.1353850. Epub 2017 Jul 25.. |
| 234 | Aijaz Ahmed, Stevan Gonzalez, George Cholankeril, Ryan Perumpail, Justin McGinnis, Sammy Saab, Rachel Beckerman, Zobair M Younossi. Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States., Hepatology. 2017 Jul;66(1):46-56. doi: 10.1002/hep.29137. Epub 2017 May 27.. |
| 235 | Christophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, Laure Elkrief, Dominique Valla, Markus Peck-Radosavljevic, Anne McCune, Victor Vargas, Macarena Simon-Talero, Juan Cordoba, Paolo Angeli, Silvia Rosi, Stewart MacDonald, Massimo Malago, Maria Stepanova, Zobair M Younossi, Claudia Trepte, Randall Watson, Oleg Borisenko, Sun Sun, Neil Inhaber, Rajiv Jalan. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study., Journal of Hepatology. J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21.. |
| 236 | Haley Bush, Pegah Golabi, Zobair M Younossi. Pediatric Non-Alcoholic Fatty Liver Disease, Children. Children (Basel). 2017 Jun 9;4(6). pii: E48. doi: 10.3390/children4060048.. |
| 237 | Zobair M Younossi, Maria Stepanova, Nila Rafiq, Linda Henry, Rohit Loomba, Hala Makhlouf, Zachary Goodman. Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease, Hepatology Communications. Hepatol Commun. 2017 Jun 6;1(5):421-428. doi: 10.1002/hep4.1054. eCollection 2017 Jul.. |
| 238 | Osama Siddique, Mairin Joseph-Talreja, Eric R. Yoo, Ryan Perumpail, George Cholankeril, Stephen A. Harrison, Zobair M Younossi, Robert John Wong, Aijaz Ahmed. Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States, Journal of Clinical and Translational Hepatology. J Clin Transl Hepatol. 2017 Sep 28;5(3):193-196. doi: 10.14218/JCTH.2017.00003. Epub 2017 Jun 3.. |
| 239 | Manuel Ramos-Casals, Anna Linda Zignego, Clodoveo Ferri, Pilar Brito-Zeron, Soledad Retamozo, Milvia Casato, Peter Lamprecht, Alessandra Mangia, David Saadoun, Athanasios G. Tzioufas, Zobair M Younossi, Patrice Cacoub. Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection, Journal of Hepatology. J Hepatol. 2017 Jun;66(6):1282-1299. doi: 10.1016/j.jhep.2017.02.010. Epub 2017 Feb 20.. |
| 240 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, David Wyles, Shyam Kottilil, Sharon Hunt. Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study., Liver International. Liver Int. 2017 Dec;37(12):1796-1804. doi: 10.1111/liv.13462. Epub 2017 May 25.. |
| 241 | Zobair M Younossi. Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis., Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1144-1147. doi: 10.1016/j.cgh.2017.05.029. Epub 2017 May 23.. |
| 242 | Hesam Tavakoli, Ann Robinson, Benny Liu, Taft Bhuket, Zobair M Younossi, Sammy Saab, Aijaz Ahmed, Robert John Wong. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma., Digestive Diseases And Sciences. Dig Dis Sci. 2017 Aug;62(8):2174-2181. doi: 10.1007/s10620-017-4595-x. Epub 2017 May 4.. |
| 243 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society, Liver International. Liver Int. 2017 May;37(5):662-668. doi: 10.1111/liv.13298. Epub 2016 Nov 29.. |
| 244 | Maria Stepanova, Leyla de Avila, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Zobair M Younossi. Direct and Indirect Economic Burden of Chronic Liver Disease in the United States, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 May;15(5):759-766.e5. doi: 10.1016/j.cgh.2016.07.020. Epub 2016 Jul 25.. |
| 245 | Mario Mondelli, Zobair M Younossi, Francesco Negro. Editor's Note., Liver International. Liver Int. 2017 May;37(5):768. doi: 10.1111/liv.13400.. |
| 246 | Pegah Golabi, Mehmet Sayiner, Haley Bush, Lynn Gerber, Zobair M Younossi. Patient-Reported Outcomes and Fatigue in Patients with Chronic Hepatitis C Infection., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):565-578. doi: 10.1016/j.cld.2017.03.011. Epub 2017 Apr 26.. |
| 247 | Fasiha Kanwal, Bruce R. Bacon, Lauren A. Beste, Joel V. Brill, Allen L. Gifford, Stuart C. Gordon, Michael A. Horberg, Jacob G. Manthey, Nancy Reau, Vinod K. Rustgi, Zobair M Younossi. Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group., Gastroenterology. Gastroenterology. 2017 May;152(6):1588-1598. doi: 10.1053/j.gastro.2017.03.039.. |
| 248 | Maria Stepanova, Zobair M Younossi. Economic Burden of Hepatitis C Infection., Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):579-594. doi: 10.1016/j.cld.2017.03.012. Epub 2017 Apr 22.. |
| 249 | Zobair M Younossi. Hepatitis C Infection: A Systemic Disease, Clinical Liver Disease. Clin Liver Dis. 2017 Aug;21(3):449-453. doi: 10.1016/j.cld.2017.03.001. Epub 2017 Apr 20.. |
| 250 | Pegah Golabi, Munkhzul Otgonsuren, Mehmet Sayiner, Aimal Arsalla, Trevor Gogoll, Zobair M Younossi. The Prevalence of Parkinson Disease among Patients with Hepatitis C Infection., Annals of Hepatology. 2017 May - Jun;16(3):342-348. doi: 10.5604/16652681.1235476.. |
| 251 | Maria Stepanova, Stephen C. Clement, Robert John Wong, Sammy Saab, Aijaz Ahmed, Zobair M Younossi. Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States., Clinical Diabetes. Clin Diabetes. 2017 Apr;35(2):79-83. doi: 10.2337/cd16-0018.. |
| 252 | Maria Patrizia Carrieri, Camelia Protopopescu, Zobair M Younossi, Antoine Vilotitch, Helene Fontaine, Ventzislava Petrov-Sanchez, Fabienne Marcellin, Fabrice Carrat, Christophe Hezode, Marc Bourliere. Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial), The Patient - Patient-Centered Outcomes Research. Patient. 2017 Mar 28. doi: 10.1007/s40271-017-0232-1. [Epub ahead of print]. |
| 253 | Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G. Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement, Autoimmunity Reviews. Autoimmun Rev. 2017 May;16(5):523-541. doi: 10.1016/j.autrev.2017.03.004. Epub 2017 Mar 7.. |
| 254 | Pegah Golabi, Sofie Fazel, Munkhzul Otgonsuren, Mehmet Sayiner, Cameron T. Locklear, Zobair M Younossi. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities., Medicine. Medicine (Baltimore). 2017 Mar;96(9):e5904. doi: 10.1097/MD.0000000000005904.. |
| 255 | Mehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, Issah Younossi, Mariam Afendy, Pegah Golabi, Linda Henry, Zobair M Younossi. Variables associated with inpatient and outpatient resource utilization among medicare beneficiaries with NAFLD with or without cirrhosis, Journal of Clinical Gastroenterology. J Clin Gastroenterol. 2017 Mar;51(3):254-260. doi: 10.1097/MCG.0000000000000567.. |
| 256 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Fatema Nader, Linda Henry. Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 Mar;15(3):421-430.e6. doi: 10.1016/j.cgh.2016.10.037. Epub 2016 Nov 12.. |
| 257 | Zobair M Younossi, Stuart C. Gordon, Aijaz Ahmed, Douglas T. Dieterich, Sammy Saab, Rachel Beckerman. Treating Medicaid Patients with Hepatitis C: Clinical and Economic Impact, American Journal of Managed Care. Am J Manag Care. 2017 Feb;23(2):107-112.. |
| 258 | Ali Weinstein, G Diao, Heibatollah Baghi, Carey Escheik, Lynn Gerber, Zobair M Younossi. Demonstration of Two Types of Fatigue in Subjects with Chronic Liver Disease using Factor Analysis, Quality of Life Research. Qual Life Res. 2017 Feb 21. doi: 10.1007/s11136-017-1516-6. [Epub ahead of print]. |
| 259 | Zobair M Younossi, Maria Stepanova, Linda Henry, Andrei Racila, Brian P. Lam, Huong T. Pham, Sharon Hunt. A Disease-Specific Quality of Life Instrument for Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: CLDQ-NAFLD, Liver International. Liver Int. 2017 Feb 17. doi: 10.1111/liv.13391. [Epub ahead of print]. |
| 260 | Zobair M Younossi, Maria Stepanova, Rafael Esteban, Ira M. Jacobson, Stefan Zeuzem, Mark S. Sulkowski, Linda Henry, Fatema Nader, Rebecca Cable, Mariam Afendy, Sharon Hunt. Superiority of Interferon-Free Regimens for Chronic Hepatitis C: The Effect on Health-Related Quality of Life and Work Productivity, Medicine. Medicine (Baltimore). 2017 Feb;96(7):e5914. doi: 10.1097/MD.0000000000005914.. |
| 261 | Jayasekera Channa R. , Rachel Beckerman, Nathaniel Smith, Ryan Perumpail, Robert John Wong, Zobair M Younossi, Aijaz Ahmed. Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States., Journal of Clinical and Translational Hepatology. J Clin Transl Hepatol. 2017 Mar 28;5(1):16-22. doi: 10.14218/JCTH.2016.00052. Epub 2017 Feb 2.. |
| 262 | George Cholankeril, Eric R. Yoo, Ryan Perumpail, Menghan Hu, Gail Skowron, Zobair M Younossi, Aijaz Ahmed. Disparities in Liver Transplantation Resulting From Variations in Regional Donor Supply and Multiple Listing Practices, Clinical Gastroenterology And Hepatology. Clin Gastroenterol Hepatol. 2017 Feb;15(2):313-315. doi: 10.1016/j.cgh.2016.08.036. Epub 2016 Sep 5.. |
| 263 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Sharon Hunt. Health utilities using SF-6D scores in Japanese patients with chronic hepatitis C treated with sofosbuvir-based regimens in clinical trials., Health and Quality of Life Outcomes. Health Qual Life Outcomes. 2017 Jan 31;15(1):25. doi: 10.1186/s12955-017-0598-8.. |
| 264 | Parambir Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J. Prokop, Zobair M Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagstrom, Patrik Nasr, Per Stal, Vincent Wai-Sun Wong, Stergios Kechagias, Rolf Hultcrantz, Rohit Loomba. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis, Hepatology. Hepatology. 2017 May;65(5):1557-1565. doi: 10.1002/hep.29085. Epub 2017 Mar 31.. |
| 265 | Sarah Elfeky, Pegah Golabi, Munkhzul Otgonsuren, Svetolik Djurkovic, Mary E. Schmidt, Zobair M Younossi. The epidemiologic characteristics, temporal trends, predictors of death, and discharge disposition in patients with a diagnosis of sepsis: A cross-sectional retrospective cohort study., Journal of Critical Care. J Crit Care. 2017 Jun;39:48-55. doi: 10.1016/j.jcrc.2017.01.006. Epub 2017 Jan 20.. |
| 266 | Pegah Golabi, Thomas Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayiner, Alita Mishra, Chapy Venkatesan, Madeline Erario, Zobair M Younossi. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma., Annals of Hepatology. 2017 Jul-Aug;16(4):555-564. doi: 10.5604/01.3001.0010.0290.. |
| 267 | Maria Stepanova, Cameron T. Locklear, Nila Rafiq, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry., Clinical Transplantation. Clin Transplant. 2016 Dec;30(12):1570-1577. doi: 10.1111/ctr.12859. Epub 2016 Nov 8.. |
| 268 | Maria Stepanova, Mehmet Sayiner, Leyla de Avila, Zahra Younoszai, Andrei Racila, Zobair M Younossi. Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor., BMC Gastroenterology. BMC Gastroenterol. 2016 Nov 15;16(1):137.. |
| 269 | Pegah Golabi, Elzafir Elsheikh Abdelrahman, Azza Karrar, James M. Estep, Issah Younossi, Maria Stepanova, Lynn Gerber, Zobair M Younossi. The Levels of Monoamine Neurotransmitters and Measures of Mental and Emotional Health in HCV Patients Treated with Ledipasvir (LDV) and Sofosbuvir (SOF) with or without Ribavirin (RBV) , Medicine. Medicine (Baltimore). 2016 Nov;95(46):e5066.. |
| 270 | Zobair M Younossi. Sofosbuvir (SOF) and Ledipasvir (LDV) Improves Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) (manuscript), Journal of Viral Hepatitis. Volume 23, Issue 11,November 2016 ,Pages 857–865. |
| 271 | Zobair M Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young-Suk Lim, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, C Brooks-Rooney, Francesco Negro, Mario Mondelli. The impact of hepatitis C virus outside the liver: evidence from Asia , Liver International. Liver Int. 2017 Feb;37(2):159-172. doi: 10.1111/liv.13272. Epub 2016 Nov 10.. |
| 272 | Linda Henry, Zobair M Younossi. Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C., Expert Review of Pharmacoeconomics and Outcomes Research. Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):659-665. Epub 2016 Oct 12.. |
| 273 | Elliot B. Tapper, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Lauren Guest, Kris V. Kowdley, Yoori Lee, Naoky Tsai, Zobair M Younossi, Nid Afdhal. Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study., Journal of Viral Hepatitis. J Viral Hepat. 2017 Jan;24(1):22-27. doi: 10.1111/jvh.12611. Epub 2016 Oct 11.. |
| 274 | Zobair M Younossi, Haesuk Park, Douglas T. Dieterich, Sammy Saab, Aijaz Ahmed, Stuart C. Gordon. Assessment of Cost of Innovation versus the Value of Health Gains Associated with Treatment of Chronic Hepatitis C in the United States: The Quality-Adjusted Cost of Care, Medicine. 2016 Oct;95(41):e5048. |
| 275 | Zobair M Younossi, Aybike Birerdinc, Linda Henry. Hepatitis C Infection: A Multi-Faceted Systemic Disease with Clinical, Patient Reported and Economic Consequences, Journal of Hepatology. 2016 Oct;65(1 Suppl):S109-19. doi: 10.1016/j.jhep.2016.07.005. |
| 276 | Maria Stepanova, Zobair M Younossi. Letter: effects of hepatitis C infection on the post-lung transplant mortality - authors' reply., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2016 Oct;44(7):768-9. doi: 10.1111/apt.13759. |
| 277 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. The Economic and Clinical Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States and Europe, Hepatology. Hepatology. 2016 Nov;64(5):1577-1586. doi: 10.1002/hep.28785. Epub 2016 Sep 26.. |
| 278 | Ryan Perumpail, Eric R. Yoo, George Cholankeril, Luke Hogan, Melodie Deis, Waldo Concepciom, Clark Bonham, Zobair M Younossi, Robert John Wong, Aijaz Ahmed. Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher, Journal of Clinical and Translational Hepatology. J Clin Transl Hepatol. 2016 Sep 28;4(3):169-174. Epub 2016 Sep 25.. |
| 279 | Rohini Mehta, Jeiran Kianoush, Aaron B. Koenig, Munkhzul Otgonsuren, Zachary Goodman, Ancha Baranova, Zobair M Younossi. The Role of Mitochondrial Genomics in Patients with Non-Alcoholic Steatohepatitis (NASH) , Biomed Central Medical Genetics. BMC Med Genet. 2016 Sep 5;17(1):63. doi: 10.1186/s12881-016-0324-0. |
| 280 | Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, M Sebastiani, Milvia Casato, C. Lamprecht, Alessandra Mangia, Athanasios G. Tzioufas, Zobair M Younossi, Patrice Cacoub, ISG-EHCV co-authors . International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement, Autoimmunity Reviews. 2016 Sep 16. pii: S1568-9972(16)30201-4. doi: 10.1016/j.autrev.2016.09.006. [Epub ahead of print. |
| 281 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Ali Weinstein, Fatema Nader, Sharon Hunt. Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus, Journal of Viral Hepatitis. 2016 Aug;23(8):623-30. doi: 10.1111/jvh.12528. Epub 2016 Mar 14. |
| 282 | Elliot B. Tapper, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Steven L. Flamm, Lauren Guest, Kris V. Kowdley, Yoori Lee, Naoky Tsai, Zobair M Younossi, Nezam H. Afdhal. Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study., Hepatology. Hepatology. 2016 Aug 17. doi: 10.1002/hep.28782. [Epub ahead of print]. |
| 283 | Mehmet Sayiner, Maria Stepanova, Huong T. Pham, Bashir Noor, Mercedes Walters, Zobair M Younossi. Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease, BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2016 Aug 16;3(1):e000106. doi: 10.1136/bmjgast-2016-000106. eCollection 2016.. |
| 284 | Zobair M Younossi, Maria Stepanova, Michael R. Charlton, Michael P. Curry, Robert S. Brown, Sharon Hunt. Patient-Reported Outcomes in Decompensated Cirrhotics with Hepatitis C Treated with Sofosbuvir and Velpatasvir with or without Ribavirin: Results from a Phase 3 Randomised Controlled Trial, The Lancet Gastroenterology and Hepatology. Lancet Gastroenterol Hepatol. 2016 Oct;1(2):122-132. doi: 10.1016/S2468-1253(16)30009-7. Epub 2016 Aug 3.. |
| 285 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Sharon Hunt. Quality of Life of Japanese Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir, Medicine. Medicine (Baltimore). 2016 Aug;95(33):e4243. doi: 10.1097/MD.0000000000004243. |
| 286 | Elzafir Elsheikh Abdelrahman, Thomas Jeffers, Zahra Younoszai, Sharon Hunt, Brian P. Lam, Munkhzul Otgonsuren, Maria C. Albano, Ingrid Schneider, Brian Marsiglia, Bryan Raybuck, Zobair M Younossi. Non-Hematopoietic Circulating Progenitor Cells and Presence of Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease, Journal of Cytology & Histology. Elsheikh et al., J Cytol Histol 2016, 7:3 DOI: 10.4172/2157-7099.1000423. |
| 287 | Rohini Mehta, Munkhzul Otgonsuren, Zahra Younoszai, Hussain Allawi, Bryan Raybuck, Zobair M Younossi. Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease, BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2016 Jul 26;3(1):e000096. doi: 10.1136/bmjgast-2016-000096. eCollection 2016. |
| 288 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, Norbert Brau, Stuart Roberts, Nezam H. Afdhal, Fatema Nader, Linda Henry. RIBAVIRIN-FREE REGIMEN WITH SOFOSBUVIR AND VELPATASVIR IS ASSOCIATED WITH HIGH EFFICACY AND IMPROVEMENT OF PATIENT-REPORTED OUTCOMES IN PATIENTS WITH GENOTYPES 2 AND 3 CHRONIC HEPATITIS C: RESULTS FROM ASTRAL-2 AND 3 CLINICAL TRIALS, Clinical Infectious Diseases. Clin Infect Dis. 2016 Oct 15;63(8):1042-8. doi: 10.1093/cid/ciw496. Epub 2016 Jul 20.. |
| 289 | Kellie Young, M Aquilar, R. Gish, Zobair M Younossi, Sammy Saab, Taft Bhuket, Benny Liu, Aijaz Ahmed, Robert John Wong. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma., Liver Transplantation. Liver Transpl. 2016 Oct;22(10):1356-66. doi: 10.1002/lt.24507. |
| 290 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Linda Henry, Sharon Hunt. Sofosbuvir and Ledipasvir Improve Patient-Reported Outcomes in Patients Co-infected with Hepatitis C and Human Immunodeficiency Virus, Journal of Viral Hepatitis. 2016 Jun 13. doi: 10.1111/jvh.12554. |
| 291 | Aaron B. Koenig, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Robert John Wong, Zobair M Younossi. Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry., Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2016 Aug;44(3):271-8. doi: 10.1111/apt.13693. Epub 2016 Jun 9. |
| 292 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Youssef Younossi, Sharon Hunt. ADHERENCE TO TREATMENT OF CHRONIC HEPATITIS C: FROM INTERFERON CONTAINING REGIMENS TO INTERFERON AND RIBAVIRIN FREE REGIMENS, Medicine. 2016 Jul;95(28):e4151. doi: 10.1097/MD.0000000000004151. PubMed PMID: 27428205; PubMed Central PMCID. |
| 293 | Aaron B. Koenig, Maria Stepanova, Sean C. Felix, Shirley Kalwaney, Stephen C. Clement, Zobair M Younossi. Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?, Liver International. Liver Int. 2016 Aug;36(8):1096-100. doi: 10.1111/liv.13164. Epub 2016 Jun 2. |
| 294 | Zobair M Younossi, Haesuk Park, Stuart C. Gordon, John R. Ferguson, Aijaz Ahmed, Douglas T. Dieterich, Sammy Saab. Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C, American Journal of Managed Care. Am J Manag Care. 2016 May;22(6 Spec No.):SP205-11. |
| 295 | Zobair M Younossi, Maria Stepanova, Linda Henry. Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C, Value in Health. Value Health. 2016 Jul-Aug;19(5):544-51. doi: 10.1016/j.jval.2016.02.005. Epub 2016 Apr 26. |
| 296 | Pegah Golabi, Cameron T. Locklear, Patrick Austin, Sophie K. Afdhal, Melinda Byrns, Lynn Gerber, Zobair M Younossi. Effectiveness of exercise in hepatic fat mobilization in nonalcoholic fatty liver disease: Systematic review, World Journal of Gastroenterology. 2016 July 21; 22(27): 6318-6327. DOI: 10.3748/wjg.v22.i27.6318 . |
| 297 | Mehmet Sayiner, Maria Stepanova, Huong T. Pham, Bashir Noor, Mercedes Walters, Zobair M Younossi. Assessment of Health Utilities and Patients’ Quality of Life in Patients with Non-Alcoholic Fatty Liver Disease, BMJ Open Gastroenterology. BMJ Open Gastroenterol. 2016 Aug 16;3(1):e000106. doi: 10.1136/bmjgast-2016-000106. eCollection 2016.. |
| 298 | George Cholankeril, Ryan Perumpail, Menghan Hu, Gail Skowron, Zobair M Younossi, Aijaz Ahmed. Chronic Hepatitis B is Associated with Higher Inpatient Resource Utilization and Mortality versus Chronic Hepatitis C, Digestive Diseases And Sciences. Dig Dis Sci. 2016 Sep;61(9):2505-15. doi: 10.1007/s10620-016-4160-z. Epub 2016 Apr 15.. |
| 299 | Zobair M Younossi, Louis L. LaLuna, John J. Santoro, Flavia Mendes, Victor Araya, Natarajan Ravendhran, Lisa Pedicone, Idania Lio, Fatema Nader, Sharon Hunt, Andrei Racila, Maria Stepanova. Implementation of Baby Boomer Hepatitis C Screening and Linking to Care in Gastroenterology Practices: A Multi-Center Pilot Study, BMC Gastroenterology. BMC Gastroenterol. 2016 Apr 4;16(1):45. doi: 10.1186/s12876-016-0438-z. |
| 300 | Zobair M Younossi, Douglas T. Dieterich, Bruce R. Bacon, Michael P. Curry, Steven L. Flamm, Kris V. Kowdley, Yoori Lee, Naoky Tsai, Nezam H. Afdhal. Access to Therapy in the Era of All Direct Acting Antiviral Regimens: Real World Experience From the TRIO Network, Gastroenterology. APRIL 2016 Vol 5 Issue 4 Supplement 4 _ S1-S1271. |
| 301 | Zobair M Younossi, Puneetinder Mann, Mark Wymer. Reply to the letter to the editor: Global Epidemiology of Non-alcoholic Fatty Liver Disease (NAFLD), Hepatology. 2016 Mar 31. doi: 10.1002/hep.28587. [Epub ahead of print]. |
| 302 | Mehmet Sayiner, Zobair M Younossi. Identifying Patients at Risk from Non-alcoholic Fatty Liver-Related Hepatocellular Carcinomas, Hepatic Oncology. (2016) 3(2), 101–103, ePub March 23, 2016. |
| 303 | Kelly Grotzinger, Zobair M Younossi, EG Giannini, P.J. Chen, R Rendas-Baum, D Theodore. Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies, Health and Quality of Life Outcomes. 2016 Mar 22;14(1):49. doi: 10.1186/s12955-016-0447-1. |
| 304 | Zobair M Younossi, Linda Henry. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality, Gastroenterology. 2016 Jun;150(8):1778-85. doi: 10.1053/j.gastro.2016.03.005. Epub 2016 Mar 12. |
| 305 | Zobair M Younossi, Maria Stepanova, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Linda Henry. Patient-Reported Outcomes in Asian Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir, Medicine. 2016 Mar;95(9):e2702. doi: 10.1097/MD.0000000000002702. |
| 306 | Mehmet Sayiner, Mark Wymer, Pegah Golabi, Joel Ford, Indie Srishord, Zobair M Younossi. Presence of Hepatitis C (HCV) Infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation , Alimentary Pharmacology & Therapeutics. 15 MAR 2016 DOI: 10.1111/apt.13592. |
| 307 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens, American Journal of Gastroenterology. 2016 Mar 29. doi: 10.1038/ajg.2016.99. [Epub ahead of print]. |
| 308 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Ira M. Jacobson, Kosh Agarwal, Christophe Hezode, Fatema Nader, Linda Henry, Sharon Hunt. Sofosbuvir/Velpatasvir Improves Patient-Reported Outcomes in HCV Patients: Results from ASTRAL-1 Placebo-Controlled Trial, Journal of Hepatology. J Hepatol. 2016 Jul;65(1):33-9. doi: 10.1016/j.jhep.2016.02.042. Epub 2016 Mar 5. |
| 309 | Maria Stepanova, Zobair M Younossi. Letter: new treatments for hepatitis C have implications for quality of life in people who inject drug – authors' reply, Alimentary Pharmacology & Therapeutics. Aliment Pharmacol Ther. 2016 Apr;43(7):841-2. doi: 10.1111/apt.13545. |
| 310 | Ryan Perumpail, Robert John Wong, Andy Liu, Jayasekera Channa R. , Douglas T. Dieterich, Zobair M Younossi, Aijaz Ahmed. Trends in Liver Transplantation in Hepatitis C Virus-Infected Persons, United States, Emerging Infectious Diseases. 2016 Mar; 22(3): 565–567. doi: 10.3201/eid2203.151650. |
| 311 | Zobair M Younossi, Linda Henry, Haesuk Park, Ayoade Adeyemi, Maria Stepanova. The Extra-Hepatic Manifestations of Hepatitis C - A Meta-Analysis of Prevalence Rates, Effects on Patient-Reported Outcomes and Economic Burden, Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00230-4. doi: 10.1053/j.gastro.2016.02.039. [Epub ahead of print]. |
| 312 | Zobair M Younossi, Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology. Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22. |
| 313 | Pegah Golabi, Munkhzul Otgonsuren, Rebecca Cable, Sean C. Felix, Aaron B. Koenig, Mehmet Sayiner, Zobair M Younossi. Non-alcoholic Fatty Liver Disease (NAFLD) Is Associated with Impairment of Health Related Quality of Life (HRQOL), Health and Quality of Life Outcomes. 2016 Feb 9;14(1):18. doi: 10.1186/s12955-016-0420-z. |
| 314 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Linda Henry. Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens, Journal of the American Geriatrics Society. 2016 Feb;64(2):386-93. doi: 10.1111/jgs.13928. Epub 2016 Jan 30. |
| 315 | Yousef Fazel, Aaron B. Koenig, Mehmet Sayiner, Zachary Goodman, Zobair M Younossi. Epidemiology and natural history of non-alcoholic fatty liver disease, Metabolism: Clinical & Experimental. Metabolism. 2016 Aug;65(8):1017-25. doi: 10.1016/j.metabol.2016.01.012. Epub 2016 Jan 29. |
| 316 | Ryan Perumpail, Thomas A Hahambis, Avin Aggarwal, Zobair M Younossi, Aijaz Ahmed. Treatment strategies for chronic hepatitis C prior to and following liver transplantation, World Journal of Hepatology. 2016 Jan 8;8(1):69-73. doi: 10.4254/wjh.v8.i1.69. |
| 317 | Chapy Venkatesan, Alita Mishra, Amanda Morgan, Maria Stepanova, Linda Henry, Zobair M Younossi. Outcomes Trends for Acute Myocardial Infarction, Congestive Heart Failure, and Pneumonia, 2005-2009, American Journal of Managed Care. 2016 Jan 1;22(1):e9-17. |
| 318 | Ali Weinstein, Carey Escheik, Bibiana Oe, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease, Physical Medicine and Rehabilitation Clinics of North America. 2016 Jan;8(1):28-34. doi: 10.1016/j.pmrj.2015.06.001. Epub 2015 Jun 11. |
| 319 | Lynn Gerber, James M. Estep, Maria Stepanova, Carey Escheik, Ali Weinstein, Zobair M Younossi. Effects of Viral Eradication with Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients with Chronic HCV Infection, Clinical Gastroenterology And Hepatology. 2016 Jan;14(1):156-164.e3. doi: 10.1016/j.cgh.2015.07.035. Epub 2015 Aug 1. |
| 320 | Issah Younossi, Ali Weinstein, Maria Stepanova, Sharon Hunt, Zobair M Younossi. Mental and Emotional Impairment in Patients With Hepatitis C is Related to Lower Work Productivity, Psychosomatics. 2016 Jan-Feb;57(1):82-8. doi: 10.1016/j.psym.2015.10.005. Epub 2015 Oct 23. |
| 321 | Ali Weinstein, Carey Escheik, Bibiana Oe, Jillian Kallman Price, Lynn Gerber, Zobair M Younossi. Perception of Effort During Activity in Patients with Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease, PM&R. 2016 Jan;8(1):28-34. doi: 10.1016/j.pmrj.2015.06.001. Epub 2015 Jun 11. |
| 322 | Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron B. Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis, Expert Review of Gastroenterology Hepatology. 2016 Jan;10(1):63-71. doi: 10.1586/17474124.2016.1099433. Epub 2015 Oct 15. |
| 323 | Pegah Golabi, Munkhzul Otgonsuren, Winnie Suen, Aaron B. Koenig, Bashir Noor, Zobair M Younossi. Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients with Chronic Hepatitis C (CH-C) in the United States, Medicine. 2016 Jan;95(3):e2482. doi: 10.1097/MD.0000000000002482. |
| 324 | Zobair M Younossi, Maria Stepanova, James M. Estep, Francesco Negro, Paul Clark, Sharon Hunt, Qinghua Song, Matthew Paulson, Luisa Stamm, Diana Brainard, Mani Subramanian, John McHutchison, Keyur Patel. Dysregulation of Distal Cholesterol Biosynthesis in Association with Relapse and Advanced Disease in CHC Genotype 2 and 3 Treated with Sofosbuvir and Ribavirin , Journal of Hepatology. 2016 Jan;64(1):29-36. doi: 10.1016/j.jhep.2015.08.027. Epub 2015 Sep 1. |
| 325 | Zobair M Younossi, Maria Stepanova, Stanislas Pol, Jean-Pierre Bronowicki, Maria Patrizia Carrieri, Marc Bourliere. The Impact of Ledipasvir/Sofosbuvir on Patient-Reported Outcomes in Cirrhotic Patients with Chronic Hepatitis C: The SIRIUS Study., Liver International. 2016 Jan;36(1):42-8. doi: 10.1111/liv.12886. Epub 2015 Jun 24. |
| 326 | Zobair M Younossi, Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Global Epidemiology of Non-Alcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence and Outcomes, Hepatology. 2015 Dec 28. doi: 10.1002/hep.28431. [Epub ahead of print]. |
| 327 | Andy Liu, Ryan Perumpail, Ameeta Kumar, Zobair M Younossi, Robert John Wong, Aijaz Ahmed. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy, World Journal of Hepatology. 2015 Dec 18;7(29):2871-9. doi: 10.4254/wjh.v7.i29.2871. |
| 328 | Maria Stepanova, Linda Henry, Rishi Garg, Shirley Kalwaney, Sammy Saab, Zobair M Younossi. Risk of Post-Transplant Type 2 Diabetes in Patients Undergoing Liver Transplant for Non-Alcoholic Steatohepatitis , BMC Gastroenterology. BMC Gastroenterol. 2015 Dec 15;15:175. doi: 10.1186/s12876-015-0407-y.. |
| 329 | Maria Stepanova, Linda Henry, Rishi Garg, Shirley Kalwaney, Sammy Saab, Zobair M Younossi. Risk of De Novo Post-Transplant Type 2 Diabetes in Patients Undergoing Liver Transplant for Non-Alcoholic Steatohepatitis, BMC Gastroenterology. 2015 Dec 15;15:175. doi: 10.1186/s12876-015-0407-y. |
| 330 | Mehmet Sayiner, Aaron B. Koenig, Linda Henry, Zobair M Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World, Clinics In Liver Disease. May;20(2):205-14. doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14. |
| 331 | Zobair M Younossi. Ethics of Prescribing New Direct Acting Antiviral Agents, Clinical Liver Disease. Volume 6, Issue 5, Version of Record online: 9 DEC 2015. |
| 332 | Zobair M Younossi, Linda Henry. Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease, PharmacoEconomics. 2015 Dec;33(12):1245-53. doi: 10.1007/s40273-015-0316-5. |
| 333 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009., Hepatology. 2015 Dec;62(6):1723-30. doi: 10.1002/hep.28123. Epub 2015 Oct 24. |
| 334 | Zobair M Younossi. What is the ethical responsibility of a provider when prescribing the new direct-acting antiviral agents to patients with hepatitis C infection?, Clinical Liver Disease. November 2015 Volume 6, Issue 5 Pages 117–1119 DOI: 10.1002/cld.509. |
| 335 | Haesuk Park, Ayoade Adeyemi, Linda Henry, Maria Stepanova, Zobair M Younossi. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection, Journal of Viral Hepatitis. 2015 Nov;22(11):897-905. doi: 10.1111/jvh.12413. Epub 2015 Apr 22. |
| 336 | Maria Stepanova, Zobair M Younossi. Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage, Digestive Diseases And Sciences. 2015 Nov;60(11):3248-51. doi: 10.1007/s10620-015-3709-6. Epub 2015 May 19. |
| 337 | Zobair M Younossi. The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?, Clinical Liver Disease. November 2015 Volume 6, Issue 5 Pages 126–128 DOI: 10.1002/cld.514. |
| 338 | Zobair M Younossi, Ashley S. Brown, Maria Buti, Stefano Fagiuoli, Stefan Mauss, William Rosenberg, Lawrence Serfaty, Ankur Srivastava, Nathaniel Smith, Maria Stepanova, Rachel Beckerman. Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries, Journal of Viral Hepatitis. 20 OCT 2015 DOI: 10.1111/jvh.12483. |
| 339 | Ryan Perumpail, Robert John Wong, J.D. Scandling, L.D. Ha, T Todo, Clark Bonham, Sammy Saab, Zobair M Younossi, Aijaz Ahmed. HCV Infection is Associated with Lower Survival in Simultaneous Liver Kidney Transplant Recipients in the U.S., Clinical Transplantation. 2015 Oct;29(10):920-6. doi: 10.1111/ctr.12598. Epub 2015 Aug 29. |
| 340 | Lynn Gerber, Zobair M Younossi. Reply to Debilitating fatigue as a treatment indication in chronic hepatitis C, Journal of Hepatology. December 2015 Volume 63, Issue 6, Pages 1534–1535 . |
| 341 | Brian P. Lam, Thomas Jeffers, Zahra Younoszai, Yousef Fazel, Zobair M Younossi. The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment, Therapeutic Advances in Gastroenterology. 2015 Sep;8(5):298-312. doi: 10.1177/1756283X15587481. |
| 342 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Fatema Nader, Sharon Hunt. The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: a study of health-related quality of life, Alimentary Pharmacology & Therapeutics. 2015 Aug;42(3):286-95. doi: 10.1111/apt.13269. Epub 2015 Jun 9. |
| 343 | Maria Stepanova, Homan Wai, Sammy Saab, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. The outcomes of adult liver transplants in the United States from 1987 to 2013, Liver International. 2015 Aug;35(8):2036-41. doi: 10.1111/liv.12779. Epub 2015 Jan 21. |
| 344 | Zobair M Younossi, Maria Stepanova, Nid Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon Hunt, Patrick Marcellin. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir., Journal of Hepatology. 2015 Aug;63(2):337-45. doi: 10.1016/j.jhep.2015.03.014. Epub 2015 Mar 17. |
| 345 | Yousef Fazel, Brian P. Lam, Pegah Golabi, Zobair M Younossi. Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C, Expert Opinion on Drug Safety. 2015 Aug;14(8):1317-26. doi: 10.1517/14740338.2015.1053868. Epub 2015 Jun 4. |
| 346 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Massimo Puoti, Chloe Orkin, Sharon Hunt. Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes., Journal of Infectious Diseases. 2015 Aug 1;212(3):367-77. doi: 10.1093/infdis/jiv005. Epub 2015 Jan 12. |
| 347 | Zobair M Younossi, Linda Henry. Overall Health-Related Quality of Life in Patients With End-Stage Liver Disease, Clinical Liver Disease. 28 JUL 2015; 6(1). DOI:10.1002/cld.480. |
| 348 | Zobair M Younossi, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Lynn Gerber, Fatema Nader, Luisa Stamm, Diana Brainard, John McHutchison. Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels, Journal of Viral Hepatitis. 2015 July 1; doi:10.1111/jvh.12448. |
| 349 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Brian P. Lam, Manirath Srishord, Chapy Venkatesan, Homan Wai, Linda Henry. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes, Journal of Viral Hepatitis. doi: 10.1111/jvh.12449. Epub 2015 Aug 20. |
| 350 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon Hunt. Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials, Hepatology. 2015 Jun;61(6):1798-808. doi: 10.1002/hep.27724. Epub 2015 Mar 18. |
| 351 | Tarek Hassanein, Karen D. Sims, Michael Bennett, Norman Gitlin, Eric Lawitz, Tuan Nguyen, Lynn Webster, Zobair M Younossi, Howard Schwartz, Paul J. Thuluvath, Helen Zhou, Bhaskar. Rege, Fiona McPhee, Nannan Zhou, Megan Wind-Rotolo, Ellen Chung, Amber Griffies, Dennis M. Grasela, David F. Gardiner. A Randomized Trial of Daclatasvir in Combination With Asunaprevir and Beclabuvir in Patients With Chronic Hepatitis C Virus Genotype 4 Infection, Journal of Hepatology. 2015 May;62(5):1204-6. doi: 10.1016/j.jhep.2014.12.025. Epub 2015 Jan 2. |
| 352 | Zobair M Younossi, Yushan Jiang, Nathaniel Smith, Maria Stepanova, Rachel Beckerman. Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States, Hepatology. 2015 May;61(5):1471-8. doi: 10.1002/hep.27757. Epub 2015 Mar 23. |
| 353 | Azza Karrar, Maria Stepanova, Lakshmi Alaparthi, Sneha Lingam, Zahra Younoszai, Li Zheng, Khatera Salem Malik, Elena Younossi, Fanny Monge, Sharon Hunt, Zachary Goodman, Zobair M Younossi. Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease, Journal of Gastroenterology and Hepatology. J Gastroenterol Hepatol. 2015 May;30(5):900-8. doi: 10.1111/jgh.12856.. |
| 354 | James M. Estep, Zachary Goodman, Haveesh Sharma, Elena Younossi, Hazem Elariny, Ancha Baranova, Zobair M Younossi. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD, Liver International. Liver Int. 2015 Apr;35(4):1367-72. doi: 10.1111/liv.12555. Epub 2014 Apr 23.. |
| 355 | Aybike Birerdinc, Zobair M Younossi. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?, Journal of Hepatology. 2015 Apr;62(4):761-2. doi: 10.1016/j.jhep.2015.01.005. Epub 2015 Jan 17. |
| 356 | Monica Shah, Zobair M Younossi. Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--diagnosis and management., American Journal of Managed Care. 2015 Mar;21(5 Suppl):s86-96. |
| 357 | Robert John Wong, Maria Aguilar, Ramsey Cheung, Ryan Perumpail, Stephen A. Harrison, Zobair M Younossi, Aijaz Ahmed. Nonalcoholic Steatohepatitis is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the U.S., Gastroenterology. 2015 Mar;148(3):547-55. doi: 10.1053/j.gastro.2014.11.039. Epub 2014 Nov 25. |
| 358 | Maria Stepanova, Zobair M Younossi. The association of hepatitis C virus infection and post-liver transplant diabetes - authors' reply, Alimentary Pharmacology & Therapeutics. 2015 Mar;41(5):489. doi: 10.1111/apt.13072. |
| 359 | Zobair M Younossi, Li Zheng, Maria Stepanova, Linda Henry, Chapy Venkatesan, Alita Mishra. Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease, Journal of Clinical Gastroenterology. 2015 Mar;49(3):222-7. |
| 360 | Monica Shah, Zobair M Younossi, Yekaterina Opsha. Revolutionizing treatment outcomes in hepatitis c: managed care implications and considerations-a clinical overview, American Journal of Managed Care. 2015 Mar;21(5 Suppl):s76-8. |
| 361 | Zobair M Younossi, Haesuk Park, Sammy Saab, Aijaz Ahmed, Douglas T. Dieterich, Stuart C. Gordon. Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection, Alimentary Pharmacology & Therapeutics. 2015 Mar;41(6):544-63. doi: 10.1111/apt.13081. Epub 2015 Jan 26. |
| 362 | Zobair M Younossi, Linda Henry. Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens, Alimentary Pharmacology & Therapeutics. 2015 Mar;41(6):497-520. doi: 10.1111/apt.13090. Epub 2015 Jan 23. |
| 363 | T Berg, P Andreone, Stanislas Pol, Stuart Roberts, Zobair M Younossi, Moises Diago, Eric Lawitz, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Isabelle Lonjon-Domanec, Ralph DeMasi, Gaston Picchio, Don Luo, Sandra De Meyer, Stefan Zeuzem. Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study, Liver International. 2015 Feb;35(2):448-54. doi: 10.1111/liv.12703. Epub 2014 Nov 11. |
| 364 | Emmi Suomela, Mervi Oikonen, Johanna Virtanen, Riita Parkkola, Eero Jokinen, Tomi Laitnen, Nina Hutri-Kahonen, Mika Kahonen, Terho Lehtimaki, Leena Taittonen, Paivi Tossavainen, Antti Jula, Britt-Marie Loo, Zobair M Younossi, Jorma S. A. Viikari, Markus Juonala, Olli T. Raitakari. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study, Annals of Medicine. 2015 Feb;47(1):40-6. doi: 10.3109/07853890.2014.966752. Epub 2014 Oct 21. |
| 365 | Munkhzul Otgonsuren, Linda Henry, Sharon Hunt, Chapy Venkatesan, Alita Mishra, Zobair M Younossi. Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease., Digestive Diseases And Sciences. 2015 Feb;60(2):320-32. doi: 10.1007/s10620-014-3318-9. Epub 2014 Aug 10. |
| 366 | J Aggarwal, M Vera-Llonch, M Donepudi, E Suthoff, Zobair M Younossi, T Goss. Work productivity among treatment-naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment, Journal of Viral Hepatitis. 2015, 22, 8–17. |
| 367 | Rohini Mehta, Arpan Neupane, Lei Wang, Zachary Goodman, Ancha Baranova, Zobair M Younossi. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects, BMC Gastroenterology. 2014 Dec 16;14:208. doi: 10.1186/s12876-014-0208-8. |
| 368 | Zobair M Younossi, Linda Henry. The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C, Digestive and Liver Disease. 2014 Dec 15;46 Suppl 5:S186-96. doi: 10.1016/j.dld.2014.09.025. Epub 2014 Nov 10. |
| 369 | Munkhzul Otgonsuren, James M. Estep, Noreen Hossain, Elena Younossi, Spencer Frost, Linda Henry, Sharon Hunt, Yun Fang, Zachary Goodman, Zobair M Younossi. A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), Journal of Gastroenterology and Hepatology. 2014 Dec;29(12):2006-13. |
| 370 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Linda Henry. The Association of Hepatitis C Virus Infection and Post-Liver Transplant Diabetes: Data from 17,000 HCV-infected Transplant Recipients, Alimentary Pharmacology & Therapeutics. 21 NOV 2014 DOI: 10.1111/apt.130272014,. |
| 371 | Eric Lawitz, Mark S. Sulkowski, Reem Ghalib, Maribel Rodriguez-Torres, Zobair M Younossi, Ana Corregidor, Edwin Dejesus, Brian Pearlman, Mordechai Rabinovitz, Norman Gitlin, Joseph K Lim, Paul J. Pockros, J.D. Scott, Bart Fevery, Tom Lambrecht, Sivi Ouwerkerk-Mahadevan, Katleen Callewaert, William Symonds, Gaston Picchio, Karen L Lindsay, Maria Beumont, Ira M. Jacobson. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study, Lancet. 2014 Nov 15;384(9956):1756-65. doi: 10.1016/S0140-6736(14)61036-9. Epub 2014 Jul 28. |
| 372 | Maria Stepanova, Zobair M Younossi. Editorial: Patients’ preferences and health utility assessment in those with HCV treated with sofosbuvir – stating the obvious? Authors’ reply, Alimentary Pharmacology & Therapeutics. 3 OCT 2014 DOI: 10.1111/apt.12955. |
| 373 | Zobair M Younossi. Curing Chronic Hepatitis C With Sofosbuvir-Based Regimens, American Journal of Managed Care. Oct 2014, Volume 20, Special Issue 15. |
| 374 | Timothy Leslie, Lisa Pawloski, Jillian Kallman Price, Carey Escheik, Noreen Hossain, Yun Fang, Lynn Gerber, Zobair M Younossi. Survey of Health Status, Nutrition and Geography of Food Selection of Chronic Liver Disease Patients, Annals of Hepatology. 2014 Sep-Oct;13(5):533-40. |
| 375 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Shirley Kalwaney, Stephen C. Clement, Linda Henry, Spencer Frost, Sharon Hunt. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US, Alimentary Pharmacology & Therapeutics. 2014 Sep;40(6):676-85. doi: 10.1111/apt.12880. Epub 2014 Jul 15. |
| 376 | Sammy Saab, Stuart C. Gordon, Haesuk Park, Mark S. Sulkowski, Aijaz Ahmed, Zobair M Younossi. Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavririn in the treatment of chronic hepatitis C virus genotype 1 infection, Alimentary Pharmacology & Therapeutics. Volume 40, Issue 6, pages 657–675, September 2014. |
| 377 | Brian P. Lam, Linda Henry, Zobair M Younossi. Sofosbuvir (Sovaldi) for the treatment of hepatitis C, Expert Review of Clinical Pharmacology. 2014 Sep;7(5):555-66. doi: 10.1586/17512433.2014.928196. Epub 2014 Jun 11. |
| 378 | Linda Henry, Zobair M Younossi. Hepatitis. Chronic HCV infection, diabetes and liver-related outcomes, Nature Reviews Gastroenterology & Hepatology. 2014 Sep;11(9):520-1. doi: 10.1038/nrgastro.2014.122. Epub 2014 Jul 1. |
| 379 | Maria Stepanova, Fatema Nader, Sandrine Cure, Francois Bourhis, Sharon Hunt, Zobair M Younossi. Patients' Preferences and Health Utility Assessment with SF-6D and EQ-5D in Patients with Chronic Hepatitis C Treated with Sofosbuvir Regimens, Alimentary Pharmacology & Therapeutics. 2014 Sep;40(6):676-85. doi: 10.1111/apt.12880. Epub 2014 Jul 15. |
| 380 | Zobair M Younossi, Maria Stepanova, Linda Henry, Edward J. Gane, Eric Lawitz, David R. Nelson, Lynn Gerber, Fatema Nader, Sharon Hunt. Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C, Clinical Gastroenterology And Hepatology. 2014 Aug;12(8):1349-59.e13. doi: 10.1016/j.cgh.2013.11.032. Epub 2013 Dec 6. PubMed PMID: 24316172. |
| 381 | Maria Stepanova, Homan Wai, Alita Mishra, Chapy Venkatesan, Zobair M Younossi. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013, Journal of American Medical Association Internal Medicine. 2014 Aug;174(8):1407-9. doi: 10.1001/jamainternmed.2014.2903. |
| 382 | Zobair M Younossi, Linda Henry, E Mendel Singer. Reply to: "Cost-effectiveness of upcoming treatments for hepatitis C: we need to get the models right"., Journal of Hepatology. 2014 Aug;61(2):454-5. doi: 10.1016/j.jhep.2014.05.006. Epub 2014 May 10. |
| 383 | Zobair M Younossi, Maria Stepanova, Stefan Zeuzem, Geoffrey Dusheiko, Rafael Esteban, Christophe Hezode, Hendrik W. Reesink, Ola Weiland, Fatema Nader, Sharon Hunt. Patient-Reported Outcomes Assessment in Chronic Hepatitis C Treated with Sofosbuvir and Ribavirin: The VALENCE Study, Journal of Hepatology. 2014 Aug;61(2):228-34. doi: 10.1016/j.jhep.2014.04.003. Epub 2014 Apr 5. |
| 384 | Robert John Wong, Fasiha Kanwal, Zobair M Younossi, Aijaz Ahmed. Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature., Digestive Diseases And Sciences. 2014 Jul;59(7):1586-93. doi: 10.1007/s10620-014-3222-3. Epub 2014 Jun 4. |
| 385 | Zobair M Younossi, Linda Henry. Monitoring and Treatment of Inactive Chronic Hepatitis B: IS it Cost-Effective?, Hepatology. 2014 Jul;60(1):19-21. doi: 10.1002/hep.27062. Epub 2014 May 27. PubMed PMID: 24504789. |
| 386 | Janus P. Ong, Zobair M Younossi. Editorial: Probiotics in NASH - more studies needed, Alimentary Pharmacology & Therapeutics. 19 JUN 2014 DOI: 10.1111/apt.12812. |
| 387 | Anthony Loria, Katherine Doyle, Ali Weinstein, Patrice Winter, Carey Escheik, Jillian Kallman Price, Lei Wang, Aybike Birerdinc, Ancha Baranova, Lynn Gerber, Zobair M Younossi. Multiple Factors Predict Physical Performance in People with Chronic Liver Disease, American Journal of Physical Medicine and Rehabilitation. 2014 Jun;93(6):470-6. doi: 10.1097/PHM.0000000000000050. PubMed PMID: 24398583. |
| 388 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Ira M. Jacobson, Edward J. Gane, David R. Nelson, Eric Lawitz, Sharon Hunt. Patient-reported Outcomes in Chronic Hepatitis C Patients with Cirrhosis Treated with Sofosbuvir-containing Regimens, Hepatology. 2014 Jun;59(6):2161-9. doi: 10.1002/hep.27161. Epub 2014 Apr 30. |
| 389 | Zobair M Younossi, Li Zheng, Maria Stepanova, Chapy Venkatesan, Alita Mishra. Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study (spelling is European), British Medical Journal-Open. 2014 May 16;4(5):e004318. doi: 10.1136/bmjopen-2013-004318. |
| 390 | Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, Zareen Arsalla, Maria Stepanova, Alita Mishra, Chapy Venkatesan, Sharon Hunt. Inpatient Resource Utilization, Disease Severity, Mortality and Insurance Coverage for Patients Hospitalized for Hepatitis C Virus in the United States, Journal of Viral Hepatitis. 2014 May 12. doi: 10.1111/jvh.12262. |
| 391 | Rohini Mehta, Aybike Birerdinc, Lei Wang, Zahra Younoszai, Amir Moazzez, Hazem Elariny, Zachary Goodman, Vikas Chandhoke, Ancha Baranova, Zobair M Younossi. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease, BMC Gastroenterology. 2014 Apr 9;14:72. doi: 10.1186/1471-230X-14-72. |
| 392 | Zobair M Younossi, Maria Stepanova, Linda Henry, Edward J. Gane, Ira M. Jacobson, Eric Lawitz, David R. Nelson, Fatema Nader, Sharon Hunt. Minimal Impact of Sofosbuvir and Ribavirin on Health Related Quality of Life in Chronic Hepatitis C (CH-C), Journal of Hepatology. 2014 Apr;60(4):741-7. doi: 10.1016/j.jhep.2013.12.006. Epub 2013 Dec 11. PubMed PMID: 24333184. |
| 393 | James M. Estep, Zachary Goodman, Haveesh Sharma, Elena Younossi, Hazem Elariny, Ancha Baranova, Zobair M Younossi. Adipocytokine Expression Associated with miRNA Regulation and Diagnosis in Obese Patients with NAFLD, Liver International. 2014 Mar 29. doi: 10.1111/liv.12555. [Epub ahead of print] PubMed PMID: 24684403. |
| 394 | Zobair M Younossi, Fasiha Kanwal, Sammy Saab, K. A. Brown, H.B. El-Serag, W.R. Kim, Aijaz Ahmed, Marcelo Kugelmas, Stuart C. Gordon. The impact of hepatitis C burden: an evidence-based approach, Alimentary Pharmacology & Therapeutics. 2014 Mar;39(5):518-31. doi: 10.1111/apt.12625. |
| 395 | Zobair M Younossi, E Mendel Singer, Heshaam Mir, Linda Henry, Sharon Hunt. Impact of Interferon Free Regimens on Clinical and Cost Outcomes for chronic hepatitis C genotype I patients: A Decision Analytic Assessment , Journal of Hepatology. 2014 Mar;60(3):530-7. doi: 10.1016/j.jhep.2013.11.009. Epub 2013 Nov 19. PubMed PMID: 24269472. |
| 396 | Yusuf Yilmaz, Zobair M Younossi. Obesity-associated nonalcoholic Fatty liver disease, Clinics In Liver Disease. 2014 Feb;18(1):19-31. doi: 10.1016/j.cld.2013.09.018. Epub 2013 Oct 24. Review. PubMed PMID: 24274862. |
| 397 | Zobair M Younossi. Obesity and Liver Disease, Clinics In Liver Disease. 2014 Feb;18(1):xiii-xiv. doi: 10.1016/j.cld.2013.09.020. Epub 2013 Oct 25. PubMed PMID: 24274879. |
| 398 | Zahra Younoszai, Li Zheng, Maria Stepanova, Madeline Erario, Rebecca Cable, Zobair M Younossi. Statin use is not associated with liver related mortality, Annals of Hepatology. 2013 Jan-2014 Feb;13(1):84-90. |
| 399 | Nila Rafiq, Maria Stepanova, Brian P. Lam, Fatema Nader, Manirath Srishord, Zobair M Younossi. Predictors of chronic liver disease in individuals with human immunodeficiency virus infection, Annals of Hepatology. 2013 Jan-2014 Feb;13(1):60-4. |
| 400 | Rohini Mehta, Aybike Birerdinc, Zobair M Younossi. Host Genetic Variants in Obesity-Related Non-Alcoholic Fatty Liver Disease (NAFLD), Clinics In Liver Disease. 2014 Feb;18(1):249-67. doi: 10.1016/j.cld.2013.09.017. Epub 2013 Oct 24. Review. PubMed PMID: 24274878. |
| 401 | C. McGown, Aybike Birerdinc, Zobair M Younossi. Adipose Tissue as an Endocrine Organ, Clinics In Liver Disease. 2014 Feb;18(1):41-58. doi: 10.1016/j.cld.2013.09.012. Review. PubMed PMID: 24274864. |
| 402 | Zobair M Younossi, Reyes , Alita Mishra, Rohini Mehta, Linda Henry. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets, Alimentary Pharmacology & Therapeutics. 2014 Jan;39(1):3-14. doi: 10.1111/apt.12543. |
| 403 | Homan Wai, Maria Stepanova, Sammy Saab, Madeline Erario, Manirath Srishord, Zobair M Younossi. Inpatient Economic and Mortality Assessment for Liver Transplantation: A Nationwide Study of the United States Data from 2005 to 2009, Transplantation. 2014 Jan 15;97(1):98-103. doi: 10.1097/TP.0b013e3182a716ac. PubMed PMID: 24056627. |
| 404 | Elzafir Elsheikh Abdelrahman, Zahra Younoszai, Munkhzul Otgonsuren, Sharon Hunt, Bryan Raybuck, Zobair M Younossi. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease, Journal of Gastroenterology and Hepatology. 2014;29(7):1528-34. |
| 405 | Zobair M Younossi, Linda Henry, Maria Stepanova. A New Comorbidity Model for Predicting Mortality in Patients With Cirrhosis: Does It Work? , Gastroenterology. 2014 Jan;146(1):19-24. doi: 10.1053/j.gastro.2013.11.026. Epub 2013 Nov 25. PubMed PMID: 24287302. |
| 406 | Zobair M Younossi, Francesco Negro, Lawrence Serfaty, Stanislas Pol, Moises Diago, Stefan Zeuzem, Pietro Anderone, Eric Lawitz, Stuart Roberts, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Isabelle Lonjon-Domanec, Bruce Coate, Ralph DeMasi, Gaston Picchio, James Witek. Homeostasis Model Assessment of Insulin Resistance Does Not Seem to Predict Response to Telaprevir in Chronic Hepatitis C in the REALIZE Trial, Hepatology. 2013 Dec;58(6):1897-906. doi: 10.1002/hep.26437. |
| 407 | Elzafir Elsheikh Abdelrahman, Linda Henry, Zobair M Younossi. Current Management of Patients with Non Alcoholic Fatty Liver Disease, Expert Review of Endocrinology and Metabolism. November 2013, Vol 8, No. 6, Pages 549-558 (doi: 10.1586/1744651.2013.846212) . |
| 408 | Zobair M Younossi, Maria Stepanova, Alita Mishra, Chapy Venkatesan, Linda Henry, Sharon Hunt. The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010 , Alimentary Pharmacology & Therapeutics. 2013 Nov;38(9):1065-75. doi: 10.1111/apt.12485. |
| 409 | Maria Stepanova, Nila Rafiq, Hala Makhlouf, R Agarwal, I Kaur, Zahra Younoszai, Arthur McCullough, Zachary Goodman, Zobair M Younossi. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD), Digestive Diseases And Sciences. 2013 Oct;58(10):3017-23. doi: 10.1007/s10620-013-2743-5. Epub 2013 Jun 18. |
| 410 | Gregory Trimble, Li Zheng, Alita Mishra, Heshaam Mir, Zobair M Younossi. Mortality Associated with Alcohol-related liver disease, Alimentary Pharmacology & Therapeutics. 2013 Sep;38(6):596-602. doi: 10.1111/apt.12432. |
| 411 | Alita Mishra, Zobair M Younossi. Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-a2a/ribavirin in combination with a direct-acting anti-viral, Alimentary Pharmacology & Therapeutics. 2013 Sep;38(5):557-8. doi: 10.1111/apt.12419. |
| 412 | Dusan Popovic, Nada V. Kovacevic, Darija B. Tepavevic, Goran Z. Trajkovic, Tamara M. Alempijevic, Milan M. Spuran, Miodrag N. Krstic, Rada S. Jesic, Zobair M Younossi, Tatjana D. Pekmezovic. Validation of the chronic liver disease questionnaire in Serbian patients, World Journal of Gastroenterology. 2013 Aug 14;19(30):4950-7. doi: 10.3748/wjg.v19.i30.4950. |
| 413 | Haveesh Sharma, James M. Estep, Amir Moazzez, Arian Afendy, Aybike Birerdinc, Hazem Elariny, Zachary Goodman, Ancha Baranova, Zobair M Younossi, Vikas Chandhoke. Expression of Genes for miRNAs-Processing Enzymes is Altered in Advanced Non-alcoholic Fatty Liver Disease, Journal of Gastroenterology and Hepatology. 2013 Aug;28(8):1410-5. doi: 10.1111/jgh.12268. |
| 414 | Zobair M Younossi, Maria Stepanova, Mariam Afendy, Brian P. Lam, Alita Mishra. Knowledge about Infection is the Only Predictor of Treatment in Patients with Chronic Hepatitis C, Journal of Viral Hepatitis. 2013 Aug;20(8):550-5. doi: 10.1111/jvh.12080. |
| 415 | M Vera-Llonch, M Martin, J Aggarwal, M Donepudi, M Bayliss, T Goss, Zobair M Younossi. Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study., Alimentary Pharmacology & Therapeutics. 2013 Jul;38(2):124-33. doi: 10.1111/apt.12354. |
| 416 | John Paul Verderese, Zobair M Younossi. Interaction of type 2 diabetes and nonalcoholic fatty liver disease, Expert Review of Gastroenterology Hepatology. 2013 Jul;7(5):405-7. doi: 10.1586/17474124.2013.811047. |
| 417 | Zobair M Younossi, Jillian Kallman Price, Lynn Gerber, C Bai, G Diao. Comparison of Activity Level among Patients with Chronic Liver Disease, Disability and Rehabilitation. 2013 Jun;35(11):907-12. doi: 10.3109/09638288.2012.712601. |
| 418 | Zobair M Younossi, Ancha Baranova, Q. Tran, Arian Afendy, Lei Wang, Vikas Chandhoke, Rohini Mehta, Aybike Birerdinc, A. Shamsaddini. Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS), Journal of Translational Medicine. 2013 May 31;11:133. |
| 419 | Alita Mishra, Zobair M Younossi, Munkhzul Otgonsuren, Chapy Venkatesan, Mariam Afendy, Madeline Erario. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample, Liver International. 2013;33(8):1281-86. |
| 420 | Zobair M Younossi, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Paul J. Pockros, Gaston Picchio, Stefan Zeuzem, Stanislas Pol, Pietro Anderone, Eric Lawitz, Stuart Roberts, Jeroen Aerssens, Maria Beumont, Martyn Botfield, Don Luo, Sandra De Meyer, Rolf P.G. Van Heeswijk. Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure, Journal of Hepatology. 2013 May;58(5):883-9. doi: 10.1016/j.jhep.2012.12.023. |
| 421 | Zobair M Younossi, Eric Lawitz, Edgar Rodriguez, Tarek Hassanein, Stuart C. Gordon, Ira M. Jacobson, Kris V. Kowdley, Lisa M. Nyberg, Mani Subramanian, Diana Brainard, William Symonds, Edward J. Gane. Sofosbuvir for previously untreated chronic hepatitis C infection, New England Journal of Medicine. 2013; 368:1878-1887. |
| 422 | Maria Stepanova, Chapy Venkatesan, Laith Altaweel, Alita Mishra, Zobair M Younossi. Recent Trends in Inpatient Mortality and Resource Utilization for Patients with Stroke in the United States: 2005-2009, Journal of Stroke and Cerebrovascular Disease. 2013 May;22(4):491-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.03.005. |
| 423 | Zobair M Younossi, Li Zheng, Maria Stepanova, Heshaam Mir, Chapy Venkatesan. Moderate Alcohol Consumption in Patients with Chronic Hepatitis C (CH-C) Is Associated with Higher Risk of Mortality, Alimentary Pharmacology & Therapeutics. 2013;37(7):703-709. |
| 424 | Zobair M Younossi, Munkhzul Otgonsuren, Maria Stepanova, Lynn Gerber. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease, Digestive Diseases And Sciences. 2013 Apr;58(4):1132-40. |
| 425 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Zahra Younoszai, Elzafir Elsheikh Abdelrahman. Associations of chronic hepatitis C with metabolic and cardiac Outcomes, Alimentary Pharmacology & Therapeutics. 2013 Mar;37(6):647-52. doi: 10.1111/apt.12234. |
| 426 | Graham R. Foster, Stefan Zeuzem, Pietro Anderone, Stanislas Pol, Eric Lawitz, Moises Diago, Stuart Roberts, Paul J. Pockros, Zobair M Younossi, Isabelle Lonjon-Domanec, Sandra De Meyer, Don Luo, Maria Beumont, Gaston Picchio, Shelley George. Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure 2012, Journal of Hepatology. 2013 Mar;58(3):488-94. doi: 10.1016/j.jhep.2012.11.013. |
| 427 | Zobair M Younossi, Munkhzul Otgonsuren, Chapy Venkatesan, Alita Mishra. In Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Metabolically Abnormal Individuals are at Higher Risk for Mortality while Metabolically Normal Individuals are not, Metabolism: Clinical & Experimental. 2013 Mar;62(3):352-60. doi: 10.1016/j.metabol.2012.08.005. |
| 428 | Zobair M Younossi, Anna Zhang, Maria Stepanova, Heshaam Mir, Chapy Venkatesan. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics. Volume 37, Issue 7, Article first published online: 24 FEB 2013. |
| 429 | Rohini Mehta, Aybike Birerdinc, Arpan Neupane, Arian Afendy, Hazem Elariny, Vikas Chandhoke, Ancha Baranova, Zobair M Younossi, A. Shamsaddini. Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD, Mediators of Inflammation. 2013 Feb; vol. 2013, Article ID 684237, 10 pages, 2013. doi:10.1155/2013/684237 . |
| 430 | Aybike Birerdinc, James M. Estep, Maria Stepanova, Arian Afendy, Zobair M Younossi, Vikas Chandhoke, Ancha Baranova, Emanuel F. Petricoin, Sandra Page. Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example, PLOS One. 2013;8(2): e56009. |
| 431 | Keanu Lee, Munkhzul Otgonsuren, Zahra Younoszai, Heshaam Mir, Zobair M Younossi. Association of chronic liver disease with depression: a population-based study, Psychosomatics. 2013 Jan-Feb;54(1):52-9. doi: 10.1016/j.psym.2012.09.005. PubMed PMID: 23295007. |
| 432 | Anthony Loria, Carey Escheik, Lynn Gerber, Zobair M Younossi. Quality of Life in Cirrhosis, Current Gastroenterology Report. 2013 Jan;15(1):301. doi: 10.1007/s11894-012-0301-5. |
| 433 | Rishi Garg, Zachary Goodman, Zobair M Younossi. Commentary: phlebotomy in non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics. 2013 Jun;37(11):1112. doi: 10.1111/apt.12322. |
Journal Supplements
| Num | Title |
|---|---|
| 1 | Z. Younossi (Guest Editor). The Impact of Obesity and Nutrition on Chronic Liver Diseases. Clinics in Liver Disease 2014 Feb; 18(1):xiii-xiv.doi:10.1016/j.cld.2013.9.020. |
Book Chapters
| Num | Title |
|---|---|
| 1 | Z. Younossi. Health-related Quality of Life Measurement in Patients with Chronic Liver Disease. Advances in Hepatic Encephalopathy & Metabolism in Liver Disease. Yurdaydin C, Bozkaya H (Editors). Ankara University Press. 2000. |
| 2 | G. Grant, V. Chandhoke, Z. Younossi. Specific Disorders Associated with Non-Alcoholic Fatty Liver Disease. (Book Chapter). Fatty Liver Diseases: Non-Alcoholic Steatohepatitis and Related Disorders. Blackwell Publishers, 1st edition. 2004. |
| 3 | A. Baranova, Z. Younossi. Adipokines in Non-alcoholic Fatty Liver Diseases. Adipose Tissue and Adipokines in Health and Disease (First Edition). The Humana Press. 2006. |
| 4 | J. Ong, Z. Younossi. Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Clinics in Liver Disease 2007; 11(1):1-16. |
| 5 | P.Mishra, N. Rafiq, Z. Younossi. Non-Alcoholic Fatty Liver Disease. Practical Management of Liver Diseases. (Younossi Z, Editor), Cambridge Press. 2008. |
| 6 | A. Baranova, L. Liotta, E. Petricoin. New Technologies in the Study of Liver Diseases. Clinician�s Guide to Common Liver Diseases. (Younossi Z, Editor), Cambridge Press. 2008. |
| 7 | A. Dan, Z. Younossi. Depressive Symptoms and Health-Related Quality Of Life. Handbook of Disease Burdens and Quality of Life Measures. (Victor Preedy and Ronald Ross Watson, Editors). Springer Press. 2008 |
| 8 | A. Baranova, A. Birerdinc, M Estep, ZM Younossi. Pathogenesis of obesity-related chronic liver diseases as the study case for the systems biology. Textbook of Systems Biology for Signaling Networks (Sangdun Choi, Editor). 2010 |
| 9 | Z. Younossi. Epidemiology and Clinical Presentation of Non Alcoholic Fatty Liver Disease. Proceeding of 8th International Meeting on Therapy in Liver Disease 2011. |
| 10 | J. Kallman, Z. Younossi. Quality of Life After Liver Transplantation for Hepatitis C. Hepatitis C And Liver Transplantation Textbook (Sandeep Mukherjee, MBBCh, Editor), 2010 |
| 11 | N. Rafiq, Z. M. Younossi. Hepatic Changes of Obesity and the Effects of Weight Loss. Handbook of Obesity Surgery. Current Concepts and Therapy of Morbid Obesity and Related Diseases. Editors: Mervyn Deitel, Michel Gagner, John B. Dixon, Atul K. Madan, Jacques Himpens 2012. |
| 12 | J. Kallman, Z.M. Younossi. Health-related Quality of Life in Patients with Hepatic Encephalopathy., Hepatic Encephalopathy Textbook. Mullen & Prakash, Editors. Springer Science 2012 |
| 13 | M.Erario, Z. Younossi. Nonalcoholic Fatty Liver Disease in Adults: Diagnosis, Clinical Management and Potential Targets for therapy. Diet Quality: An Evidence-Based Approach. Springer Sci 2012. |
| 14 | A. Baranova, Z. Younossi. Adipokines in Non-alcoholic Fatty Liver Diseases. Adipose Tissue and Adipokines in Health and Disease (Second Edition). The Humana Press. 2012. |
| 15 | Z Younossi. Quality of Life for Patients with Cirrhosis. Complications of Cirrhosis: Evaluation and Management. Springer (New York). 2014 |
| 16 | Z Younossi. Epidemiology of NAFLD � A global perspective. Alcoholic and Non-lacoholic Fatty Liver Disease. Springer 2014 |
| 17 | ZM Younossi, L Henry. Quality of Life Issues for Patients with Cirrhosis, Publication house �Springer�. Chapter Complications of Cirrhosis pp 323-336 April 09 2015. |
| 18 | M Sayiner, A Koenig, L Henry, ZM Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clin Liver Dis. 2016 May; 20(2):205-14.doi: 10.1016/j.cld.2015.10.001. Epub 2015 Dec 14. Review. |
| 19 | Z. Younossi. The burden of NAFLD worldwide. Textbook: Non-Alcoholic Fatty Liver Disease: A 360-degree Overview. Buginaesi E, Editor 2018 |
| 20 | M Stepanova, ZM Younossi. Economic Burden of Hepatitis C Infection. Clinics in Liver Disease. 2017 Aug; 21(3):579-594.doi: 10.1016/j.cld.2017.03.012. |
| 21 | Z. Younossi. Preface. Clinics in Liver Disease. 2017 Aug; 21(3):xiii.doi: 10.1016/j.cld.2017.05.001 |
Presentations
| Num | Title |
|---|---|
| 1 | Jillian Kallman Price, Leyla de Avila, Maria Stepanova, Huong T. Pham, Manisha Verma, Carey Escheik, Lynn Gerber, Zobair M Younossi. CHRONIC LIVER DISEASE (CLD) PATIENTS ARE AT RISK FOR SYMPTOM PROFILE AFTER SARS-COV-2 (COVID-19) INFECTION, American Association for the Study of Liver Diseases. Washington, D.C.. |
| 2 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. DEVELOPMENT AND VALIDATION OF A PRIMARY SCLEROSING CHOLANGITIS (PSC)-SPECIFIC HEALTH-RELATED QUALITY OF LIFE INSTRUMENT: CLDQ-PSC, American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 3 | Maria Stepanova, Marlen Fernandez, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Vasily Isakov, Vincent Wai-Sun Wong, Yuichiro Eguchi, Khaled Alswat, Nahum Mendez-Sanchez, Ajay Duseja, Maria Buti, Georgios Papatheodoridis, Saeed S Hamid, Jacob George, Elisabetta Bugianesi, Wah Kheong Chan, Ashwani K. Singal, Stuart C. Gordon, Jian-Gao Fan, Manuel Romero-Gomez, Ziad Younes, Stuart Roberts, Aijaz Ahmed, Janus P. Ong, Brian P. Lam, Marcelo Kugelmas, Saleh Alqahtani, Issah Younossi, Fatema Nader, Andrei Racila, Zobair M Younossi. DEPRESSION AND EMOTIONAL DISTRESS IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY™ (GLR™), American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 4 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Khaled Alswat, Maria Buti, Marlen Castellanos-Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay Duseja, Stuart C. Gordon, Vasily Isakov, Stuart Roberts, Jian-Gao Fan, Yuichiro Eguchi, Ashwani K. Singal, Manuel Romero-Gomez, Brian P. Lam, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOME (PRO) PROFILE OF PATIENTS WITH HEPATITIS B VIRAL (HBV) INFECTION FROM THE GLOBAL LIVER REGISTRY™ (GLR™), American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 5 | Sean C. Felix, Elena Younossi, Thomas Jeffers, Brian P. Lam, Amish Gandhi, Evis Hudson, Nagashree Gundurao, Z Chris, Maria Castillo-Catoni, Maria Ramirez, Mehreen Husain, Evangeline Delgado, Ambika R. Baru, Merica Shrestha, Romona D. Satchi, Yemsrach Gami, Pegah Golabi, Andrei Racila, Fatema Nader, Maria Stepanova, Zobair M Younossi. HIGH-RISK PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) FROM PRIMARY CARE AND ENDOCRINOLOGY PRACTICES CAN BE IDENTIFIED USING A SIMPLE ALGORITHM BASED ON NON-INVASIVE TESTS (NITS), American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 6 | Zobair M Younossi, Reem Al Shaheeb, Michael Harring, Janus P. Ong, Saleh Alqahtani, Youssef Younossi, Gregory Trimble, Linda Henry, Maria Stepanova. NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS RAPIDLY BECOMING THE MOST COMMON INDICATION FOR LIVER TRANSPLANTATION IN THE CANDIDATES WITH HEPATOCELLULAR CARCINOMA (HCC) IN THE UNITED STATES (U.S.), American Association for the Study of Liver Diseases. Washington, D.C. 2022. |
| 7 | Zobair M Younossi, Reem Al Shaheeb, Michael Harring, Janus P. Ong, Saleh Alqahtani, Linda Henry, Maria Stepanova. The Portrait of Adult Liver Transplant Recipients in the United States from 2002-2020, European Association for the Study of the Liver. London, UK. June 25, 2022.. |
| 8 | Zobair M Younossi, Maria Stepanova, Sean C. Felix, Thomas Jeffers, Elena Younossi, Brian P. Lam, Linda Henry. Performance of the Enhanced Liver Fibrosis (ELF) Test in Real World Practice versus Clinical Trials of Non-Alcoholic Steatohepatitis, European Association for the Study of the Liver. London, UK. June 24, 2022.. |
| 9 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Janus P. Ong, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. Negative Impact of COVID-19 Infection Related to Life Disruption Events and Health Scores on Patients with Chronic Liver Disease, European Association for the Study of the Liver. London, UK. June 24, 2022.. |
| 10 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Andrei Racila, Brian P. Lam, Maria Stepanova. The Combination of the ELF and FIB-4 Scores have High Predictive Performance for Significant Fibrosis in Patients with NAFLD, European Association for the Study of the Liver. London, UK. June 24, 2022.. |
| 11 | Zobair M Younossi, Maria Stepanova, Robert P. Myers, Reem Al Shaheeb, Issah Younossi, Linda Henry. The Potential Role of Fatigue in Identifying Patients with NASH and Advanced Fibrosis who Experience Disease Progression, European Association for the Study of the Liver. . |
| 12 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Castellanos-Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, George A Papandreou, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. Lean Non-Alcoholic Fatty Liver Disease Patients from the Global NASH Registry, European Association for the Study of the Liver. London, UK. June 23, 2022.. |
| 13 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Andrei Racila, Brian P. Lam, Maria Stepanova. The Combination of the ELF and FIB-4 Scores have High Predictive Performance for Significant or Advanced Fibrosis in Patients with NAFLD, American Diabetes Association. New Orleans, LA. June 4, 2022.. |
| 14 | Sean C. Felix, Elena Younossi, Thomas Jeffers, Brian P. Lam, Amish Gandhi, Evis Hudson, Nagashree Gundurao, Z Chris, Maria Castillo-Catoni, Maria Ramirez, Mehreen Husain, Evangeline Delgado, Ambika R. Baru, Merica Shrestha, Romona D. Satchi, Pratima Fozdar, Yemsrach Gami, Pegah Golabi, Andrei Racila, Fatema Nader, Maria Stepanova, Zobair M Younossi. IDENTIFICATION OF HIGH-RISK PATIENTS WITH NON-ALCOHOLOC FATTY LIVER DISEASE (NAFLD) USING NON-INVASIVE TESTS FROM ENDOCRINOLOGY AND PRIMARY CARE PRACTICES , Digestive Disease Week. San Diego, CA. May 23, 2022.. |
| 15 | Zobair M Younossi, James Minhui Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader. THE GROWING BURDEN OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES, Digestive Disease Week. San Diego, CA. May 23, 2022.. |
| 16 | Ali Weinstein, Leyla de Avila, Jillian Kallman, Pegah Golabi, Carey Escheik, Maria Stepanova, Lynn Gerber, Zobair M Younossi. FATIGUE IN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS STILL PRESENT IN THOSE WITHOUT SLEEP DISTURBANCES, Digestive Disease Week. San Diego, CA. May 22, 2022.. |
| 17 | Katherine Barker, T Ganoe, L Clevenger, C Visco, J.M. Gibson, R. Karimi, N.N. Naderi, Brian P. Lam, Maria Stepanova, Linda Henry, Aditya Kasarabada. Prolonged Use of High Flow Nasal Cannula ( HFNC) in Young Patients Increases Mortality in COVID + Mechanically Ventilated Patients, American Thoracic Society. . |
| 18 | Zobair M Younossi, James Minhui Paik, Linda Henry, Joe Yang, Gail Fernandes, Maria Stepanova, Fatema Nader. BURDEN OF ILLNESS AND ECONOMIC IMPACT OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES ACCORDING TO THE PRESENCE OF OBESITY, American Association for the Study of Liver Diseases. . |
| 19 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Janus P. Ong, Issah Younossi, Andrei Racila, Mariam Ziayee, Arian Afendy, Maria Stepanova. COVID-19 PANDEMIC AND CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 20 | Zobair M Younossi, Daisong Tan, Hala Abdelaal, Lakshmi Alaparthi, Fanny Monge, Robert P. Myers, Fatema Nader, Zachary Goodman, Maria Stepanova. ASSOCIATIONS OF ENHANCED LIVER FIBROSIS SCORE (ELF) WITH HEPATIC COLLAGEN QUANTITATION AND DISEASE ACTIVITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 21 | Zobair M Younossi, Yusuf Yilmaz, Vincent Wai-Sun Wong, Marlen Fernandez, Elisabetta Bugianesi, Patrizia Burra, Ming-Lung Yu, Wah Kheong Chan, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. FATIGUE AND NON-ALCOHOLIC FATTY LIVER DISEASE: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 22 | Maria Stepanova, Khaled W. Kabbara, Denise Mohess, Roche-green Alva, Manisha Verma, Zobair M Younossi. NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST COMMON INDICATION FOR LIVER TRANSPLANTATION (LT) AMONG THE ELDERLY: DATA FROM THE UNITED STATES SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 23 | Zobair M Younossi, Andrei Racila, Fatema Nader, Issah Younossi, Linda Henry, Maria Stepanova. THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PROs) AND HEALTH UTILITIES IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 24 | Sean C. Felix, Brian P. Lam, Thomas Jeffers, Zachary Goodman, Maria Stepanova, Zobair M Younossi. ASSOCIATIONS OF ENHANCED LIVER FIBROSIS (ELF) AND PRO-C3 WITH STAGE OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 25 | Jillian Kallman Price, Carey Escheik, Patrick Austin, Leyla de Avila, Maria Stepanova, Ali Weinstein, Lynn Gerber, Zobair M Younossi. DEVELOPMENT OF AN ABRIDGED HUMAN ACTIVITY PROFILE (HAP-A) FOR CHRONIC LIVER DISEASE (CLD), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 26 | Zobair M Younossi, Michael Herring, Khaled W. Kabbara, Katherine Elizabeth Eberly, Youssef Younossi, Janus P. Ong, Saleh Alqahtani, Maria Stepanova. THE IMPACT OF HEPATOCELLULAR CARCINOMA (HCC) ON LIVER TRANSPLANTATION (LT) IN THE UNITED STATES (U.S.), American Association for the Study of Liver Diseases. Virtual, November 2021. |
| 27 | Aybike Birerdinc, Sean C. Felix, James M. Estep, Fanny Monge, Lakshmi Alaparthi, Maria Stepanova, Brian P. Lam, Bijal Rajput, Pegah Golabi, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, Thomas Spires, Mellisa Yarde, Yi Luo, Anthony Sanfiz, John Thompson, Mary Ellen Cvijic, Edgar Charles, Lei Zhao, David Gordon, Azza Karrar, Daisong Tan, Hala Abdelaal, Fatema Nader, Zachary Goodman, Zobair M Younossi. Fibrosis Biomarkers CA15-3 and Thrombospondin-2 are Associated with Higher Hepatic Collagen Content in Non-alcoholic Steatohepatitis (NASH)-related Fibrosis, European Association for the Study of the Liver. Virtual, June 2021. |
| 28 | Zobair M Younossi, Thomas Jeffers, Aybike Birerdinc, Sean C. Felix, James M. Estep, Brian P. Lam, Bijal Rajout, Pegah Golabi, Arathi Krishnakumar, Elizabeth Brown, Qing Xiao, Samuel Hellings, Ashok Dongre, John Thompson, Yi Luo, Edgar Charles, Lei Zhao, David Gordon, Azza Karrar, Fatema Nader, Zachary Goodman, Maria Stepanova. Proteomics Signature of Advanced Fibrosis in Non-alcoholic Steatohepatitis (NASH) using Data-independent Acquisition (DIA) Mass Spectrometry, European Association for the Study of the Liver. Virtual, June 2021. |
| 29 | Zobair M Younossi, Maria Stepanova, Khaled W. Kabbara, Elisabeth Eberly, Michael Herring, Saleh Alqahtani. Changes in the profile and outcomes of paediatric liver transplantation in the United States Liver transplantation and hepatobiliary surgery: Clinical aspects, European Association for the Study of the Liver. Virtual, June 2021. |
| 30 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Duseja, Saeed S Hamid, Gamal Esmat, Nahum Mendez-Sanchez, Wah Kheong Chan, Ashwani K. Singal, Brian P. Lam, Sean C. Felix, Elena Younossi, Manisha Verma, Jillian Kallman Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry, European Association for the Study of the Liver. Virtual, June 2021. |
| 31 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Zachary Goodman. PATIENTS WITH EARLY NON-ALCOHOLIC STEATOHEPATITIS REGRESSION OF FIBROSIS IS ASSOCIATED WITH IMPROVEMENT OF PATIENT REPORTED OUTCOMES (PROS), Digestive Disease Week. Virtual, May 2021. |
| 32 | Brian P. Lam, Thomas Jeffers, Sean C. Felix, Elena Younossi, Henry A. Tran, Maria Stepanova, Fatema Nader, Zobair M Younossi. CARDIAC SERUM BIOMARKERS PREDICTING SEVERE CORONARY ARTERY DISEASE (CAD) AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2021. |
| 33 | Ming-Lung Yu, Mohamed El Kassas, Yusuf Yilmaz, Marlen Castellanos-Fernandez, Maria Buti, George A Papandreou, Ajay Duseja, Khaled Alswat, Vasily Isakov, Wah Kheong Chan, Saeed S Hamid, Stuart C. Gordon, Jian-Gao Fan, Yuichiro Eguchi, Ashwani K. Singal, Aijaz Ahmed, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Zobair M Younossi. CLINICAL PRESENTATION AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS: DATA FROM THE GLOBAL LIVER REGISTRY™, Digestive Disease Week. Virtual, May 2021. |
| 34 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vincent Wai-Sun Wong, Marlen Fernandez, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian-Gao Fan, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Ashwani K. Singal, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL PRESENTATION OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY, Digestive Disease Week. Virtual, May 2021. |
| 35 | Zobair M Younossi, Hirokazu Takahashi, Yuichiro Eguchi, Yusuf Yilmaz, Mohamed El Kassas, Maria Buti, Moises Diago, Ming-Hua Zheng, Jian-Gao Fan, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Janus P. Ong, Manuel Romero-Gomez, Saleh Alqahtani, Mariam Ziayee, Brian P. Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. A GLOBAL SURVEY OF PHYSICIANS KNOWLEDGE ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), Digestive Disease Week. Virtual, May 2021. |
| 36 | Brian P. Lam, Thomas Jeffers, Sean C. Felix, Elena Younossi, Henry A. Tran, Maria Stepanova, Fatema Nader, Zobair M Younossi. Cardiac Serum Biomarkers Predicting Severe Coronary Artery Disease among Patients with Non-Alcoholic Fatty Liver Disease, Digestive Disease Week. Virtual, May 2021. |
| 37 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Martin Bonacci, Bruce Wong, Rohit Loomba, Mary E. Rinella, Mazen Noureddin, Stephen A. Harrison. ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN A LARGE COHORT OF NASH PATIENTS WITHOUT CIRRHOSIS, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 38 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vasily Isakov, Ajay Duseja, Yuichiro Eguchi, Jacob George, Elisabetta Bugianesi, Georgios Papatheodoridis, Wah Kheong Chan, Khaled Alswat, Saeed S Hamid, Manuel Romero-Gomez, Stuart C. Gordon, Stuart Roberts, Mohamed El Kassas, Aijaz Ahmed, Brian P. Lam, Saleh Alqahtani, Issah Younossi, Fatema Nader, Janus P. Ong, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES DATA OF NON-ALCOHOLIC FATTY LIVER DISEASE: LONGITUDINAL DATA FROM THE GLOBAL NASH REGISTRY™, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 39 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. DEVELOPMENT AND VALIDATION OF A HEPATITIS B (HBV)-SPECIFIC HEALTH-RELATED QUALITY OF LIFE INSTRUMENT: CLDQ-HBV, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 40 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Rebecca Cable, Sean C. Felix, Thomas Jeffers, Elena Younossi, Huong T. Pham, Manirath Srishord, Patrick Austin, James M. Estep, Kathy Terra, Carey Escheik, Leyla de Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Lynn Gerber. COVID-19 INFECTION AND INPATIENT MORTALITY AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 41 | Zobair M Younossi, Maria Stepanova, Rebecca A Taub, Jordan Mark Barbone, Sam Moussa, Stephen A. Harrison. IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH IMPROVEMENT OF FAT FRACTION BY MRI-PDFF IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS TREATED WITH RESMETIROM, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 42 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Huong T. Pham, Arian Afendy, Rebecca Cable, Andrei Racila, Zahra Younoszai, Brian P. Lam, Pegah Golabi, Linda Henry, Maria Stepanova. PERFORMANCE OF ENHANCED LIVER FIBROSIS (ELF) TEST TO PREDICT ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 43 | Zobair M Younossi, Maria Stepanova, Naim Alkhouri, Mazen Noureddin, Kris V. Kowdley, Anita Kohli, Aasim M. Sheikh, Guy Neff, Bal Raj Bhandari, Nadege T Gunn, Caldwell. Stephen H. , Ryan S Huss, Robert P. Myers, Ziad Younes, Magdy Elkhashab, Peter Ruane, Mitchell L. Shiffman, Simone Strasser, Vincent Wai-Sun Wong, Zachary Goodman, Rohit Loomba. FIBROSIS REGRESSION AND IMPROVEMENT IN DISEASE ACTIVITY ARE ASSOCIATED WITH IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH): DATA FROM THE PHASE 2 ATLAS TRIAL, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 44 | Yusuf Yilmaz, Ming-Lung Yu, Brian P. Lam, Maria Buti, Georgios Papatheodoridis, Wah Kheong Chan, Ajay Duseja, Khaled Alswat, Mohamed El Kassas, Saeed S Hamid, Vasily Isakov, Stuart C. Gordon, Stuart Roberts, Jian-Gao Fan, Yuichiro Eguchi, Aijaz Ahmed, Ashwani K. Singal, Manuel Romero-Gomez, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. THE IMPACT OF CHRONIC HEPATITIS B ON PATIENT-REPORTED OUTCOMES FROM THE GLOBAL LIVER REGISTRY™, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 45 | Zobair M Younossi, Hirokazu Takahashi, Yuichiro Eguchi, Yusuf Yilmaz, Mohamed El Kassas, Ming-Hua Zheng, Jian-Gao Fan, Vincent Wai-Sun Wong, Khaled Alswat, Wah Kheong Chan, Nahum Mendez-Sanchez, Patrizia Burra, Elisabetta Bugianesi, Ajay Duseja, Maria Buti, Moises Diago, Manuel Romero-Gomez, Jacob George, Georgios Papatheodoridis, Saeed S Hamid, Laurent Castera, Marco Arrese, Marcelo Kugelmas, Janus P. Ong, Mariam Ziayee, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova. SIGNIFICANT KNOWLEDGE GAP ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN REAL-WORLD PRACTICES: A GLOBAL SURVEY OF HEPATOLOGISTS, GASTROENTEROLOGISTS, ENDOCRINOLOGISTS AND PRIMARY CARE PHYSICIANS, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 46 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Martin Bonacci, Bruce Wong, Rohit Loomba, Mary E. Rinella, Mazen Noureddin, Stephen A. Harrison. PRURITUS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA), American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 47 | Ming-Lung Yu, Mohamed El Kassas, Brian P. Lam, Gamal Esmat, Marlen Fernandez, Maria Buti, Georgios Papatheodoridis, Vasily Isakov, Ajay Duseja, Yusuf Yilmaz, Stuart C. Gordon, Saeed S Hamid, Manuel Romero-Gomez, Wah Kheong Chan, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Janus P. Ong, Saleh Alqahtani, Zobair M Younossi. PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS С: DATA FROM THE GLOBAL LIVER REGISTRY™, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 48 | Zobair M Younossi, Huong T. Pham, Sean C. Felix, Thomas Jeffers, Elena Younossi, Brian P. Lam, Fatema Nader, Henry A. Tran, Ingrid Schneider, Maria Stepanova. HIGH-SENSITIVITY CARDIAC TROPONIN I INDEPENDENTLY PREDICTS PRESENCE OF CORONARY ARTERY DISEASE (CAD) AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 49 | Maria Stepanova, Khaled W. Kabbara, Saleh Alqahtani, Issah Younossi, Alita Mishra, Zobair M Younossi. LIVER TRANSPLANT (LT) CENTER SIZE AND THE IMPACT ON THE CLINICAL OUTCOMES AND RESOURCE UTILIZATION, American Association for the Study of Liver Diseases. Virtual, November 2020. |
| 50 | Elizabeth Brown, Azza Karrar, Samuel Hellings, Maria Stepanova, Bethanne Warrack, Brian P. Lam, Joelle Onorato, Sean C. Felix, Abraham Apfel, Thomas Jeffers, Bijal Rajput, Edgar Charles, Fatema Nader, Yi Luo, Michael Reily, Lei Zhao, John Thompson, Zachary Goodman, Zobair M Younossi. Metabolomics composite biomarkers selected by machine learning predict NASH, European Association for the Study of the Liver. Virtual, August 2020. |
| 51 | Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Vincent Wai-Sun Wong, Ajay Duseja, Nahum Mendez-Sanchez, Jacob George, Wah Kheong Chan, Laurent Castera, Marco Arrese, Khaled Alswat, Hirokazu Takahashi, Manuel Romero-Gomez, Janus P. Ong, Mariam Ziayee, Issah Younossi, Andrei Racila, Maria Stepanova. Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: A global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians, European Association for the Study of the Liver. Virtual, August 2020. |
| 52 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. The clinical and patient reported outcomes (pros) profile of patients with non-alcoholic fatty liver disease (nafld) from real-world practices varies across the world, European Association for the Study of the Liver. Virtual, August 2020. |
| 53 | Zobair M Younossi, Stephen A. Harrison, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Michael Trauner, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Mani Subramanian, Robert P. Myers, Zachary Goodman, Maria Stepanova. Fibrosis non-invasive tests capture changes in patient-reported outcomes of patients with advanced nonalcoholic steatohepatitis, European Association for the Study of the Liver. Virtual, August 2020. |
| 54 | Quentin Anstee, Vincent Wai-Sun Wong, Michael Trauner, Marianne Camargo, Zachary Goodman, Linda Henry, Maria Stepanova, Manuel Romero-Gomez, Robert P. Myers, Eric Lawitz. High Prevalence Of Fatigue And Pruritus In Patients With Advanced Fibrosis Due To Nonalcoholic Steatohepatitis (NASH): The Impact On Patient-reported Outcomes (PROs), American Diabetes Association. Virtual, June 2020. |
| 55 | Zobair M Younossi, Sean C. Felix, Thomas Jeffers, Elena Younossi, Fatema Nader, Huong T. Pham, Arian Afendy, Rebecca Cable, Andrei Racila, Linda Henry, Maria Stepanova. Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease (NAFLD), American Diabetes Association. Virtual, June 2020. |
| 56 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Bijal Rajput, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, Anthony Sanfiz, Mette J. Nielsen, Natasja Gudmann, Diana J. Leeming, Thomas Spires, Mellisa Yarde, Yi Luo, Leonid Zhelnin, Mary Ellen Cvijic, Edgar Charles, Sumanta Mukherjee, Lei Zhao, Morten A. Karsdal, David Gordon, Fatema Nader, Zachary Goodman. COLLAGEN NEO-EPITOPE RATIOS ARE ASSOCIATED WITH SIGNIFICANT WEIGHT LOSS, AND IMPROVEMENT OF NON-INVASIVE TEST (NIT) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH), Digestive Disease Week. Virtual, May 2020. |
| 57 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, Jacob George, Susanne Beckebaum, David Orr, Giuseppe Mazzella, Victor Vargas, Lise L. Gluud, Rifaat Safadi, James F. Trotter, Jaideep Behari, David A. Sheridan, Muhammad Y. Sheikh, Martin Bonacci, Gail Cawkwell, Bruce Wong, Pierre Bedossa, Zachary Goodman, Mary E. Rinella. OBESITY-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: RESULTS FROM THE REGENERATE STUDY , Digestive Disease Week. Virtual, May 2020. |
| 58 | Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR), Digestive Disease Week. Virtual, May 2020. |
| 59 | Zobair M Younossi, Yusuf Yilmaz, Ming-Lung Yu, Mohamed El Kassas, Marlen Castellanos-Fernandez, Vincent Wai-Sun Wong, Vasily Isakov, Ajay Duseja, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Jian-Gao Fan, Elisabetta Bugianesi, Yuichiro, Eguchi, Ziad Younes, Manuel Romero-Gomez, Stuart Roberts, Stuart C. Gordon, Saeed S Hamid, Aijaz Ahmed, Janus P. Ong, Saleh Alqahtani, Brian P. Lam, Mariam Ziayee, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova. The Clinical and Patient-Reported Outcomes (PRO) Profile of Patients with Chronic Liver Disease (CLD) in Asian Countries: Data from Real-World Practices Varies Across the World, Asian Pacific Association for the Study of Liver. Virtual, September 2020. |
| 60 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, James F. Trotter, Aasim M. Sheikh, Aldo J Montano-Loza, Antonio Olveria, Laura M. Stinton, David A. Sheridan, Victor Vargas, Lise L. Gluud, Rifaat Safadi, Jorn M. Schattenberg, Mandana Khalili, David Orr, Markus Peck-Radosavljevic, Michael E. Allison, Gail Cawkwell, Bruce Wong, Pierre Bedossa, Zachary Goodman. ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA): RESULTS FROM REGENERATE PHASE 3 CLINICAL TRIAL, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 61 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Robert P. Myers, Stephen Djedjos, Stephen A. Harrison, Zachary Goodman. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIAL , American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 62 | Brian P. Lam, Huong T. Pham, Elena Younossi, Thomas Jeffers, Arian Afendy, Sean C. Felix, Fatema Nader, Maria Stepanova, Nila Rafiq, Z Chris, Madeline Erario, Yasser Ousman, Nahrain Al-Zubaidi, Zobair M Younossi. SCREENING AND LINKAGE TO CARE ALGORITHM TO IDENTIFY PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) WITH ADVANCED FIBROSIS IN THE PRIMARY CARE AND ENDOCRINOLOGY SETTINGS - THE PRELIMINARY ANALYSIS, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 63 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin Anstee, Vlad Ratziu, Stephen A. Harrison, Arun J. Sanyal, Jacob George, Susanne Beckebaum, David Orr, Giuseppe Mazzella, Victor Vargas, Lise L. Gluud, Rifaat Safadi, James F. Trotter, Jaideep Behari, David A. Sheridan, Muhammad Y. Sheikh, Gail Cawkwell, Bruce Wong, Pierre Bedossa, Zachary Goodman, Mary E. Rinella. THE IMPACT OF PRURITUS ON PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA), American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 64 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, John Thompson, Thomas Spires, Mellisa Yarde, Yi Luo, Anthony Sanfiz, Leonid Zhelnin, Mary Ellen Cvijic, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Zachary Goodman. IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE, SIGNIFICANT WEIGHT LOSS, AND IMPROVEMENT OF NON-INVASIVE TEST (NITS) ARE ASSOCIATED WITH COLLAGEN DEGRADATION PROFILES, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 65 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, John Thompson, Joelle Onorato, Michael Reily, Bethanne Warrack, Yi Luo, Leonid Zhelnin, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Fatema Nader, Zachary Goodman. METABOLOMICS PROFILE OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 66 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian Aresse, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS (HBV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 67 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian Aresse, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. CLINICAL AND PATIENT-REPORTED OUTCOMES DATA FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 68 | Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveriro, Rafael Esteban, Zobair M Younossi. HEPATITIS DELTA INFECTION IS ASSOCIATED WITH IMPAIRMENT OF PATIENT REPORTED OUTCOMES (PROs), American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 69 | Issah Younossi, Maria Stepanova, Linda Henry, Arian Afendy, Zobair M Younossi, Mercedes Walters. IMPAIRMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQL) AND HEALTH CARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD) AND PRIMARY LIVER CANCER (LC) IN THE UNITED STATES (U.S.): DATA FROM THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS), American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 70 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Gregory Trimble, Aijaz Ahmed, Saleh Alqahtani, Issah Younossi, Andrei Racila. NON-ALCOHOLIC STEATOHEPATITIS (NASH) IS THE MOST RAPIDLY GROWING CAUSE OF LISTING FOR LIVER TRANSPLANTATION: THE SCIENTIFIC REGISTRY OF TRANSPLANT RECIPIENTS (SRTR) DATA FROM 1994 TO 2018, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 71 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Aliya Gulamhusein, Bilal Hameed, Douglas Thorburn, Kris V. Kowdley, Michael Trauner. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC) DURING TREATMENT WITH CILOFEXOR (GS-9674), American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 72 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian-Gao Fan, Yuichiro Eguchi, Stuart C. Gordon, Aijaz Ahmed, Janus P. Ong, Ira M. Jacobson, Marco Arrese, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. SEVERE IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION SEEN IN REAL-WORLD PRACTICES ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY, American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 73 | Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Yusuf Yilmaz, Marlen Fernandez, Ajay Duseja, Vasily Isakov, Maria Buti, Nahum Mendez-Sanchez, Georgios Papatheodoridis, Wah Kheong Chan, Jacob George, Elisabetta Bugianesi, Manuel Romero-Gomez, Stuart Roberts, Ziad Younes, Vincent Wai-Sun Wong, Jian-Gao Fan, Yuichiro Eguchi, Stuart C. Gordon, Aijaz Ahmed, Janus P. Ong, Ira M. Jacobson, Marco Arrese, Mary E. Rinella, Saeed S Hamid, Issah Younossi, Brian P. Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova. DIFFERENCES IN THE CLINICAL PROFILE OF THE MOST COMMON CAUSES OF CHRONIC LIVER DISEASE (CLD) ACROSS THE WORLD: DATA FROM THE GLOBAL LIVER REGISTRY., American Association for the Study of Liver Diseases. Boston, MA. 2019.. |
| 74 | Leyla de Avila, Ali Weinstein, James M. Estep, Maria Stepanova, Pegah Golabi, Jillian Kallman, Carey Escheik, Lynn Gerber, Zobair M Younossi. IN COMPARISON TO CHRONIC HEPATITIS C INFECTION (CHC), PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) HAVE SIGNIFICANTLY MORE PHYSICAL AND FATIGUE RELATED IMPAIRMENTS: PATIENT REPORTED OUTCOMES (PROS), SERUM NEUROTRANSMITTER AND CHEMOKINE DATA, Digestive Disease Week. San Diego, CA, May 21, 2019. |
| 75 | Rati Deshpande, Maria Stepanova, Pegah Golabi, Chapy Venkatesan, Kimberly Brown, Zobair M Younossi. PREVALENCE, MORTALITY AND HEALTH CARE UTILIZATION OF HEPATITS C INFECTION (HCV) AMONG MEDICARE BENIFICIARIES RECEIVING CHRONIC HEMODIALYSIS (HD), Digestive Disease Week. San Diego, CA. 5/21/2019.. |
| 76 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Arian Afendy, Ira M. Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Eric Lawitz, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. CHRONIC HEPATITIS C (CHC) PATIENTS WHO DO NOT ACHIEVE SUSTAINED VIROLOGIC RESPONSE (SVR) EXPERIENCE WORSENING OF THEIR HEALTH-RELATED QUALITY OF LIFE (HRQL), Digestive Disease Week. San Diego, CA. May 21, 2019.. |
| 77 | Maria Stepanova, Elliot B. Tapper, Edward J. Gane, Mark S. Sulkowski, Marc Bourliere, Zobair M Younossi. FACTORS ASSOCIATED WITH LACK OF IMPROVEMENT OF PATIENT REPORTED OUTCOMES (PRO) IN CHRONIC HEPATITIS C (CHC) PATIENTS WITH SUSTAINED VIROLOGIC RESPONSE (SVR), Digestive Disease Week. San Diego, CA. May 21, 2019.. |
| 78 | Zobair M Younossi, Maria Stepanova, Wirth Stefan , William Balistreri, Schwarz William F., Philip Rosenthal, Regino Gonzalez-Peralta, Sanjay Bansal, Karen Murray, Fatema Nader. HEALTH-RELATED QUALITY OF LIFE IN YOUNG CHILDREN WITH HEPATITIS C TREATED WITH SOFOSBUVIR AND RIBAVIRIN AND SOFOSBUVIR/LEDIPASVIR, Digestive Disease Week. San Diego, CA. May 20, 2019. |
| 79 | Zobair M Younossi, Maria Stepanova, Alnoor Ramji, K. Rajender Reddy, Ira M. Jacobson, Issah Younossi, Fatema Nader. SOME PATIENTS WITH CHRONIC HEPATITIS C (CHC) MAY EXPERIENCE IMPROVEMENT OF HEALTH RELATED QUALITY OF LIFE WITH LONGER FOLLOW UP AFTER SUSTAINED VIROLOGIC RESPONSE (SVR), Digestive Disease Week. San Diego, CA. May 19, 2019.. |
| 80 | Maria Stepanova, Alita Mishra, Issah Younossi, Chapy Venkatesan, Zobair M Younossi. The Association of Insurance Coverage with Outcomes of Liver Transplantation in the United States, International Liver Transplantation Society. . |
| 81 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Vincent Wai-Sun Wong, Stephen A. Harrison, Takeshi Okanoue, Manuel Romero-Gomez, Stephen Djedjos, Robert P. Myers, Andrei Racila, Fatema Nader. What are the Predictors of Impairment of Patient-reported Outcome in Non-alcoholic Steatohepatitis?, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019.. |
| 82 | Zobair M Younossi, Azza Karrar, Maria Stepanova, Brian P. Lam, Sean C. Felix, Thomas Jeffers, Samuel Hellings, Elizabeth Brown, Thomas Spires, Mellisa Yarde, Yi Luo, Anthony Sanfiz, Leonid Zhelnin, Gabor Jarai, Mary Ellen Cvijic, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Fatema Nader, Zachary Goodman. A simple biomarker panel predictive of advanced fibrosis in patients with non-alcoholic steatohepatitis, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019.. |
| 83 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Arian Afendy, Ira M. Jacobson, Andrew J. Muir, Stanislas Pol, Stefan Zeuzem, Eric Lawitz, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. The sustained deleterious impact of viremia on patient reported outcomes in patients with chronic hepatitis C who don't achieve sustained virologic response, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019.. |
| 84 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Ira M. Jacobson, Andrew J. Muir, Stefan Zeuzem, Eric Lawitz, Stanislas Pol, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader. Sustained virologic response in patients with cirrhosis from chronic hepatitis C leads to sustained and long-term improvement of health-related quality of life, fatigue, and work productivity, European Association for the Study of the Liver. Vienna, Austria. April 12, 2019.. |
| 85 | Maria Stepanova, Alita Mishra, Issah Younossi, Donghee Kim, Aijaz Ahmed, Zobair M Younossi. Predictors of outcomes for patients with non-alcoholic steatohepatitis undergoing liver transplantation in the United States, European Association for the Study of the Liver. Vienna, Austria. April 12, 2019.. |
| 86 | Zobair M Younossi, Maria Stepanova, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Stephen Djedjos, Robert P. Myers, Issah Younossi, Andrei Racila, Fatema Nader. The presence of type 2 diabetes is independently associated with impairment of patient-reported outcomes in patients with non-alcoholic steatohepatitis, European Association for the Study of the Liver. Vienna, Austria. April 11, 2019.. |
| 87 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, K. Rajender Reddy, Vincent Wai-Sun Wong, Alessandra Mangia, Andrew J. Muir, Stephen Djedjos, Anuj Gaggar, Robert P. Myers, Issah Younossi, Fatema Nader, Andrei Racila. Patients with non-alcoholic steatohepatitis experience severe impairment of health related quality of life, European Association for the Study of the Liver. Vienna, Austria. April 11, 2019.. |
| 88 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Association of patient-reported outcomes with cerebral metabolism in patients with chronic hepatitis C at baseline and post sustained virologic response, European Association for the Study of the Liver. Vienna, Austria. April 13, 2019.. |
| 89 | Azza Karrar, Anatoly Ulyanov, Mariaelena Pierobon, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Bijal Rajput, Jeiran Kianoush, Alex Hodge, Weidong Zhou, Zachary Goodman, Emanuel F. Petricoin, Zobair M Younossi. Signature of Circulating Proteome Associated with Non-Alcoholic Steatohepatitis (NASH) As Detected By Nano LC- Mass Spectrometry, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018.. |
| 90 | Zobair M Younossi, Maria Stepanova, Arian Afendy, Fatema Nader, Aliya Gulamhusein, Bilal Hameed, Douglas Thorburn, Xiaomin Lu, Georgia Li, Chuhan Chung, GM Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley, Michael Trauner. Longitudinal Evaluation of Patient-Reported Outcomes (PROs) in Patients with Primary Sclerosing Cholangitis (PSC), American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018.. |
| 91 | Zobair M Younossi, Eric Lawitz, Naim Alkhouri, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Kathryn Kersey, Georgia Li, GM Subramanian, Robert P. Myers, CS Djedjos, Ling Han, G Chen, Tuan Nguyen, Anita Kohli, Natalie Bzowej, Ziad Younes, Shiv Sarin, Mitchell L. Shiffman, Stephen A. Harrison, Zachary Goodman, Nezam H. Afdhal, Maria Stepanova, Quentin Anstee. Algorithms Using Noninvasive Tests Can Accurately Identify Patients with Advanced Fibrosis Due to Nash: Data from the Stellar Clinical Trials, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018.. |
| 92 | Zobair M Younossi, Maria Stepanova, Fanny Monge, Lakshmi Alaparthi, Daisong Tan, Hala Abdul-Al, Hala Abdelaal, Bryan McColgan, GM Subramanian, Robert P. Myers, Vlad Ratziu, Nezam H. Afdhal, Stephen A. Harrison, Arun J. Sanyal, Zachary Goodman. Independent Predictors of Spontaneous Progression and Regression in Nonalcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018.. |
| 93 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Kathryn Kersey, Georgia Li, GM Subramanian, Robert P. Myers, CS Djedjos, Takeshi Okanoue, Michael Trauner, Stephen A. Harrison, Zachary Goodman. Advanced Fibrosis Based on Noninvasive Tests in Nonalcoholic Steatohepatitis (NASH) Is Associated with Impairment of Patient-Reported Outcomes, American Association for the Study of Liver Diseases. San Francisco, CA. November 12, 2018.. |
| 94 | James M. Estep, Leyla de Avila, Ali Weinstein, Carey Escheik, Pegah Golabi, Jillian Kallman Price, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. The Increase in the Circulating Chemokine Ligand 2 (CCL2) Levels in Patients with Chronic Hepatitis C Post Sustained Virologic Response (SVR) Is Not Associated with Detrimental Impact on Health-Related Quality of Life, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018.. |
| 95 | Zobair M Younossi, Maria Stepanova, Quentin Anstee, Eric Lawitz, Vincent Wai-Sun Wong, Manuel Romero-Gomez, Kathryn Kersey, GM Subramanian, Robert P. Myers, CS Djedjos, Takeshi Okanoue, Michael Trauner, Stephen A. Harrison, Zachary Goodman. Severe Impairment of Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Non-Alcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018.. |
| 96 | Zobair M Younossi, Maria Stepanova, Janus P. Ong, Yusuf Yilmaz, Ajay Duseja, Yuichiro Eguchi, Mohamed El Kassas, Marlen Fernandez, Jacob George, Ira M. Jacobson, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Marco Arrese, Victor de Ledinghen, Manuel Romero-Gomez, Nahum Mendez-Sanchez, Aijaz Ahmed, Robert John Wong, Georgios Papatheodoridis, Lawrence Serfaty, Philippe Mathurin, Issah Younossi, Fatema Nader, Mariam Ziayee, Arian Afendy. Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcoholic Fatty Liver Disease (AFLD): The Impact of Alcohol Consumption and Metabolic Syndrome on Mortality, American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018.. |
| 97 | Leyla de Avila, James M. Estep, Ali Weinstein, Carey Escheik, Pegah Golabi, Aybike Birerdinc, Maria Stepanova, Trevor Gogoll, Lynn Gerber, Zobair M Younossi. Improvements in Patient Reported Outcomes after Sustained Virologic Response in Patients with Hepatitis C Virus Infection Correlates with Increases in Serotonin and Catechol-O-Methyltransferase (COMT), American Association for the Study of Liver Diseases. San Francisco, CA. November 11, 2018.. |
| 98 | Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Extensive Validation of a Disease-Specific Health Related Quality of Life Instrument in Patients with Biopsy-proven Non-alcoholic Steatohepatitis (NASH): Chronic Liver Disease Questionnaire-NASH (CLDQ-NASH), American College Gastroenterology. Philadelphia, PA. October 10, 2018.. |
| 99 | Azza Karrar, Anatoly Ulyanov, Maria Stepanova, Daisong Tan, Kira Tokarz, Thomas Jeffers, Sean C. Felix, Zachary Goodman, Zobair M Younossi. Epithelial-Mesenchymal Cell Transition (EMT) Stimulation Is Associated With Hepatic Fibrosis in Non-Alcoholic Steatohepatitis (NASH): Pathway Analysis of MicroRNA and Phosphoproteomics Data , American College Gastroenterology. Philadelphia, PA. October 7, 2018.. |
| 100 | Zobair M Younossi, Maria Stepanova, Linda Henry, Zhongping Duan, Qing Xie, Jin Lin Hou, Jidong Jia, Lai Wei. HIGH EFFICACY AND SUBSTANTIAL IMPROVEMENT OF HEALTH-RELATED QUALITY OF LIFE (HRQL) IN CHINESE PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION TREATED WITH LEDIPASVIR AND SOFOSBUVIR (LDV/SOF). (DDW), Digestive Disease Week. Washington D.C., June 4, 2018.. |
| 101 | Zobair M Younossi, Maria Stepanova, Robert S. Epstein, Marcie Strauss, Pegah Golabi, Fatema Nader, Andrei Racila. FACTORS ASSOCIATED WITH PROGRESSIVE COURSE OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE UNITED STATES: DATA FROM A LARGE-REAL WORLD DATABASE, Digestive Disease Week. Washington D.C., June 4, 2018.. |
| 102 | Zobair M Younossi, Maria Stepanova, Linda Henry, Christophe Hezode, Armand Abergel, Stanislas Pol, Marc Bourliere. PATIENT REPORTED OUTCOMES IN CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS C: THE IMPACT OF PLACEBO, ACTIVE TREATMENT AND SUSTAINED VIRAL ERADICATION, Digestive Disease Week. Washington D.C., June 3, 2018.. |
| 103 | Zobair M Younossi, Maria Stepanova, Stephen A. Harrison, Arun J. Sanyal, Vlad Ratziu, Bryan McColgan, Robert P. Myers, Nezam H. Afdhal, Manal F. Abdelmalek, Zachary Goodman. The Conundrum of Cryptogenic Liver Disease with Advanced Fibrosis: Poor Clinical Outcomes without Treatment Options, European Association for the Study of the Liver. . |
| 104 | Zobair M Younossi, Maria Stepanova, Leyla de Avila, Lynn Gerber, Eric Lawitz, Steven L. Flamm, Bernard Willems. The Impact of Sustained Virologic Response on Severe Fatigue in Patients with Chronic Hepatitis C: The Role of HCV Viremia and Co-Morbidities, European Association for the Study of the Liver. . |
| 105 | Zobair M Younossi, Maria Stepanova, Andrei Racila, Issah Younossi, Fatema Nader, Andrew J. Muir, Marc Bourliere, Alessandra Mangia. Sustainable Improvement of Patient-Reported Outcomes (PROs) in Cirrhotic Patients with Hepatitis C (HCV) who Achieved Sustained Virologic Response (SVR), European Association for the Study of the Liver. Paris, France. April 13, 2018.. |
| 106 | Zobair M Younossi, Azza Karrar, Kira Tokarz, Mariaelena Pierobon, Anatoly Ulyanov, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Daisong Tan, Jeiran Kianoush, Alex Hodge, Ahmad Moin. Hepatic microRNA and phosphoproteomic analysis provide insights about hepatic collagen deposition and stage of fibrosis in non-alcoholic steatohepatitis, European Association for the Study of the Liver. . |
| 107 | Zobair M Younossi, Maria Stepanova, Robert S. Epstein, Marcie Strauss, Pegah Golabi, Fatema Nader, Andrei Racila. Independent Predictors of Primary Biliary Cholangitis (PBC) at High Risk for Progressive Course in the United States: Data from a Large - Real World Database, European Association for the Study of the Liver. Paris, France. April 13, 2018.. |
| 108 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Pegah Golabi, James M. Estep, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Changes in Serum Neurotransmitters (NTs) are Associated with Changes in Patient Report Outcomes (PROs) and Neurocognitive Performance (NP) in patients with Hepatitis C Virus (HCV)-Genotype 1 (GT1) who achieved Sustained Virologic Response (SVR), European Association for the Study of the Liver. . |
| 109 | Zobair M Younossi, Maria Stepanova, Michael Manns, K. Rajender Reddy, Stuart C. Gordon, Marc Bourliere. Patient-Reported Outcomes in Chronic Hepatitis C: The Impact of Placebo, Active Treatment, and Sustained Viral Eradication, European Association for the Study of the Liver. . |
| 110 | Maria Stepanova, Issah Younossi, Fatema Nader, Naoky Tsai, Mindie H. Nguyen, Edward J. Gane, Kosh Agarwal, Harry Janssen. Patient-Reported Outcomes in Viral Hepatitis without Advanced Fibrosis: Chronic Hepatitis B vs. Hepatitis C Infection, Asian Pacific Association for the Study of Liver. . |
| 111 | Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V. Nguyen, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. Sofosbuvir (SOF) and Ledipasvir (LDV) Combination is Associated with High Sustained Virologic Response (SVR) and Improvement of Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection, Asian Pacific Association for the Study of Liver. . |
| 112 | Zobair M Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young-Suk Lim, Ming-Lung Yu, Maria Stepanova, Yock Young Dan. A Systematic Review of the Extrahepatic Manifestations of Hepatitis C Infection in East Asia, Asian Pacific Association for the Study of Liver. . |
| 113 | Zobair M Younossi, Maria Stepanova, Linda Henry, Zhongping Duan, Qing Xie, Jin Lin Hou, Jidong Jia, Wei MD Lai. High Efficacy and Substantial Improvement of Health-Related Quality of Life (HRQL) in Chinese Patients with Hepatitis C Virus (HCV) Infection Treated with Ledipasvir and Sofosbuvir (LDV/SOF) (APASL), Asian Pacific Association for the Study of Liver. . |
| 114 | Zobair M Younossi, Maria Stepanova, Zachary Goodman, Eric Lawitz, Michael R. Charlton, Rohit Loomba, Robert P. Myers, Mani Subramanian, John McHutchison, Sharon Hunt. Improvements of Hepatic Fibrosis and Hepatic Collagen Deposition in Non-Alcoholic Steatohepatitis (Nash) Treated with Selonsertib are Associated with Improvement of Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. . |
| 115 | Rohini Mehta, Hala Abdul-Al, James M. Estep, Maria Stepanova, Sean C. Felix, Zahra Younoszai, Thomas Jeffers, Zachary Goodman, Zobair M Younossi. Polymorphisms in TFAM (rs1937) and NOS2 (rs2297518) Which Are Markers of Mitochondrial Dysfunction Are Associated with Significant Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. . |
| 116 | Zobair M Younossi, Maria Stepanova, Thomas Saenz, Gayle Cooper, Christa Schmidt, Steve Petruccelli. A National Survey of Physicians Regarding Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH): The Disease and Clinical Trial Awareness Program for NASH, American Association for the Study of Liver Diseases. . |
| 117 | Zobair M Younossi, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Bryan McColgan, Robert P. Myers, Mani Subramanian, John McHutchison, Nezam H. Afdhal, Manal F. Abdelmalek, Jaime Bosch, Zachary Goodman. Predictors of Fibrosis Progression and Regression by Histology and Morphometrically Quantified Collagen in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis, American Association for the Study of Liver Diseases. . |
| 118 | Zobair M Younossi, Azza Karrar, Kira Tokarz, Anatoly Ulyanov, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Daisong Tan, Ahmad Moin, Ramaswamy Iyer, John Deeken, Zachary Goodman. Hepatic Signature Expression of miR-199a-5p, miR-21-3p, miR-224-5p, and miR-150-5p Detected by NextSeq Technology are Independently Associated with Fibrosis in Non-alcoholic Steatohepatitis (NASH) and Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. . |
| 119 | Zobair M Younossi, Masoom Priyadarshini, Mariam Afendy, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova. Burden of Illness Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States, American Association for the Study of Liver Diseases. Washington D.C. October 23, 2017.. |
| 120 | Zobair M Younossi, Maria Stepanova, Pegah Golabi, Huong T. Pham, Rebecca Cable, James Cooper, Nila Rafiq, Haley Bush, Puneetinder Mann, Trevor Gogoll. Presumed Non-alcoholic Steatofibrosis Can Independently Predict Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. . |
| 121 | Zobair M Younossi, Maria Stepanova, Stephen A. Harrison, Arun J. Sanyal, Vlad Ratziu, Bryan McColgan, Robert P. Myers, Mani Subramanian, John McHutchison, Nezam H. Afdhal, Manal F. Abdelmalek, Jaime Bosch, Zachary Goodman. Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis, American Association for the Study of Liver Diseases. . |
| 122 | Pegah Golabi, Omer Shahab, Maria Stepanova, Mehmet Sayiner, Stephen C. Clement, Zobair M Younossi. Long-Term Outcomes of Diabetic Patients with Non-alcoholic Fatty Liver Disease (NAFLD), American Association for the Study of Liver Diseases. . |
| 123 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Kosh Agarwal, Mindie H. Nguyen, Edward J. Gane, Naoky Tsai, Issah Younossi, Sharon Hunt. The impact of treatment of chronic hepatitis B (CHB) on patient-reported outcomes (PROs), American Association for the Study of Liver Diseases. . |
| 124 | Zobair M Younossi, Maria Stepanova, Edward J. Gane, Ira M. Jacobson, David R. Nelson, Ashley S. Brown, Issah Younossi, Linda Henry. Significant and Sustained Improvement of Health-Related Quality of Life (HRQL) Scores in Patients with Hepatitis C (HCV) and Sustained Virologic Response (SVR), American Association for the Study of Liver Diseases. . |
| 125 | Zobair M Younossi, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, Robert P. Myers, Mani Subramanian, John McHutchison, Cynthia Levy, Christopher L. Bowlus, Kris V. Kowdley, Andrew J. Muir. Development and Validation of a Primary Sclerosing Cholangitis Patient-Reported Outcome (PSC-PRO) Instrument, American Association for the Study of Liver Diseases. Washington D.C. October 22, 2017.. |
| 126 | Zobair M Younossi, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, Gregory Trimble, Madeline Erario, Chapy Venkatesan, Issah Younossi, Aimal Arsalla, Wisna'odom Keo, Zachary Goodman. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Non-alcoholic Steatohepatitis (NASH) Cirrhosis: Twenty-Two Years Data from the Scientific Registry of Transplant Recipients (SRTR), American Association for the Study of Liver Diseases. . |
| 127 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Pegah Golabi, James M. Estep, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Changes in Serum Neurotransmitters (NTs) and Patient-Reported Outcomes (PROs) and Neurocognitive Performance (NCP) After Viral Eradication of Hepatitis C Virus (HCV)-Genotype 1 (GT1), American Association for the Study of Liver Diseases. . |
| 128 | Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham R. Foster, Keyur Patel, Norbert Brau, Mark G. Swain, Tram T. Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C (HCV) in Patients Without Fibrosis or with Minimal Fibrosis: The Impact of Treatment and Sustained Virologic Response (SVR) on Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. . |
| 129 | Zobair M Younossi, Maria Stepanova, Elliot B. Tapper, Linda Henry, Aasim M. Sheikh, Mindie H. Nguyen, Nancy Reau, Eric Lawitz. Long-Term Follow-Up of Patient-Reported Outcomes (PROs) in Chronic Hepatitis C (HCV) Patients with Compensated and Decompensated Cirrhosis with Sustained Virologic Response (SVR), American Association for the Study of Liver Diseases. . |
| 130 | Zobair M Younossi, Maria Stepanova, Leyla de Avila, Aijaz Ahmed, Robert John Wong, Sammy Saab, Kris V. Kowdley, Kimberly Brown, Marcelo Kugelmas, Andrei Racila. Liver Transplant (LT) Candidates with Primary Biliary Cholangitis (PBC) Experience Higher Wait List Mortality: Data from the Scientific Registry of Transplant Recipients (SRTR), American Association for the Study of Liver Diseases. Washington D.C. October 20, 2017.. |
| 131 | Maria Stepanova, Alexander Thompson, Joseph S. Doyle, Leyla de Avila, Issah Younossi, Linda Henry, Zobair M Younossi. Hepatitis C Virus (HCV)-Infected Patients Receiving Opioid Substitution Therapy (OST) Experience Significant Increases in Patient-Reported Outcomes (PROs) Following Treatment with Anti-Viral Regimens, American Association for the Study of Liver Diseases. . |
| 132 | Patrice Cacoub, Marc Bourliere, Tarik Asselah, Victor de Ledinghen, Philippe Mathurin, Christophe Hezode, Linda Henry, Maria Stepanova, Zobair M Younossi. French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. . |
| 133 | Leyla de Avila, Ali Weinstein, Michael P. Curry, Pegah Golabi, Carey Escheik, Maria Stepanova, Lynn Gerber, Zobair M Younossi. Relationship between Neurocognitive Performance (NCP) and Patient-Reported Outcomes (PROs) in Patients with Genotype 1 (GT1) Hepatitis C Virus (HCV) With or Without Viremia, American Association for the Study of Liver Diseases. . |
| 134 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Maria Stepanova, Jeiran Kianoush, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Alex Hodge, Dinan Abdelatif, Fanny Monge, Lakshmi Alaparthi, Aybike Birerdinc, Zachary Goodman, Vikas Chandhoke, Emanuel F. Petricoin. Apoptosis Signal-regulating Kinase1-MAPKinase p38 (ASK1-p38) Pathway Associated with IL-10 is Independently Correlated to Higher Percent (%) Collagen in Patients with Non-alcoholic Steatohepatitis (NASH), American Association for the Study of Liver Diseases. . |
| 135 | Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh Nguyen Van, Ching-Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei MD Lai. Health-Related Quality of Life (HRQL) in East Asian Patients with Hepatitis C Virus (HCV) Infection: The Impact of Treatment and Sustained Virologic Response (SVR), American Association for the Study of Liver Diseases. . |
| 136 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Andrei Racila. Primary Biliary Cholangitis (PBC) is Associated with Significant Mortality and Health Care Utilization (HCU) in Medicare Population, American College Gastroenterology. Orlando, Florida October 16, 2017. |
| 137 | Zobair M Younossi, Azza Karrar, Kira Tokarz, Anatoly Ulyanov, Maria Stepanova, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Daisong Tan, Ahmad Moin, Ramaswamy Iyer, John Deeken, Zachary Goodman. Signature of Circulating microRNA (miR) Detected by NextSeq Differentiates Non-alcoholic Fatty Liver Disease (NAFLD) Patients with Higher Percentage Hepatic Collagen: A Potential Role for A Prognostic Biomarker, American College Gastroenterology. Orlando, Florida October 10, 2017. |
| 138 | Zobair M Younossi, Aybike Birerdinc, Azza Karrar, Mariaelena Pierobon, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, James M. Estep, Dinan Abdelatif, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Pathway Analysis of Serum Analytes and Phosphorylated Proteins and their Involvement in Regulatory Pathways in Patients with Non-alcoholic Steatohepatitis (NASH), Digestive Disease Week. McCormick Place, Chicago, IL, May 9, 2017. |
| 139 | Lynn Gerber, Azza Karrar, Maria Stepanova, Carey Escheik, Patrick Austin, Sarah Bondurant, Shaun Meyer, Indie Srishord, Xiaochen Zhu, Ramona Raya, Zobair M Younossi. Associations of Obesity-related Non-alcoholic Fatty Liver Disease (NAFLD) and Autoimmune Diseases: A Secondary Data Analysis of the National Health and Nutrition Examination Survey (NHANES) 1999-2014, Digestive Disease Week. McCormick Place in Chicago, IL, May 8, 2017. |
| 140 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Stefan Zeuzem, Marc Bourliere, Graham R. Foster, Stuart Roberts, Tarik Asselah, Alexander Thompson, Edward J. Gane, Bernard Willems, Eric Lawitz, Stuart C. Gordon, Michael Manns, K. Rajender Reddy, Curtis L. Cooper, Steven L. Flamm, Kris V. Kowdley, Sharon Hunt. Sofosbuvir/Velpatasvir (SOF/VEL) with or without Voxilaprevir (VOX) is Associated with Excellent Efficacy and Significant Improvements of Patient-Reported Outcomes (PROs) During Treatment and after Achieving Sustained Virologic Response (SVR), Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017. |
| 141 | Aybike Birerdinc, Azza Karrar, Elzafir Elsheikh Abdelrahman, Rohini Mehta, James M. Estep, Mariaelena Pierobon, Maria Stepanova, Leo Druker, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, Dinan Abdelatif, Zachary Goodman, Emanuel F. Petricoin, Zobair M Younossi. The Molecular Crosstalk Between Hepatic Tissue and Visceral Adipose Tissue in Patients with Obesity-related Non-Alcoholic Fatty Liver Disease (NAFLD): The Interactions Between Inflammation and Immune Activation, Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017. |
| 142 | Leyla de Avila, Maria Stepanova, Elena Younossi, Andrei Racila, Pegah Golabi, Trevor Gogoll, Zobair M Younossi. Outcomes of wait-listed liver transplant (LT) candidates with hepatocellular carcinoma (HCC) in the United States from 2001 to 2014, Digestive Disease Week. McCormick Place, Chicago, IL, May 8, 2017. |
| 143 | Maria Stepanova, Leyla de Avila, Amanda Morgan, Mehmet Sayiner, Madeline Erario, Zobair M Younossi. Outcomes of Wait-listed Liver Transplant (LT) Candidates with Chronic Liver Disease (CLD) in the United States: The Impact of Model of End Stage Liver Disease (MELD) Scores and Disease Etiology, Digestive Disease Week. McCormick Place, Chicago, IL, May 7, 2017. |
| 144 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Naoky Tsai, Kosh Agarwal, Mindie H. Nguyen, Magdy Elkhashab, Issah Younossi, Sharon Hunt. HEPATITIS B (HBV) VIRAL SUPPRESSION IS INDEPENDENTLY ASSOCIATED WITH BETTER PATIENT-REPORTED OUTCOMES (PROS), Digestive Disease Week. McCormick Place, Chicago, IL, May 6, 2017. |
| 145 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Zahra Younoszai, Thomas Jeffers, Sean C. Felix, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Dinan Abdelatif, Fanny Monge, Lakshmi Alaparthi, Aybike Birerdinc, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Association of Serum and Liver Proteomic Profiling of Patients with Non-alcoholic Fatty Liver Disease (NAFLD) Reveals Common Pathways Linking Non-alcoholic Steatohepatitis (NASH) and Metabolic Abnormalities, Digestive Disease Week. McCormick Place in Chicago, IL, May 6, 2017. |
| 146 | Zobair M Younossi, Maria Stepanova, Andrew J. Muir, Maria Buti, K. Rajender Reddy, Steven L. Flamm, Issah Younossi, Sharon Hunt. The long-term impact of sustained virologic response (SVR) on patient-reported outcomes in cirrhotics with Hepatitis C infection, European Association for the Study of the Liver. . |
| 147 | Zobair M Younossi, Maria Stepanova, Harry Janssen, Kosh Agarwal, Edward J. Gane, Naoky Tsai, Issah Younossi, Sharon Hunt. Virally suppressed patients with chronic HBV infection without cirrhosis have better patient-reported outcomes (PROS), European Association for the Study of the Liver. . |
| 148 | Zobair M Younossi, Maria Stepanova, Zachary Goodman, Eric Lawitz, Michael R. Charlton, Rohit Loomba, Sharon Hunt. Improvement of hepatic fibrosis in patients with non-alcoholic steatohepatitis treated with selonsertib is associated with improvement of patient-reported outcomes (PROS), European Association for the Study of the Liver. Amsterdam, Netherlands, April 21, 2017. |
| 149 | Zobair M Younossi, Maria Stepanova, Ira M. Jacobson, Stefan Zeuzem, Marc Bourliere, Graham R. Foster, Stuart Roberts, Tarik Asselah, Alexander Thompson, Edward J. Gane, Bernard Willems, Eric Lawitz, Stuart C. Gordon, Michael Manns, K. Rajender Reddy, Curtis L. Cooper, Steven L. Flamm, Kris V. Kowdley, Sharon Hunt. High Efficacy is Accompanied with Substantial Gains in Patient Reported Outcomes in Cirrhotic Patients with Chronic Hepatitis C Treated with Sofosbuvir (SOF), Velpatasvir with or without Voxilaprevir (VOX): Data from POLARIS 1, 2, 3 and 4, European Association for the Study of the Liver. . |
| 150 | Zobair M Younossi, Maria Stepanova, Nila Rafiq, Pegah Golabi, Leyla de Avila, Fanny Monge, Zachary Goodman. Non-alcoholic Steatofibrosis is Independently Associated with both Overall Mortality and Liver related Mortality in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. . |
| 151 | Zobair M Younossi, Maria Stepanova, Wirth Stefan , Kathleen B. Schwarz, Philip Rosenthal, Regino Gonzalez-Peralta, Karen Murray, Sharon Hunt. Health-Related Quality of Life in Children with Hepatitis C Viral Infection Treated with Sofosbuvir and Ribavirin, European Association for the Study of the Liver. . |
| 152 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Zahra Younoszai, Sean C. Felix, Thomas Jeffers, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, Dinan Abdelatif, Aybike Birerdinc, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Nano LC- Mass Spectrometry Based Proteomic Profiling Associated with Significant Fibrosis and Collagen Deposition in Non-alcoholic Fatty Liver Disease (NAFLD), European Association for the Study of the Liver. . |
| 153 | Zobair M Younossi, Maria Stepanova, Nila Rafiq, Pegah Golabi, Leyla de Avila, Fanny Monge, Zachary Goodman. Non-alcoholic steatofibrosis is independently associated with both overall mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD), European Association for the Study of the Liver. . |
| 154 | Zobair M Younossi, Maria Stepanova, Leyla de Avila, Aijaz Ahmed, Robert John Wong, Sammy Saab, Kris V. Kowdley, Kimberly Brown, Marcelo Kugelmas, Andrei Racila. Inpatient Mortality, Payer Status and Length of Inpatient Stay (LoS) for United States (US) Liver Transplant (LT) Recipients with Primary Biliary Cholangitis (PBC): Data from the Scientific Registry of Transplant Recipients (SRTR), Academy of Managed Care Pharmacy. Denver, CO. March 27, 2017.. |
| 155 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Atsushi Tanaka, Yuichiro, Eguchi, Norifumi Kawada, Andrei Racila, Sharon Hunt. The prevalence and costs associated with clinically overt extrahepatic manifestations of hepatitis C virus infection in Japan, Asian Pacific Association for the Study of Liver. Shanghai, China. February 16, 2017.. |
| 156 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Young-Suk Lim, Issah Younossi, Sharon Hunt. The Impact of all Oral Regimen Ledipasvir/Sofosbuvir (LDV/SOF) On Patient-reported Outcomes (PROs) of Asian Patients with Chronic Hepatitis C (CHC), Asian Pacific Association for the Study of Liver. Shanghai, February 18, 2017. |
| 157 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Jillian Kallman, Leyla de Avila, Andrei Racila. PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH CHRONIC HEPATITIS B WITH OR WITHOUT VIREMIA, Asian Pacific Association for the Study of Liver. Shanghai, China. February 16, 2017.. |
| 158 | Zobair M Younossi, Deidre Blissett, Rob Blissett, Maria Stepanova, Linda Henry, Youssef Younossi, Rachel Beckerman, Sharon Hunt. The Economic and Clinical Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the United States and Europe: A Steady-State Prevalence Model (abstract), American Association for the Study of Liver Diseases. Boston, November 14, 2016. |
| 159 | Zobair M Younossi, Issah Younossi, Huong T. Pham, Maria Stepanova, Brian P. Lam, Sharon Hunt. Development and Validation of a Disease-Specific Health-Related Quality (HRQL) Instrument for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): The CLDQ-NAFLD, American Association for the Study of Liver Diseases. Boston, November 14, 2016. |
| 160 | Maria Stepanova, Leyla de Avila, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Lynn Gerber, Zobair M Younossi. Extensive Economic and Quality of Life Burden of Viral Hepatitis (VH): The Data from the U.S. Medical Expenditure Panel Survey (MEPS), American Association for the Study of Liver Diseases. Boston, November 11, 2016. |
| 161 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, David Wyles, Shyam Kottilil, Sharon Hunt. The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5, American Association for the Study of Liver Diseases. Boston, November 13, 2016. |
| 162 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Fatema Nader, Linda Henry, Sharon Hunt. Sofosbuvir/Velpatasvir (SOF/VEL)-Based Regimens are Associated with Excellent Efficacy and a Significant Improvement of Patients-Reported Outcomes (PROs) across Patient Populations: From Non-Cirrhotics to Compensated Cirrhotics to Decompensated Cirrhotics, American Association for the Study of Liver Diseases. Boston, November 13, 2016. |
| 163 | Zobair M Younossi, Maria Stepanova, Kwang-Hyub Han, Wan-Long Chuang, Henry Lik-Yuen Chan, Young-Suk Lim, Rong-Nan Chien, Sang Hoon Ahn, Sook-Hyang Jeong, Ting-Tsung Chang, Seung-Woon Paik, Cheng-Yuan Peng, Chi-Jen Chu, Youn-Jae Lee, Ching-Lung Lai, Jia-Horng Kao, Sharon Hunt. Comparison of Health-Related Quality of Life (HRQL) in Asian Patients with Chronic Hepatitis C Treated with Interferon (IFN)-free Ribavirin (RBV)-Containing Regimens vs Interferon-free and Ribavirin-free Regimens, American Association for the Study of Liver Diseases. Boston, November 12, 2016. |
| 164 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Maria Stepanova, Jeiran Kianoush, Alex Hodge, Fanny Monge, Lakshmi Alaparthi, Dinan Abdelatif, Aybike Birerdinc, Vikas Chandhoke, Zachary Goodman, Emanuel F. Petricoin. Protein Pathway Activation Mapping of Non-alcoholic Steatohepatitis (NASH): The Role Phosphorylation of Proteins Involved in Apoptosis and Collagen Deposition, American Association for the Study of Liver Diseases. Boston, November 12, 2016. |
| 165 | Zobair M Younossi, Maria Stepanova, William Balistreri, Kathleen B. Schwarz, Karen Murray, Philip Rosenthal, Sanjay Bansal, Sharon Hunt. High Efficacy and Significant Improvement of Quality of Life (QoL) in Adolescent Patients with Hepatitis C Genotype 1 (GT1) Treated with Sofosbuvir (SOF) and Ledipasvir (LDV), American Association for the Study of Liver Diseases. Boston, November 11, 2016. |
| 166 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Sharon Hunt, Christophe Bureau, Neil Inhaber, Rajiv Jalan. Patients with Refractory Ascites Treated with alfapump® System (AP) have Better Health-related Quality of Life (HRQL) as Compared to those Treated with Large Volume Paracentesis (LVP): Results of a Multicenter Randomized Controlled Study, American Association for the Study of Liver Diseases. Boston, November 11, 2016. |
| 167 | Zobair M Younossi, Maria Stepanova, Kwang-Hyub Han, Sook-Hyang Jeong, Seung-Woon Paik, Ting-Tsung Chang, Chi-Jen Chu, Henry Lik-Yuen Chan, Ching-Lung Lai, Sharon Hunt. A Mild and Reversible Health Related Quality of Life (HRQL) Impairments is observed in Asian Patients with Hepatitis C Virus (HCV) Infection Who Are Treated with Ribavirin-Containing Regimens, Asian Pacific Digestive Week. Kobe, November 02, 2016. |
| 168 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Mercedes Walters, Fatema Nader, Sharon Hunt. Improvement of Health-related Quality of Life(HRQL) Scores in Japanese Cirrhotic Patients with Chronic Hepatitis C(CH-C) who are Treated with Sofosbuvir(SOF)-Containing Regimens, Asian Pacific Digestive Week. Kobe, November 2, 2016. |
| 169 | Zobair M Younossi, Maria Stepanova, Kwang-Hyub Han, Young-Suk Lim, Youn-Jae Lee, Wan-Long Chuang, Jia-Horng Kao, Rong-Nan Chien, Ting-Tsung Chang, Cheng-Yuan Peng. Asian Patients with Hepatitis C (HCV) Genotype 1 Treated with Ledipasvir and Sofosbuvir (LDV/SOF) Experience Very High Efficacy and Improvement of Health-related Quality of Life (HRQL), Asian Pacific Digestive Week. Kobe, November 02, 2016. |
| 170 | Zobair M Younossi, Maria Stepanova, Sharon Hunt. Development of A Validated Disease-Specific Health-Related Quality (HRQL) Instrument for Patients with Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): CLDQ-NAFLD (ADA), American Diabetes Association. New Orleans, La, June 10, 2016. |
| 171 | Zobair M Younossi, Linda Henry, Maria Stepanova, Youssef Younossi, Sharon Hunt, Rachel Beckerman. Non-alcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes (DM): A Costly Combination, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 172 | Aaron B. Koenig, Maria Stepanova, Sammy Saab, Aijaz Ahmed, Robert John Wong, Trevor Gogoll, Zobair M Younossi. Long-Term Outcomes of Lung Transplantation in Patients with Hepatitis C Infection: The Data from the U.S. Transplant Registry, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 173 | Mehmet Sayiner, Maria Stepanova, Huong T. Pham, Bashir Noor, Mercedes Walters, Zobair M Younossi. Health-Related Quality of Life and Health Utilities in Patients with Non-alcoholic Fatty Liver Disease, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 174 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, Norbert Brau, Stuart Roberts, Nezam H. Afdhal, Fatema Nader, Sharon Hunt. Ribavirin-Free Regimen with Velpatasvir and Sofosbuvir is Associated with High Efficiency and Improvement of Patient-Reported Outcomes in Patients with Genotypes 2 and 3 Chronic Hepatitis C: Results From ASTRAL-2 and 3 Clinical Trials, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 175 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Fatema Nader, Sharon Hunt. Patient-Reported Outcomes in Chronic Hepatitis C Patients with Cirrhosis Treated with Ribavirin-Containing Regimens: Sofosbuvir/Velpatasvir and Ribavirin or Sofosbuvir and Ribavirin, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 176 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Ira M. Jacobson, Kosh Agarwal, Christophe Hezode, Sharon Hunt. The Use of Sofosbuvir and Velpatasvir is Associated with High Efficacy and Improvement in Patient-Reported Outcomes in Patients with Genotype 1, 2, 4, 5 and 6 Chronic Hepatitis C: Results from the ASTRAL-1 Clinical Trials - (DDW), Digestive Disease Week. San Diego, May 21, 2016. |
| 177 | Leo Mclaughlin, Sean C. Felix, Zahra Younoszai, Thomas Jeffers, Ossman Cossio, Ameeta Kumar, Hussain Allawi, Maria Stepanova, Jason Poff, Bryan Raybuck, Sharon Hunt, Zobair M Younossi. Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease in Patients Undergoing Coronary Angiography, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 178 | Spencer Frost, James M. Estep, Kellie Perry, Sean C. Felix, Leo Mclaughlin, Brian P. Lam, Maria Stepanova, Pegah Golabi, Lynn Gerber, Zobair M Younossi. Interferon lambda 4 (IFN-λ4) genotype is associated with fatigue in patients with chronic hepatitis C (CH-C) receiving direct-acting antiviral (DAA) treatment, Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 179 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Fatema Nader, Sharon Hunt. FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN , International Society of Pharmacoeconomics and Outcomes Research. Washington, DC, May 21, 2016. |
| 180 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Fatema Nader, Sharon Hunt. HEALTH UTILITY ASSESSMENT IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS TREATED WITH INTERFERON-FREE REGIMENS , International Society of Pharmacoeconomics and Outcomes Research. Washington, DC, May 21, 2016. |
| 181 | Leyla de Avila, Maria Stepanova, Mariam Afendy, Issah Younossi, Huong T. Pham, Rebecca Cable, Amanda Morgan, Lynn Gerber, Zobair M Younossi. Chronic Liver Disease (CLD) is Associated with Significant Health Care Expenditure in the United States (U.S.), Digestive Disease Week. San Diego, CA, May 21, 2016. |
| 182 | Maria Stepanova, Mehmet Sayiner, Leyla de Avila, Zahra Younoszai, Andrei Racila, Zobair M Younossi. LONG-TERM OUTCOMES IN LIVER TRANSPLANT RECIPIENTS TRANSPLANTED FROM HCV-POSITIVE DONORS, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 183 | Maria Stepanova, Leyla de Avila, Thomas Jeffers, Robert John Wong, Aijaz Ahmed, Zobair M Younossi. LONG-TERM OUTCOMES OF HEART TRANSPLANT RECIPIENTS WITH HEPATITIS C INFECTION, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 184 | Zobair M Younossi, Linda Henry, Maria Stepanova, Youssef Younossi, Andrei Racila, Sharon Hunt, Rachel Beckerman. THE ECONOMIC AND CLINICAL BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 185 | Zobair M Younossi, Maria Stepanova, Jordan J Feld, Stefan Zeuzem, Mark S. Sulkowski, Graham R. Foster, Alessandra Mangia, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Sharon Hunt. IMPRESSIVE GAINS IN PATIENT-REPORTED OUTCOMES ARE OBSERVED IN CHRONIC HEPATITIS C PATIENTS WITH OR WITHOUT CIRRHOSIS WHO ARE TREATED WITH SOFOSBUVIR AND VELPATASVIR: RESULTS FROM ASTRAL-1, -2, -3 AND -4, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 186 | Pegah Golabi, Elzafir Elsheikh Abdelrahman, Azza Karrar, James M. Estep, Issah Younossi, Maria Stepanova, Lynn Gerber, Zobair M Younossi. THE LEVELS OF MONOAMINE NEUROTRANSMITTERS IN HCV PATIENTS TREATED WITH LEDIPASVIR (LDV)/SOFOSBUVIR (SOF), European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 187 | Zobair M Younossi, Maria Stepanova, Michael R. Charlton, Jacqueline G O'Leary, Michael P. Curry, Robert S. Brown, Sharon Hunt. EFFICACY AND PATIENT-REPORTED OUTCOMES IN DECOMPENSATED CIRRHOTIC WITH CHRONIC HEPATITIS C TREATED WITH SOFOSBUVIR AND VELPATASVIR WITH OR WITHOUT RIBAVIRIN: RESULTS FROM ASTRAL-4 CLINICAL TRIAL (abstract), European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 188 | Zobair M Younossi, Azza Karrar, Mariaelena Pierobon, Maria Stepanova, Jeiran Kianoush, Kimberly Reeder, Thomas Jeffers, Zahra Younoszai, Zachary Goodman, Emanuel F. Petricoin. PHOSPHOPROTEOMIC ANALYSIS OF INTRACELLULAR SIGNALING IN THE HUMAN HEPATIC TISSUE OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND FIBROSIS, European Association for the Study of the Liver. Barcelona, Spain, April 2016. |
| 189 | Zobair M Younossi, Maria Stepanova, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Linda Henry. Work Productivity Impairment in Asian Patients with Hepatitis C Treated with Different Regimens, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016. |
| 190 | Zobair M Younossi, Maria Stepanova, Masao Omata, Masashi Mizokami, Sharon Hunt. Quality of Life of Japanese Patients with Chronic Hepatitis C Treated with Ledipasvir and Sofosbuvir (poster), Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016. |
| 191 | Zobair M Younossi, Maria Stepanova, Masashi Mizokami, Masao Omata, Sharon Hunt. Higher Quality of Life Gains in Japanese Hepatitis C Patients treated with Ledipasvir/Sofosbuvir , Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016. |
| 192 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. HCV Patients Treated with IFN‐Free Regimens Experience Improvement of Patient-Reported Outcomes, Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016. |
| 193 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Predictors of Adherence to Treatment of Chronic Hepatitis C (CHC), Asian Pacific Association for the Study of Liver. Tokyo, Japan, February 20, 2016. |
| 194 | Zobair M Younossi, Maria Stepanova, Henry Lik-Yuen Chan, Mei Hsuan Lee, Ming-Lung Yu, Yock Young Dan, Moon Seok Choi, Linda Henry. Patient Reported Outcomes (PROs) in Asian Patients with Chronic Hepatitis C (CH-C) Treated with Ledipasvir (LDV) and Sofosbuvir (SOF), Asian Pacific Digestive Week. Medicine (Baltimore). 2016 Mar;95(9):e2702. doi: 10.1097/MD.0000000000002702. |
| 195 | Maria Stepanova, Kathryn Brodie, Aybike Birerdinc, Bashir Noor, Nina Badoe, Zobair M Younossi. In Female Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Presence of Type 2 Diabetes (DM) and Chronic Kidney Disease (CKD) are Independently Associated with the Risk of Mortality, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 196 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Superiority and Durability of Improvements in Work Productivity (WP) and Patient Reported Outcomes (PROs) with Interferon (IFN)-Free and Ribavirin (RBV)-Free Regimens for Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 197 | Pegah Golabi, Mehmet Sayiner, James M. Estep, Elzafir Elsheikh Abdelrahman, Brian P. Lam, Huong T. Pham, Maria Stepanova, Zobair M Younossi. Treatment of Hepatitis C Virus with Direct Acting Antivirals (DAA) and Ribavirin (RBV) is Associated with Changes in Serum Apolipoprotein and TNF-alpha Levels, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 198 | Zobair M Younossi, Maria Stepanova, Linda Henry, Issah Younossi, Ali Weinstein, Fatema Nader, Sharon Hunt. Reduced Work Productivity (WP), Absenteeism and Presenteeism of Patients Infected with Hepatitis C Virus (HCV) are Independently Predicted by Physical Component of Patient-Reported Outcomes (PROs), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 199 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Linda Henry, Sharon Hunt. Sofosbuvir (SOF) and Ledipasvir (LDV) Improves Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) , American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 200 | Zobair M Younossi, Maria Stepanova, James M. Estep, Azza Karrar, Bibiana Oe, Elzafir Elsheikh Abdelrahman, Siddharth Hariharan, Kazi Ahmed, Patricia Tran, Fatema Nader, Linda Henry, Ali Weinstein, Lynn Gerber. TNF-alpha is the Most Consistent Predictor of Impairment of Mental Health-Related Patient-Reported Outcomes (PROs) in Patients with Chronic Hepatitis C (CH-C) Treated with Ledipasvir (LDV) and Sofosbuvir (SOF) with or without Ribavirin (RBV), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 201 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Interferon (IFN), Ribavirin (RBV), Duration of Treatment and Baseline Patient-Reported Outcomes (PROs) Predict Adherence to the New Regimens for Treatment of Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 202 | Zobair M Younossi, Maria Stepanova, Sarah Elfeky, A. Rose Srishord, Carey Escheik, Leo Mclaughlin, Mariam Afendy, Robert John Wong, Aijaz Ahmed, Sharon Hunt. The Prevalence and Mortality of Chronic Liver Disease (CLD) in the Baby Boomer Cohort (BB) in the United States, American Association for the Study of Liver Diseases. San Francisco, November 13, 2015. |
| 203 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. The Impact of Interferon (IFN)-Free Regimens for Treatment of Hepatitis C Viral (HCV) Infection on Health Related Quality of Life (HRQL), Fatigue and Work Productivity, American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 204 | Issah Younossi, Ali Weinstein, Maria Stepanova, Sharon Hunt, Zobair M Younossi. Mental and Emotional Impairment in Patients with Hepatitis C is related to Lower Work Productivity, American College Gastroenterology. Honolulu,HI, October 16, 2015. |
| 205 | Linda Henry, Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Zobair M Younossi. Depression and Chronic Hepatitis C (CH-C): A Common and Costly Association, American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 206 | Zobair M Younossi, Louis L. LaLuna, John J. Santoro, Flavia Mendes, Victor Araya, Natarajan Ravendhran, Lisa Pedicone, Idania Lio, Fatema Nader, Sharon Hunt, Andrei Racila, Maria Stepanova. Implementation of Baby Boomer Hepatitis C (HCV) Screening and Linking to Care in Gastroenterology (GE) Practices: A Multi-Center Pilot Study, American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 207 | Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Linda Henry, Zobair M Younossi. Hepatitis C Virus (HCV) Related Arthritis and Arthralgia: The Epidemiologic and Economic Burden in the United States, American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 208 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader, Sharon Hunt. Adherence to Interferon (IFN) and Ribavirin (RBV)-Free Regimens for Treatment of Chronic Hepatitis C (CH-C): Are There Any Associations with Clinical and Patient-Reported Outcomes (PROs)? , American College Gastroenterology. Honolulu, HI, October 16, 2015. |
| 209 | Zobair M Younossi, Nathaniel Smith, Maria Stepanova, Ashley S. Brown, Maria Buti, Stefano Fagiuoli, Stefan Mauss, William Rosenberg, Ankur Srivastava, Yushan Jiang, Rachel Beckerman. The Impact of Sustained Viral Eradication on the Work Productivity of Patients with Chronic Hepatitis C (CHC) from the Five Western European Countries and the United States, Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 210 | Zobair M Younossi, Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Linda Henry. A Meta-analytic Estimation of the Burden of Extra Hepatic Manifestations of Hepatitis C, Digestive Disease Week. Washington D.C., May 16, 2015. |
| 211 | Zobair M Younossi, Haesuk Park, Ayoade Adeyemi, Maria Stepanova, Divya Goel, Bashir Noor. Patient Reported Outcomes (PROs) in Chronic Hepatitis C (CH-C): A Meta Analysis of Health Related Quality of Life (HRQL) and Fatigue Data, Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 212 | Lynn Gerber, James M. Estep, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Carey Escheik, Zobair M Younossi. Improvement of Central and Peripheral Fatigue and Associated Biomarkers After Sustained Virologic Response (SVR) with Ledipasvir (LDV)/Sofosbuvir (SOF) in Patients with Chronic Hepatitis C Virus (CH-C), Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 213 | Stephen C. Clement, Maria Stepanova, Olivier Libert, Sammy Saab, Aijaz Ahmed, Zobair M Younossi. Presence of Diabetes and Chronic Liver Disease is Associated with an Increased Risk for Overall Mortality: A Population Study from the United States, Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 214 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Brian P. Lam, Mariam Afendy, Rebecca Cable, Sharon Hunt. Improvement of Patient-Reported Outcomes in Older Patients with Chronic Hepatitis C (CH-C) Treated with Interferon- and Ribavirin-Free Sofosbuvir (SOF)-Containing Regimens, Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 215 | Zobair M Younossi, Maria Stepanova, Stephen C. Clement, Sean C. Felix, Irfan Ali, Shirley Kalwaney, Aybike Birerdinc, Tasneem Shaikh, Keanu Lee, Manirath Srishord. Low Rates of Vaccination against Hepatitis B in Patients with Chronic Liver Disease and Type 2 Diabetes, Digestive Disease Week. Washington, D.C., May 16, 2015. |
| 216 | Haesuk Park, Ayoade Adeyemi, Linda Henry, Maria Stepanova, Zobair M Younossi. ASSOCIATION OF HEPATITIS C VIRUS INFECTION WITH RISK OF CHRONIC KIDNEY DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS , International Society of Pharmacoeconomics and Outcomes Research. Philadelphia, PA, May 16, 2015. |
| 217 | Zobair M Younossi, Maria Stepanova, Linda Henry, Fatema Nader. The Quality of Life Journey for Patients with Chronic Hepatitis C: From Interferon and Ribavirin to Interferon-Free and Ribavirin-Free Regimens, European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 218 | Zobair M Younossi, Maria Stepanova, Linda Henry, Haesuk Park, Andrei Racila, Zahra Younoszai, Sharon Hunt. Direct Medical Costs Associated with the Extrahepatic Manifestations of Hepatitis C Infection in the United States, European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 219 | Ryan Perumpail, Marcus H James, Randy Liang, Andy Liu, Anne Laurain, Sammy Saab, Maria Stepanova, Zobair M Younossi, Olivier Libert, Aijaz Ahmed. Higher Survival in Baby Boomers Following Liver Transplantation: An Analysis of the UNOS Database, European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 220 | Zobair M Younossi, Elzafir Elsheikh Abdelrahman, Maria Stepanova, Lynn Gerber, Fatema Nader, Diana Brainard, John McHutchison. Ledipasvir (LDV)/Sofosbuvir (SOF) Treatment of Hepatitis C Virus (HCV) is Associated with Reduction of Serum Apolipoprotein Levels, European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 221 | Zobair M Younossi, Maria Stepanova, Stanislas Pol, Jean-Pierre Bronowicki, Maria Patrizia Carrieri, Marc Bourliere. The Impact of Ledipasvir (LDV)/Sofosbuvir (SOF) Combination on Health-Related Quality of Life (HRQL) and Patient-Reported Outcomes (PROS) in Cirrhotic Patients with Chronic Hepatitis C (CH-C): The SIRIUS Study , European Association for the Study of the Liver. Vienna, Austria, April 2015. |
| 222 | Zobair M Younossi, Maria Stepanova, Fatema Nader, Linda Henry, Sharon Hunt. INTERFERON- AND RIBAVIRIN-FREE REGIMEN WITH LEDIPASVIR AND SOFOSBUVIR IMPROVES FATIGUE AND VITALITY DURING TREATMENT AND AFTER ACHIEVING SUSTAINED VIROLOGIC RESPONSE, Asian Pacific Association for the Study of Liver. Istanbul, Turkey, March 2015. |
| 223 | Maria Buti, Maria Stepanova, Zobair M Younossi. Impact of Sofosbuvir/Ledipasvir treatment on the economic burden associated to productivity loss due to chronic hepatitis C in Spain, ASOCIACIÓN ESPAÑOLA DEL ESTUDIO DEL HÍGADO. Madrid. February 01, 2015. |
| 224 | Zobair M Younossi, Maria Stepanova, Brian P. Lam, Manirath Srishord, Spencer Frost, Huong T. Pham, Andrei Racila, Mariam Afendy, Thomas Jeffers. Interferon (INF)-Free Regimens for Chronic Hepatitis C (CHC): Barriers to Treatment Candidacy and Insurance Coverage, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 225 | DC Alsop, Zobair M Younossi, Maria Stepanova, Nezam H. Afdhal. Cerebral MR spectroscopy and patient-reported mental health outcomes in hepatitis C genotype 1 naïve patients treated with ledipasvir and sofosbuvir, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 226 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Gregory Trimble, Alita Mishra, Shirley Kalwaney, Zahra Younoszai, Fatema Nader, Linda Henry. Hepatitis C Virus Infection is an Independent Predictor of Post-Liver Transplant Diabetes: Data from the U.S. Scientific Registry of Transplant Recipients, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 227 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon Hunt. Treatment with Interferon (IFN) and Ribavirin (RBV)-Free Regimens with Ledipasvir (LDV) and Sofosbuvir (SOF) Improves Patient-Reported Outcomes (PRO) for Patients with Genotype 1 Chronic Hepatitis C (CH-C): Results from the ION-1,2 and 3 Clinical Trials, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 228 | Zobair M Younossi, Maria Stepanova, Francesco Negro, James M. Estep, Paul Clark, Sharon Hunt, Lisa Kratz, Qinghua Song, Matthew Paulson, Luisa Stamm, Diana Brainard, Mani Subramanian, John McHutchison, Keyur Patel. Serum Lipid and Sterol Analysis in Hepatitis C (HCV) Genotype 2 and 3 Infections Treated with Sofosbuvir (SOF) and Ribavirin (RBV) Regimens, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 229 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Kameron Tavakolian, Brian P. Lam, Manirath Srishord, Chapy Venkatesan, James Cooper, Homan Wai, Linda Henry. Outcomes of Liver Transplantation in Patients with Hepatitis C and Hepatocellular Carcinoma (HCC): The U.S. Transplant Registry Data, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 230 | Zobair M Younossi, Yushan Jiang, Nathaniel Smith, Maria Stepanova, Rachel Beckerman. Sofosbuvir-Containing Regimens for Chronic Hepatitis C (CHC) Infection: Insights from a Work Productivity Economic Model, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 231 | Zobair M Younossi, Maria Stepanova, Sammy Saab, Kelly Hoyle, Rebecca Cable, Alita Mishra, Stephen C. Clement, Sharon Hunt. Patients with Non-Alcoholic Steatohepatitis are at High Risk of Developing Post-Transplant Diabetes, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 232 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon Hunt. Sustained Virologic Response with Ledipasvir (LDV) and Sofosbuvir (SOF) Regimens Leads to Substantial Improvement in Patient-Reported Outcomes (PROs) Among Chronic Hepatitis C (CHC) Patients with Early Hepatic Fibrosis as Well as Those with Advanced Hepatic Fibrosis, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 233 | Zobair M Younossi, Maria Stepanova, Mark S. Sulkowski, Susanna Naggie, Sharon Hunt. Patient-Reported Outcomes (PROs) in HIV-HCV Co-infected Patients Treated with Sofosbuvir (SOF)-containing Regimens , American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 234 | James M. Estep, Kellie Perry, Kameron Tavakolian, Zahra Younoszai, Maria Stepanova, Ali Noorzad, Richard Binder, Zobair M Younossi. Interferon Lambda-4 (IFNL4) TT allele is associated with lower expression of genes associated with early inflammation after initiation of treatment, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 235 | Azza Karrar, Li Zheng, Ali Moosvi, Siddharth Hariharan, Yun Fang, Maria Stepanova, Zachary Goodman, Zobair M Younossi. HLA Class II Alleles Are Strongly Associated with Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Fibrosis, American Association for the Study of Liver Diseases. Boston, MA, November 2014. |
| 236 | Zobair M Younossi, Azza Karrar, Rohini Mehta, Siddharth Hariharan, Keanu Lee, Maria Stepanova, Zachary Goodman. HLA-A11 Gene Loci Is Strongly Predictive of Susceptibility to Severe Hepatic Steatosis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD), American College Gastroenterology. Philadelphia, PA, October 2014. |
| 237 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Kris V. Kowdley, Stefan Zeuzem, Linda Henry, Sharon Hunt. Health Related Quality of Life (HRQL) and Health Utilities (HU) of Patients with Chronic Hepatitis C (CH-C) Treated with an Interferon (IFN)-Free Regimen Containing Ledipasvir (LDV) and Sofosbuvir(SOF), American College Gastroenterology. Philadelphia, PA, October 2014. |
| 238 | Azza Karrar, Ali Moosvi, Maria Stepanova, Siddharth Hariharan, Li Zheng, Zachary Goodman, Zobair M Younossi. HLA Class II Alleles Are Associated to Histological Inflammatory Features of Steatohepatitis (NASH), American College Gastroenterology. Philadelphia, PA, October 2014. |
| 239 | Zobair M Younossi, Ali Weinstein, Maria Stepanova, Sharon Hunt, Carey Escheik, Fatema Nader, Manirath Srishord, Lynn Gerber. Factor Analysis Identifies Types of Fatigue in Patients with Hepatitis C and Their Relationships to Health Related Quality of Life (HRQL), Work Productivity and Activity Impairment , Digestive Disease Week. Chicago, IL, May 2014. |
| 240 | Maria Stepanova, Sharon Hunt, Sammy Saab, Spencer Frost, Thomas Jeffers, Zobair M Younossi. Outcomes of Liver Transplantation in the United States: What Has Changed Over the Last 25 Years?, Digestive Disease Week. Chicago, IL, May 2014. |
| 241 | Azza Karrar, Sneha Lingam, Elena Younossi, Sharon Hunt, Zahra Younoszai, Maria Stepanova, Zachary Goodman, Zobair M Younossi. Human H-ficolin Is Independently Associated with Non Alcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH), Digestive Disease Week. Chicago, Illinois, May 2014. |
| 242 | Azza Karrar, Sneha Lingam, Elena Younossi, Sharon Hunt, Zahra Younoszai, Maria Stepanova, Zachary Goodman, Zobair M Younossi. Pentraxins are independently associated with non-alcoholic Steatohepatitis (NASH), Digestive Disease Week. Chicago, IL, May 2014. |
| 243 | Brian P. Lam, James M. Estep, Fanny Monge, Lakshmi Alaparthi, Zachary Goodman, Yun Fang, Maria Stepanova, Zobair M Younossi. Inflammatory Cytokines Are Associated with Hepatic Steatosis and Fibrosis Measured by Computer-Assisted Morphometry (CAM) in Patients with Non-Alcoholic Fatty Liver disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), Digestive Disease Week. Chicago, IL, May 2014. |
| 244 | Zobair M Younossi, Maria Stepanova, Patrick Marcellin, Nezam H. Afdhal, Sharon Hunt. Ledipasvir (LDV) and Sofosbuvir (SOF) Combination Improves Patient-Reported Outcomes (PRO) During Treatment of Chronic Hepatitis C (CH-C): The Result from ION-1 Clinical Trial, European Association for the Study of the Liver. London, UK, April 2014. |
| 245 | Zobair M Younossi, Maria Stepanova, Lynn Gerber, Fatema Nader, Spencer Frost, Sharon Hunt. Improvement of Central Fatigue is Associated with Sustained Virologic Response (SVR) Following Sofosbuvir (SOF) Containing Regimens, European Association for the Study of the Liver. London, UK, April 2014. |
| 246 | Zobair M Younossi, Maria Stepanova, Stefan Zeuzem, Hendrik W. Reesink, Ola Weiland, Fatema Nader, Sharon Hunt. Health-related Quality of Life (HRQL) and Patient-reported Outcomes (pros) assessment in chronic hepatitis C (Ch-C) treated with Sofosbuvir (SOF) and Ribavirin (RBV): the valence study, European Association for the Study of the Liver. London, UK, April 2014. |
| 247 | Zobair M Younossi, Maria Stepanova, Fatema Nader, David R. Nelson, Eric Lawitz, Ira M. Jacobson, Edward J. Gane, Sharon Hunt. Patient-reported Outcomes (PROs) in Chronic Hepatitis C Patients with Cirrhosis Treated with Sofosbuvir (SOF) Containing Regimens, European Association for the Study of the Liver. London, UK, April 2014. |
| 248 | Zobair M Younossi, Maria Stepanova, Fatema Nader, David R. Nelson, Eric Lawitz, Ira M. Jacobson, Edward J. Gane, Sharon Hunt. Independent predictors of patient-reported outcomes (PROs) and quality of life (QOL) in chronic hepatitis c patients receiving interferon (IFN)-free versus IFN-containing regimens with sofosbuvir (SOF), European Association for the Study of the Liver. London, UK, April 2014. |
| 249 | Maria Stepanova, Sammy Saab, Sharon Hunt, Thomas Jeffers, Shirley Kalwaney, Zobair M Younossi. Donor´s and recipient´s diabetes are independently associated with mortality in liver transplant recipients, European Association for the Study of the Liver. London, UK, April 2014. |
| 250 | Zobair M Younossi, Maria Stepanova, Sandrine Cure, Francois Bourhis, Fatema Nader, Sharon Hunt. Estimating health status using EQ5D for chronic hepatitis C (CH-C) patients treated with sofosbuvir (SOF) containing regimens, European Association for the Study of the Liver. London, UK, April 2014. |
| 251 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, David R. Nelson, Fatema Nader, Sharon Hunt, Ira M. Jacobson, Edward J. Gane. Health utilities in patients with Chronic Hepatitis C treated with Sofosbuvir (SOF) containing regimens: results from POSITRON, FISSON, FUSION and NEUTRINO Studies, American Association for the Study of Liver Diseases. Washington, D.C., November 2013. |
| 252 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, David R. Nelson, Curtis L. Cooper, Fatema Nader, Mariam Afendy, Sharon Hunt. Minimal Impact of Sofosbuvir+Ribavirin (SOF+RBV) on Work Productivity of Patients with Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. Washington, D.C., November 1-5, 2013. |
| 253 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, David R. Nelson, Fatema Nader, Spencer Frost. Successful Treatment with Sofosbuvir Regimen Improves Fatigue Scores in Patients with Chronic Hepatitis C (CH-C), American Association for the Study of Liver Diseases. Washington, D.C., November 2013. |
| 254 | Zobair M Younossi, Maria Stepanova, Linda Henry, James Cooper, Shirley Kalwaney, Chapy Venkatesan, Alita Mishra. Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS) is an Independent Predictor of Mortality in Patients with NAFLD, American Association for the Study of Liver Diseases. Washington, D.C., November 2013. |
| 255 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, Fatema Nader, Sharon Hunt, David R. Nelson, Lynn Gerber. Successful Treatment with Sofosbuvir (SOF) Regimen Improves Patient-Reported Outcomes (PROs) in Patients with Chronic Hepatitis C (CH-C), American College Gastroenterology. San Diego, CA, October 11-16, 2013. |
| 256 | Zobair M Younossi, Maria Stepanova, Eric Lawitz, Fatema Nader, Sharon Hunt, David R. Nelson. Health-related Quality of Life (HRQL) in Chronic Hepatitis C (CH-C) Patients Treated with Sofosbuvir Containing Interferon-Free Regimens, International Society of Pharmacoeconomics and Outcomes Research. Buinos Aires, Argentina, September 12-14, 2013. |
| 257 | Zobair M Younossi, Maria Stepanova, Timothy Leslie, Brian P. Lam, Rebecca Cable, Manirath Srishord. Association with Chronic Liver Disease (CLD) with Food Sources in the United States, Digestive Disease Week. Orlando, May 18, 2013. |
| 258 | Zobair M Younossi, Maria Stepanova, Alita Mishra, Heshaam Mir, Fatema Nader, Rebecca Cable. Chronic Liver Disease and Its Impact on Medicare Spending for Outpatient Care, Digestive Disease Week. Orlando, May 18, 2013. |
| 259 | Zobair M Younossi, Li Zheng, Gregory Trimble, Alita Mishra, Maria Stepanova, James Cooper. Liver Related and Overall Mortality of Patients with Alcohol Related Liver Disease, Digestive Disease Week. Orlando, May 18, 2016. |
| 260 | Zobair M Younossi, Maria Stepanova, Homan Wai, Manirath Srishord, Sammy Saab, Madeline Erario. The Inpatient Economic and Mortality Assessment for Liver Transplantation: A Nationwide Study of the United States Data from 2005 to 2009, Digestive Disease Week. Orlando, May 18, 2013. |
| 261 | Zobair M Younossi, Alita Mishra, Maria Stepanova, Shirley Kalwaney, Chapy Venkatesan, Mariam Afendy. Trend in Outpatients Resource Utilizations Among Medicare Beneficiaries with Chronic Hepatitis C: From 2005 to 2010, Digestive Disease Week. Orlando, FL, May 18 - 21, 2013. |
| 262 | Zobair M Younossi, Maria Stepanova, Alita Mishra, Chapy Venkatesan, Fatema Nader, Gregory Trimble. The Impact of Chronic Hepatitis C (CH-C) on the Inpatient Resource Utilization and Mortality for Medicare Beneficiaries between 2005 to 2010, Digestive Disease Week. Orlando, FL, May 18- 21, 2013. |
| 263 | Zobair M Younossi, Maria Stepanova, Heshaam Mir, Ira M. Jacobson, Edward J. Gane, Fatema Nader, Sharon Hunt. MINIMAL IMPACT OF SOFOSBUVIR+RIBAVIRIN ON HEALTH RELATED QUALITY OF LIFE (HRQL) COMPARED TO PEGYLATED INTERFERON+RIBAVIRIN FOR CHRONIC HEPATITIS C (CH-C): RESULTS FROM FISSION+POSITRON STUDIES, European Association for the Study of the Liver. Amsterdam, The Netherlands, April 2013. |
| 264 | Zobair M Younossi, Heshaam Mir, Maria Stepanova, Chapy Venkatesan, Li Zheng. The Impact of Moderate and Excessive Alcohol Consumption on the Long-Term Outcomes of Patients with Chronic Hepatitis C (CH-C), European Association for the Study of the Liver. Amsterdam, Netherlands, April 2013. |